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Chapter 1 
General introduction 
Alzheimer’s disease (AD) is the most common cause of dementia affecting 
approximately 1% of the population of 65 years old and up to 22% of the persons of 90 
years and older (Lobo et al. 2000). Progressive neurodegeneration results in overall 
cognitive impairment (Katzman 1986) difficulty with activities of daily living (Galasko 
et al. 1997), a variety of neuropsychiatric symptoms (Assal & Cummings 2002; Mega et 
al. 1996), circadian rhythm disruption (Van Someren et al. 1996), and sleep 
disturbances (Tractenberg et al. 2003). Caring for an AD patient places an enormous 
strain on family members (Pinquart & Sorensen 2003; Rabins 1998) and the economic 
burden of the disease to society is large and expected to rise considerably due to aging 
of the population (Hebert et al. 2003). 
Pathophysiology 
The pathogenesis of neurodegeneration in AD is not yet fully understood. A sequence 
of events starting with production and accumulation of beta-amyloid peptide leading to 
formation of neurofibrillary tangles and neuritic plaques followed by cell death is 
articulated in the amyloid cascade hypothesis (Hardy 1992; Hardy & Selkoe 2002). This 
theory is, however, not without controversy (for a review, see: Neve & Robakis 1998) 
and evidence has been put forward by Swaab et al. indicating that presence of beta-
amyloid, tangles, plaques, and cell death are independent phenomena (Swaab et al. 
1998; Swaab et al. 2003). For instance, the amyloid burden in the superior temporal 
sulcus of AD patients appears to be independent of neuronal cell loss and number of 
neurofibrillary tangles (GomezIsla et al. 1997). In addition, neuritic plaques can be 
present in up to 100% of the tissue of certain brain areas of non-demented persons of 
100 years and older (Delaere et al. 1993). Moreover, neurofibrillary tangles and neuritic 
plaques can occur independently in brain tissue of AD patients (Armstrong et al. 1993) 
and, finally, although neurofibrillary tangles coincide with cell death in some brain 
areas, such as CA1 of the hippocampus (West et al. 1994), cell loss in the neocortex of 
AD patients appeared insignificant despite presence of plaques (Regeur et al. 1994). 
 Several studies have shown that cell death in aging and AD is less widespread 
than presumed earlier (Pakkenberg & Gundersen 1997; Regeur et al. 1994; Wickelgren 
1996) and Swaab et al. argue that not cell death but decreased neuronal metabolism is  
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the major pathological hallmark of AD (Swaab 1991; Swaab et al. 1994; Swaab et al. 
1998; Swaab et al. 2003). Diminished neuronal activity is indicated by a decreased size 
of the Golgi apparatus of cells in the nucleus basalis of Meynert (Salehi et al. 1994) and 
the hippocampus (Salehi et al. 1995), brain areas typically affected in AD. Moreover, 
decreased metabolic rate in AD seems consistently correlated with clinical symptoms 
(for a review, see: Blass et al. 2002). Finally, there is evidence that presence of an 
apolipoprotein (APOE) 4 allele, a major risk factor for late onset AD (Corder et al. 
1993; Saunders et al. 1993), is related to extra diminished metabolism in the nucleus 
basalis of Meynert in patients with AD (Salehi et al. 1998), and elderly who do not, yet, 
have AD (Dubelaar et al. 2004). 
“Use it or lose it” 
Swaab et al. also state that high or enhanced metabolism during the process of aging 
may have a beneficial effect on neuronal functioning and survival and that neuronal 
stimulation may protect neurons against degenerative changes in aging and AD, a 
hypothesis which is paraphrased as “use it or lose it” (Swaab 1991; Swaab et al. 1998; 
Swaab et al. 2003). According to Swaab et al., therapeutic strategies in AD should focus 
on reactivation of metabolically impaired neurons through manipulation of trophic 
factors, hormones, neurotransmitters, and environmental stimuli (Swaab 1991; Swaab et 
al. 1998; Swaab et al. 2003). Several observations underline this theory. First, the notion 
that higher educational and occupational attainment appear to have some protective 
value for AD symptomatology (Stern 2002), second, findings that cognitively 
stimulating activities may protect against dementia (Fratiglioni et al. 2004), third, the 
fact that physical activity holds the promise for better mental health of older adults 
(Lautenschlager et al. 2004) and finally, the observation that exposure to bright light 
seems to have a positive effect on the rest-activity rhythm as well as on cognition, 
mood, and behavioral functioning in old age (for a review, see: Van Someren et al. 
2002). 
Peripheral electrical nerve stimulation in AD 
Another way of stimulating the central nervous system externally, i.e. through the 
environment, is the use of peripheral electrical nerve stimulation applied to the skin. In 
the past decades, the effects of peripheral electrical stimulation in AD have been studied 
in a series of placebo-controlled experiments (Scherder et al. 1992; Scherder et al. 1995; 
Scherder et al. 1998; Scherder et al. 1999b; Scherder & Bouma 1999; Van Someren et 
al. 1998). Improvements were found in certain aspects of cognition, behavior, and the 
Introduction 
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rest-activity rhythm. Moreover, a Japanese group replicated effects on cognition and 
found a positive effect on the pupillary light reflex (Guo et al. 2002). Although these 
findings are encouraging, the positive effects of electrical stimulation in AD must be 
interpreted with caution considering the small sample sizes, ranging from 6 (Guo et al. 
2002) to 18 (Scherder et al. 1998). 
Aim of this thesis 
The present thesis examines the effects of peripheral electrical stimulation in a 
substantially larger group of AD patients than any other study on this topic to date. In 
Chapter 2 the literature regarding the effects of peripheral electrical stimulation on 
cognitive and behavioral functioning in several conditions affecting the central nervous 
system will be reviewed including the studies on AD and aging. Chapter 3 deals with 
the stimulation parameters that have been used since the early studies of electrical 
stimulation in AD. These parameters were based on knowledge from animal 
experimental studies up to 1991. The goal of this chapter is to examine whether the 
animal experimental literature since 1991 still supports the originally selected 
stimulation parameters. Chapter 4 examines the effects of electrical nerve stimulation 
on cognition and behavior in a randomized, placebo-controlled, parallel-group clinical 
trial including 62 AD patients. The participants still lived at home and a partner or other 
family caregiver applied the daily treatment, 30 minutes a day, seven days a week, 
during six weeks. Chapter 5 presents data on the effects of electrical stimulation on the 
rest-activity rhythm in AD, derived from the same clinical study as described in the 
previous chapter. Chapter 6 deals with executive dysfunctions in terms of 
neuropsychological deficits in AD patients compared with healthy elderly controls. The 
executive functions are suitable outcome measures for evaluating treatment and the use 
of computerized tests to measure these executive functions is discussed. In Chapter 7, a 
summary and conclusions are offered. 
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Chapter 2 
Effects of Transcutaneous Electrical Nerve 
Stimulation on non-pain related cognitive and 
behavioral functioning 
Abstract 
An extensive search through 9 electronic bibliographic databases (PubMed, Cochrane 
Library, Web of Science, ERIC, PsychINFO, Psyndex, Cinahl, Biological Abstracts, 
Rehabdata) was performed in order to review the effects of Transcutaneous Electrical 
Nerve Stimulation (TENS) on non-pain related cognitive and behavioral functioning. 
Eight studies were identified on neglect due to stroke, six studies on Alzheimer's disease 
(AD), one study on aging, and two studies on coma due to traumatic brain injury. The 
results of the various studies revealed that TENS has a variety of effects. These consist 
of enhancement in somatosensory functioning, visuospatial abilities, and postural 
control in neglect, improved memory, affective behavior, and rest-activity rhythm in 
AD, and acceleration of awakening in coma. Effectiveness of TENS is discussed in 
relation to various stimulation parameters: duration, frequency, pulse width, and 
intensity. It is argued that arousal may underlie the beneficial influence of TENS in 
various conditions. Finally, suggestions are offered for future research.  
 
 
 
 
 
 
 
 
 
Van Dijk KRA, Scherder EJA, Scheltens P, Sergeant JA. Effects of Transcutaneous Electrical Nerve 
Stimulation (TENS) on non-pain related cognitive and behavioral functioning. Reviews in the Neurosciences 
2002;13(3):257-70.
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Introduction 
Transcutaneous Electrical Nerve Stimulation (TENS), a type of peripheral nerve 
stimulation, is particularly known for its analgesic effects in a variety of painful 
conditions, e.g. postoperative pain, cancer pain, and lower back pain (Carrol & Badura 
2001; Mann 1983; Pan et al. 2000). The results of clinical studies on the analgesic 
effects of TENS are, however, equivocal (White et al. 2001) primarily due to 
methodological issues (Wright & Sluka 2001). Lack of standardization of the various 
stimulation parameters (frequency, intensity, and duration of stimulation) makes 
comparison between the various studies difficult. In addition, evaluation of the effects 
of TENS is complicated by the different pain conditions studied (Wright & Sluka 2001). 
It is clear that randomized controlled studies are necessary before firm conclusions can 
be drawn concerning the analgesic effectiveness of TENS. 
 It is noteworthy that in recent studies the effects of TENS have also been 
examined using measures of non-pain related cognitive and behavioral functioning. The 
present paper reviews studies on the effects of TENS on cognitive and behavioral 
functioning in terms of attention, memory, arousal, rest-activity rhythm as well as 
affective behavior and quality of life.  
 To avoid confusion concerning the various types of electrical stimulation, the 
present review will include only those studies in which the original type of TENS has 
been used, i.e. an electrical stimulus applied to the skin and exclusively mediated 
through peripheral afferent nerve fibers. Electrical stimulation applied to the earlobes or 
on the skin of the cranium is sometimes called ‘Cranial TENS’ (Taylor et al. 1989), 
‘Cranial Electro Stimulation’ (CES) (Klawansky et al. 1995) or ‘Transcranial Electro 
Stimulation’ (TCES or TES) (Limoge et al. 1999). A possible explanation for the 
observed effects of Cranial TENS, CES, and TCES/TES on cognition and behavior is 
increased microcirculation in the brain (Omura 1983). Because Cranial TENS, CES and 
TCES/TES might only be partly mediated through the peripheral nervous system 
(Hozumi et al. 1996; Taylor et al. 1989), these types of stimulation will not be included 
in this review.  
 TENS has also been applied to enhance functional ability of a hemiparetic arm 
or leg. This type of TENS is often called ‘functional electrical stimulation’ (FES) 
(Glanz et al. 1996; Johansson et al. 2001; Sonde et al. 2000). Successful rehabilitation 
of a hemiparetic extremity requires, among other things, an increase in muscle strength, 
improved co-ordination between agonists and antagonists (Glanz et al. 1996), and 
(re)learning of motor activity. Although cognitive processes are involved, an early 
report by Ashby and Verrier (1976) suggests that peripheral electrical nerve stimulation 
Review: effects of TENS on non-pain related cognitive and behavioral functioning 
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might reduce muscle tone by activating a spinal inhibitory mechanism. Such a spinal 
mechanism possibly underlies the positive effects of FES and, therefore, a review of the 
effects of FES is beyond the scope of this paper. 
 Following an extensive search1 through nine electronic bibliographic databases 
(PubMed, Cochrane Library, Web of Science, ERIC, PsychINFO, Psyndex, Cinahl, 
Biological Abstracts, Rehabdata), studies on the effects of TENS on cognitive and 
behavioral functioning were narrowed down to the following domains: neglect due to 
stroke, Alzheimer's disease (AD), and aging, and coma due to traumatic brain injury. 
Articles written in English and with more than a single subject were included. After 
examination of the reference lists of relevant studies, eight studies on neglect were 
identified, six studies on AD, one on aging, and two on coma. 
 The review is organized as follows: the results of clinical studies in which the 
effects of TENS on the various patients groups noted above will be discussed. With 
respect to statistical significance, effect sizes2 will be stated if the data were provided in 
the specific article. Subsequently, the effectiveness of TENS on cognition will be 
related to four stimulation parameters: duration, frequency, pulse width, and intensity of 
stimulation. Next, it will be argued that an increase in arousal may underlie the effects 
of TENS on cognition and behavior. Finally, suggestions will be made for future 
research. 
Clinical studies 
TENS in neglect 
Vallar et al. (1995) were among the first to examine the effects of TENS on left 
visuospatial hemineglect in patients who suffered a stroke in the right hemisphere. In 
one experiment the superficial electrodes were placed either to the left or right posterior 
neck, improving performance in 13 out of 14 patients (93%). In another experiment 
TENS was applied either to the left neck or to the dorsal surface of the left hand, both 
leading to improved left visuospatial hemineglect (Vallar et al. 1996). The results 
                                           
 
1
 The most recent search was performed November 2001 
2
 Cohen's d = Μ1 − Μ2 / √[(σ 1²+ σ 2²) / 2], where d = 0.2 is small, d = 0.5 is medium, and d = 0.8 is large 
(Cohen, 1988) 
  
 
Table 2.1 Studies of TENS and neglect (nsa = not stated in article) 
stimulation parameters 
author 
population 
(male/female) n 
 
age site duration frequency intensity 
pulse 
width results 
posterior neck, below the 
occiput, just LEFT of the 
spine 
14 
 
M = 59.07 
range = 
34-80 
posterior neck, below the 
occiput, just RIGHT of the 
spine 
single stimulation period 
of 15-min 
100 Hz 0.5 µA/mm2 100 µs when subjects were free to move 
their head and trunk left 
stimulation improved performance 
on letter cancellation task 
right stimulation did not improve 
performance 
posterior neck, below the 
occiput, just LEFT of the 
spine 
8 
 
M = 59 
range = 
43-67 
posterior neck, below the 
occiput, just RIGHT of the 
spine 
single stimulation period 
of 15-min 
100 Hz 0.5 µA/mm2 100 µs when subjects were not free to 
move their head and trunk, 
stimulation temporarily improved 
cancellation performance as well 
posterior neck, below the 
occiput, just LEFT of the 
spine 
Vallar et al., 
1995 
visual-spatial 
hemineglect, 
right hemisphere 
lesions (nsa1) 
6 
 
M = 70.67 
range = 
65-85 
dorsal surface of the LEFT 
hand 
single stimulation period 
of 15-min 
100 Hz 0.5 µA/mm2 100 µs both hand and neck stimulation 
improved performance levels 
vibration: LEFT posterior 
neck muscle 
nsa 100 Hz 0.4 mm -  improvement of performance on 
cancellation and copy task 
TENS: LEFT posterior 
neck muscle 
nsa 100 Hz substantial non-
painful tingling 
sensation 
nsa little or no effect 
Karnath, 1995 visual neglect due 
to stroke or 
intracranial 
neoplasm (2/2) 
4 
 
M = 54 
range = 
48-61 
vibration: LEFT hand 
muscle   
nsa 100 Hz 0.4 mm -  little or no effect 
single stimulation of 15-
min 
100 Hz 0.5 µA/mm2 100 µs somatosensory 
neglect due to 
stroke in the right 
hemisphere(4/6) 
10 
 
M = 67.6 
range = 
42-81 
posterior neck, below the 
occiput, just LEFT of the 
spine no stimulation - - - 
temporary improvements of 
contralesional somatosensory 
deficits 
single stimulation of 15-
min 
100 Hz 0.5 µA/mm2 100 µs 
Vallar et al., 
1996 
somatosensory 
neglect due to 
stroke in the left 
hemisphere (1/3) 
4 
 
M = 69.75 
range = 
59-79 
posterior neck, below the 
occiput, just RIGHT of the 
spine no stimulation - - - 
beneficial effects in one out of 
four patients only 
TENS: posterior neck, 
below the occiput, just 
LEFT of the spine 
8 weeks, 5 days per week, 
60 minutes 
100 Hz 0.5 µA/mm2 100 µs positive effects in two out of four 
patients 
Pizzamiglio et 
al., 1996 
somatosensory 
hemineglect due to 
stroke in the right 
hemisphere (2/2) 
4 
 
M = 60 
range = 
47-69 
general cognitive 
rehabilitation treatment 
- - - - generalized positive effects  in all 
patients 
 
  
(Table 2.1 continued) 
LEFT neck muscle significantly affecting imaginal 
neglect compared to nostimulation 
RIGHT neck muscle 
single stimulation of 
>20-min 
100 Hz 0.5 µA/mm2, non-
noxious cutaneous 
prickling 
100 µs 
no clear effect compared to no 
stimulation 
Guariglia et 
al., 1998 
hemi neglect due 
to stroke in the 
right hemisphere 
(nsa1) 
9 
 
M = 65.25 
SD = 8.88 
no stimulation - - - -  
single stimulation of 
>20-min 
100 Hz 0.5 µA/mm2 100 µs Guariglia et 
al., 2000 
Hemispatial 
neglect due to 
stroke in the right 
hemisphere (nsa1) 
12 
 
nsa positive electrode: LEFT 
neck muscle below the 
occiput, just lateral to the 
spine 
negative electrode: LEFT 
shoulder 
no stimulation - - - 
TENS significantly improved 
(greatly impaired) ability to code 
shape-based representations 
compared to no stimulation and 
was ineffective in improving (less 
impaired) coding of non-
geometric representations (e.g. 
color). 
TENS condition: single 
stimulation of >10-min 
100 Hz mild tingling  
sensation, roughly 
10mA 
200 µs neglect related 
postural instability 
due to stroke 
with spatial 
neglect (5/1) 
6 
 
 
 sham/control condition: 
single stimulation of 
>10-min 
100 Hz 0.01 x perception 
threshold 
200 µs 
strong improvement of postural 
imbalance 
TENS condition: single 
stimulation of >10-min 
100 Hz mild tingling  
sensation, roughly 
10mA 
200 µs neglect related 
postural instability 
due to stroke 
without spatial 
neglect (11/5) 
16 
 
M = 58.3 
SD = 2.5 
dorsal neck muscle, 
contralateral to the damaged 
hemisphere 
 
sham/control condition: 
single stimulation of 
>10-min 
100 Hz 0.01 x perception 
threshold 
200 µs 
no significant effect of TENS 
Pérennou et 
al., 2001 
healthy subjects 
(9/5) 
14 
 
M = 54.7 
SD = 3 
no stimulation - - - -  
M = 66.5 medial sagittal plane of the 
foot (LEFT vs. RIGHT 
stimulation in both TENS 
and vibration condition) 
TENS 100 Hz adjusted to 2/3 of 
the interval 
between perception 
and unpleasantness 
100 µs decreased rightward orientational 
bias after LEFT and RIGHT 
stimulation 
  vibration 100 Hz moderate pressure 
0.5 mm 
- decreased rightward orientational 
bias after LEFT stimulation 
neglect due to 
stroke in the right 
hemisphere (1/1) 
2 
 
  no stimulation - - - postural imbalance 
2 
 
M = 47  TENS 100 Hz adjusted to 2/3 of 
the interval 
between perception 
and unpleasantness 
100 µs no effect 
   vibration 100 Hz moderate pressure 
0.5 mm 
- no effect  
neglect due to 
stroke in the right 
hemisphere (0/2) 
   no stimulation - - - no postural imbalance 
Richard et al., 
2001 
healthy subjects 
(1/2) 
3 M = 52 no stimulation - - - - no effect 
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suggest that TENS has a non-specific effect regarding the anatomical site (hand versus 
neck), but a specific effect regarding the body laterality (left versus right) which is 
stimulated. 
 In another study, patients with left-sided visuospatial neglect due to stroke 
were treated with either vibration of the left-neck muscle, TENS stimulation of the left 
neck, or vibration of the left hand muscle (Karnath 1995). Because vibration of the left 
neck muscle had clearly more effect than TENS stimulation of the neck and vibration of 
the muscle of the hand, this effect may be considered specific. In contrast, TENS 
activates afferent nerve fibers in a rather non-specific way, resulting in an increased 
level of arousal (Karnath 1995). 
 In a recent study, treatment with both TENS and muscle vibration, applied to 
the left and right side of the neck, had positive effects on a right sided orientation bias in 
patients with visuospatial neglect. In contrast, there was no beneficial effect in subjects 
without neglect (Richard et al. 2001). This non-specific laterality effect needs to be 
interpreted with caution due to the small sample size (n=4). 
 In another study by Vallar et al. (1996), TENS was applied to 14 patients with 
neglect hemianesthesia following a vascular lesion in the right or left hemisphere. The 
site of stimulation was the posterior neck, contralateral to the lesion. Recovery from the 
somatosensory deficit was observed in all patients with a lesion in the right hemisphere, 
irrespective of the presence or absence of visuospatial hemineglect. In one right brain 
damaged patient, the right posterior neck was stimulated with TENS, resulting in an 
increase in the left somatosensory deficit (Vallar et al. 1996). This latter finding 
strengthens the suggestion that TENS has a specific effect on cognitive functioning 
regarding laterality of stimulation. 
 Similar positive and specific effects of TENS in 9 right brain damaged patients 
with visuospatial hemineglect have been observed by Guariglia et al. (1998). TENS was 
applied to the left neck muscle. This appeared to be highly beneficial (effect size: d = 
1.05). In contrast, right neck muscle TENS yielded no significant effects (Guariglia et 
al. 1998). 
 In a study on neglect, it was argued that spatial orientation is dependent on 
different neuronal mechanisms (Guariglia et al. 2000). TENS applied to the left side of 
the neck in stroke patients with neglect improved only orientation guided by the shape 
of the environment (d = 1.08) and not by a visual environmental cue, e.g. color 
(Guariglia et al. 2000). This finding suggests a specific effect of TENS not only for 
laterality of stimulation but also a specific effect for function. Findings from a recent 
study, in which TENS restored the postural instability in neglect patients (n = 6) who  
Review: effects of TENS on non-pain related cognitive and behavioral functioning 
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had a lesion in the temporoparietal area showing a very strong effect (d = 1.90), support 
the idea of TENS acting upon a specific brain function (Perennou et al. 2001). 
 In most studies on neglect, TENS was applied in a single session with a 
duration of 10 to 20 minutes (Guariglia et al. 1998; Guariglia et al. 2000; Karnath 1995; 
Perennou et al. 2001; Vallar et al. 1995; Vallar et al. 1996). In the study by Richard et 
al. (2001) duration of stimulation was unfortunately not stated. There is only one 
publication that reports more than a single stimulation session, i.e. 60 minutes per day, 
five days a week, for a period of eight weeks (Pizzamiglio et al. 1996). In this study, 
TENS was applied to four patients with visuospatial hemineglect in addition to a 
general cognitive intervention. In the eight weeks immediately following TENS 
treatment, patients underwent a purposebuilt rehabilitation training program for neglect. 
Assessment of visuospatial neglect after the first eight weeks revealed no effect of 
TENS. Significant change was observed after the eight weeks of specific rehabilitation 
training (Pizzamiglio et al. 1996). A treatment free period between the two 
interventions, in order to minimize carry-over effects, would have given more insight in 
the effectiveness of TENS. Unfortunately, that was not part of the study design and 
hence, no firm conclusions about the effectiveness of TENS can be drawn. 
 Taken together, TENS appears to have a beneficial effect on somatosensory 
deficits and postural control. Effects on the visuospatial component of neglect are 
equivocal. A major limitation of all studies is the small sample size, i.e. groups ranged 
from 2 to 14 subjects. All studies used a within-subjects design and in only one study 
subjects received sham stimulation (Perennou et al. 2001). See Table 2.1 for an 
overview of the studies of TENS and neglect. 
TENS in Alzheimer's disease (AD) and aging 
In a series of studies, TENS was applied to patients in both an early and an advanced 
stage of AD (Scherder et al. 1992; Scherder et al. 1995; Scherder et al. 1998; Scherder 
et al. 1999b; Scherder & Bouma 1999; Van Someren et al. 1998). Patients were 
stimulated five days a week for six weeks. In one study, TENS was applied for 6 hours 
a day in which high and low frequency were alternated every 1.5 hours (Scherder et al. 
1992). In the other studies, the stimulation period consisted of 30 minutes burst-TENS 
(see section: stimulation parameters). 
 Various aspects of memory were assessed in four of these studies. The results 
suggest that TENS has a beneficial influence on visual short-term memory (d = 0.30) 
(Scherder & Bouma 1999), (d = 0.44) (Scherder et al. 1998), (d = 1.49) (Scherder et al. 
1995), a medium to strong effect on visual long-term memory (d = 0.50) (Scherder et al. 
1998), (d = 1.92) (Scherder et al. 1995), and a high effect on verbal long term memory 
(d = 3.40) (Scherder et al. 1992; Scherder et al. 1995). No effects were found on verbal 
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short term memory in any of the studies (Scherder et al. 1992; Scherder et al. 1995; 
Scherder et al. 1998; Scherder et al. 1999b). Results further suggest that TENS has a 
modest positive effect on verbal fluency (d = 0.28) (Scherder et al. 1992; Scherder et al. 
1998) and affective behavior (d = 0.82) (Scherder et al. 1995), and a small positive 
effect on activities of daily living (ADL), (d = 0.19) (Scherder et al. 1995; Scherder et 
al. 1998). The effect on ADL consisted of a small but significant decline in service 
need. Two other studies report large improvement in coupling between the rest-activity 
rhythm and supposedly stable Zeitgebers in early and advanced AD patients (d = 1.04) 
(Scherder et al. 1999b), (d = 1.86) (Van Someren et al. 1998). This latter finding 
suggests improved functioning of the suprachiasmatic nucleus (SCN), the biological 
clock of the brain (Rusak & Zucker 1979; Van Someren et al. 1998). In addition, a 
medium effect was found for improved activity during the day and less activity during 
the night (d = 0.58) (Scherder & Bouma 1999). This latter finding is particularly 
important, since nocturnal restlessness is one of the main reasons for institutionalization 
of the elderly (Pollak & Perlick 1991). 
 In one study, the effects of TENS were examined in non-demented elderly with 
benign forgetfulness (Scherder et al. 2000). Similar to the effects found in AD, verbal 
and nonverbal long term memory and nonverbal short term memory showed strong 
effects (d = 1.65, d = 2.07, d = 2. 91, respectively). Moreover, strong effects were found 
for verbal fluency and affective behavior which paralleled those observed in AD 
patients (d = 0.96, d = 1.45, respectively). However, a decline in service need was not 
observed (Scherder et al. 2000). 
 It is noteworthy that in all of the above studies in AD and non-demented 
elderly, observed TENS effects were not maintained after six weeks without treatment. 
A major limitation of the TENS-studies in demented and non-demented elderly is that 
the participating groups are relatively small, i.e. experimental and placebo group ranged 
from four to ten subjects. On the other hand, all studies included a control group which 
received sham stimulation.  
 In summary, the effects of TENS in both AD and aging must be interpreted 
with caution considering the relatively small number of patients in each study. The fact 
that the results could be replicated in various studies might be considered as support for 
treatment effects. Treatment effects of TENS in AD and aging are further supported by 
the observation that the effects disappeared after cessation of stimulation. Indeed, TENS 
is not intended to cure AD and, hence, without stimulation the disease progresses 
further. See Table 2.2 for an overview of the studies of TENS and AD. 
  
Table 2.2 Studies of TENS and AD (nsa = not stated in article) 
stimulation parameters 
author 
population 
(men/women) N age site duration frequency intensity pulse width results 
100 Hz perceptual 
threshold 
40 µs 4 (TENS) 
2 Hz strongly 
perceptual, non-
noxious 
250 µs 
Scherder et al., 
1992 
early stage AD 
(1/7) 
4 (sham) 
M = 81.4 
range = 74-91 
 
two electrodes 
between T1 and T5, 
each on one side of 
the spinal column 
6 weeks, 6 hours 
a day: 
alternating 100 
(1.5 hours) Hz 
and 2 Hz.(1.5 
hours) 
- 
- 
- 
TENS improved verbal 
long-term memory and 
verbal fluency. 
No improvement visual 
long-term memory and 
verbal/non-verbal short 
term memory  
8 (TENS) 160 Hz, 
2 bursts 
per sec 
visible painless 
muscular twitches 
40 µs Scherder et al., 
1995 
early stage AD 
(nsa) 
8 (sham) 
M = 84.6 
range = 76-92 
 
 
two electrodes 
between T1 and T5, 
each on one side of 
the spinal column 
6 weeks, 5 days 
per week, 30 
minutes 
- - - 
TENS improved some 
aspects of verbal and non-
verbal short term and long 
term memory. Improved 
affective behavior. 
 6 (TENS) 160 Hz,  
2 bursts 
per sec 
visible painless 
muscular twitches 
100 µs 
8 (sham) 
M = 84 
SD = 1.5 
two electrodes 
between T1 and T5, 
each on one side of 
the spinal column 
6 weeks, 5 days 
per week, 30 
minutes 
- - - 
TENS improved rest-
activity rhythm, i.e. nightly 
restlessness decreased 
van Someren et 
al., 1998 
early stage AD 
(4/18) 
8 (control) M = 77 
SD = 3.5 
- - - - -  
9 ( TENS) 160 Hz,  
2 bursts 
per sec 
visible painless 
muscular twitches 
100 µs Scherder et al., 
1998 
AD  
(nsa) 
9 ( sham) 
M = 83.4 
range = 78-90 
 
two electrodes 
between T1 and T5, 
each on one side of 
the spinal column 
6 weeks, 5 days 
per week, 30 
minutes 
- - - 
TENS improved nonverbal 
short-term and long term 
memory, word fluency. 
Less need of help. No 
improvement in affective 
behavior. 
8 (TENS) (burst 
TENS) 
nsa nsa Scherder et al., 
1999a 
midstage AD 
(nsa) 
7 (sham) 
M = 81.7 
range = 70-91 
 
two electrodes 
between T1 and T5, 
each on one side of 
the spinal column 
6 weeks, 5 days 
per week, 30 
minutes 
- - - 
TENS improved rest-
activity rhythm 
8 (TENS) 160 Hz,  
2 bursts 
per sec 
visible painless 
muscular twitches 
100 µs Scherder et al., 
1999b 
midstage AD 
(nsa) 
8 (sham) 
M = 81.7 
range = 70-91 
two electrodes 
between T1 and T5, 
each on one side of 
the spinal column 
6 weeks, 5 days 
per week, 30 
minutes 
- - - 
TENS improved nonverbal 
short-term memory. No 
treatment effects in 
physical, social and 
affective functioning.  
10 (TENS) M = 85.90 
range = 80-89 
(burst 
TENS) 
nsa nsa Scherder et al., 
2000 
non-demented 
elderly  
(3/17) 10 (sham) M = 87.90 
range = 82-91 
two electrodes 
between T1 and T5, 
each on one side of 
the spinal column 
6 weeks, 5 days 
per week, 30 
minutes 
- - - 
TENS improved visual 
short-term memory, verbal 
long-term memory, 
semantic verbal fluency 
and stimulated subjects felt 
less depressed. 
  
 
 
 
Table 2.3 Studies of TENS and coma (nsa = not stated in article) 
stimulation parameters 
author 
population 
(men/women) N age (years) site duration frequency intensity 
pulse 
width results 
Ingvar and Ciria, 1975 severely brain damaged 
unresponsive patients 
nsa nsa right thumb nsa nsa nsa nsa increased 
cortical blood 
flow 
3 TENS, 2 weeks, 8 hours a 
day, 20 sec/min 
40Hz 20 mA 300 µs 
3 
M = 32 
range = 13-42 
sham, 2 weeks, 8 hours a 
day, 20 sec/min 
- - - 
3 M = 15.3 
range = 14-16 
right median nerve 
2 weeks, 12 hours a day, 20 
sec/min 
40Hz 20 mA 300 µs 
Cooper et al., 1999 
 
comatose 
22 - no stimulation - - - - 
results indicate 
earlier 
awakening from 
coma 
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TENS in Coma 
In the last 20 years, sensory stimulation has become part of brain injury rehabilitation 
programs. LeWinn (1980) describes a Coma Arousal Team which attempted to achieve 
arousal by applying stimulation to all five senses, including tactile stimulation to the 
skin. Compatible types of stimulation applied in a Coma Arousal Procedure produced 
significant (d = 0.59) (Mitchell et al. 1990) and non-significant (Pierce et al. 1990) 
effects in terms of reducing the duration of coma. Cutaneous electrical stimulation 
increased cortical blood flow in, among others, patients who were comatose due to 
severe brain injury (Ingvar & Ciria 1975). In this latter study, low and high intensity 
electrical stimulation of the right thumb provoked a moderate increase in cerebral blood 
flow. Unfortunately, no details were provided on frequency and intensity of stimulation 
(Ingvar & Ciria 1975). Right median nerve stimulation (RMNS), which results in 
sensory evoked potentials (SEPs), has been used to assess brain function and predict 
clinical outcome in comatose patients (Cusumano et al. 1992; Facco et al. 1993). More 
recently, eight to twelve hours daily RMNS by TENS was applied as a therapeutic tool 
in the treatment of brain-injured comatose patients (Cooper et al. 1999). In one 
experiment, three treated patients showed a more rapid recovery from coma, spending 
an average of 7.7 days in the intensive care unit, as opposed to 17.0 days for three 
control patients who were treated with a sham stimulator (Cooper et al. 1999).  
 In another experiment, clinical observations revealed improved language 
capacities (Cooper et al. 1999). The language improvements, shown by recovery of 
speech and capacity to read aloud, might be mediated through stimulation of Broca's 
motor speech area. Although no placebo group was included in this experiment, the 
improvements in the TENS-treated patients appeared to be much faster than the rate of 
recovery of a control group that was not treated (Cooper et al. 1999). See Table 2.3 for 
an overview of the studies of TENS and coma. 
Stimulation parameters 
In the previous section, studies on TENS effects on cognition and behavior in various 
patient groups have been described in some detail. Study design and number of subjects 
have been critically reviewed. This section will address the duration, frequency, pulse 
width and intensity of stimulation, employed in the various studies. 
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Duration 
In studies of neglect, TENS was applied once for 10 to 20 minutes and effects were 
measured immediately following stimulation (Guariglia et al. 1998; Guariglia et al. 
2000; Karnath 1995; Perennou et al. 2001; Vallar et al. 1995; Vallar et al. 1996). 
Follow-up measurement after a delay of 20 to 30 minutes (Perennou et al. 2001; Vallar 
et al. 1995; Vallar et al. 1996) revealed that the effects disappeared. These data suggest 
that the effects of a single stimulation period in neglect are of short duration. 
Unfortunately, in other studies, there was no follow-up measurement at all (Guariglia et 
al. 1998; Guariglia et al. 2000; Perennou et al. 2001; Richard et al. 2001). 
 As far as the authors are aware, there is only one study in which patients with 
visuospatial hemineglect were treated with TENS for more than a single session, i.e. 60 
minutes per day, five days a week, for a period of eight weeks (Pizzamiglio et al. 1996). 
However, no clear treatment effects were observed in that study. 
 AD patients were stimulated 30 minutes a day, five days per week, during six 
consecutive weeks. In one study, the patients were stimulated six hours a day (Scherder 
et al. 1992), but the longer stimulation time yielded no more effects than a treatment of 
30 minutes a day. In contrast, Cooper et al. (1999) stimulated coma patients eight to 
twelve hours per day after which a significant reduction in the duration of coma was 
observed. Because of heterogeneity between the patient groups, no firm conclusions can 
be drawn concerning the most effective duration of stimulation. 
Frequency 
Low-frequency TENS generally implies frequencies between 2 and 10 Hz whereas 
frequencies above 10 Hz are considered high (Roche & Wright 1990). In the studies 
with neglect patients (Guariglia et al. 1998; Guariglia et al. 2000; Karnath 1995; 
Perennou et al. 2001; Pizzamiglio et al. 1996; Richard et al. 2001; Vallar et al. 1995; 
Vallar et al. 1996) and comatose patients (Cooper et al. 1999), 100 Hz and 40 Hz was 
used, respectively. Effects were enhanced somatosensory functioning, visuospatial 
abilities, and postural control in neglect (1.05 < d < 1.90), and reduction in duration of 
coma. 
 In the first TENS study of AD patients (Scherder et al. 1992), high (100 Hz) 
and low frequency (2 Hz) alternated every 1.5 hours during 6 hours per day. Effects 
observed in that study included enhancement in verbal long-term memory and verbal 
fluency. In the other studies on AD and on aging, a combination of 2 Hz and 160 Hz 
(burst-TENS) was used. In those studies, TENS appeared to exert effects on daily life 
activities, (d = 0.19) (Scherder et al. 1995; Scherder et al. 1998), on rest-activity rhythm 
(0.58 < d < 1.86) (Scherder et al. 1999b; Van Someren et al. 1998) as well as on 
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memory (0.28 < d < 3.40) (Scherder et al. 1995; Scherder et al. 1998; Scherder et al. 
1999b; Scherder et al. 2000) and verbal fluency (d = 0.28, d = 0.96) (Scherder et al. 
1998; Scherder et al. 2000). 
Pulse width and intensity  
The intensity of the stimulation in the reviewed studies was non-noxious and varied 
from at to above threshold and, in several studies, provoking mild muscular twitches. 
The pulse width was either 40 µsec, 100 µsec, 200 µsec, or 300 µsec. Strength-duration 
curves on various types of afferent nerve fibers indicate that a stimulus with a pulse 
width of at least 10 µsec but not exceeding 1 msec, in combination with an non-painful 
intensity varying from just at to above threshold is particularly suitable to excite thin-
myelinated A-Delta afferent nerve fibers (Howson 1978). Such a specific combination 
of pulse width and intensity can be applied in either a low- or high-frequency 
stimulation mode. In one study, it was observed that low-frequency TENS (2 Hz) with a 
pulse width of 100 µsec and an intensity 6 times threshold, activated the locus coeruleus 
(LC)/noradrenergic system (Hitoto et al. 1998). On the other hand, high-frequency 
stimulation (e.g. 200 Hz) with a pulse width of 100 µsec and an intensity that provoked 
muscular contractions appeared to be mediated by the raphe-serotonergic system 
(Cheng & Pomeranz 1981). Interestingly, low-frequency stimulation (2 Hz) and a 
combination of high- and low-frequency stimulation (e.g. burst-TENS) with an intensity 
high enough to provoke muscle contractions, are supposed to be conveyed by A-Delta 
nerve fibers (Duranti et al. 1988; Hitoto et al. 1998). 
 In sum, depending on the specific combination of stimulation parameters, the 
LC/noradre-nergic system or the raphe-serotonergic system may be stimulated by low-
frequency and high-frequency TENS, respectively. TENS-bursts might create the 
possibility to stimulate both systems at the same time.  
Arousal: a possible mechanism underlying TENS 
It is argued that an increase in arousal might underlie the observed effects of TENS in 
the various conditions. Robertson et al. (1998) suggested that in right brain damaged 
patients with unilateral neglect, the cortical tonic arousal system is damaged. They 
observed that a non-spatial warning signal presented at the right side improved the 
deficit in left spatial awareness in these patients. This was probably mediated by the 
ascending reticular activating system (ARAS) (Robbins & Everitt 1995). The results of 
another study confirmed a more general attention deficit underlying persistent neglect 
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(Samuelsson et al. 1998). Compared to a control group, the simple reaction times 
measuring cognitive speed were increased in patients with contralateral neglect. The 
phasic arousal system mediated by the projections of e.g. the thalamus to the posterior 
association areas (Samuelsson et al. 1998) might still be intact in these patients 
(Robertson et al. 1998).  
 The ARAS includes several brain stem areas, e.g. the LC and the nucleus raphe 
dorsalis (NRD) (Kayama & Koyama 1998). The LC and NRD are the origins of the 
noradrenergic and serotonergic neurotransmitter systems, respectively (Mann 1983; 
Rossor 1988; Saper 1988). Both brain stem areas have strong connections with the 
nucleus basalis of Meynert (NBM), the prefrontal cortex, the hippocampus, the 
amygdala, the hypothalamus, and the SCN (Bobillier et al. 1976; Legoratti-Sanchez et 
al. 1989; Petrov et al. 1992; Vertes 1991). These areas, which play a role in (working) 
memory, (affective) behavior, and the rest-activity rhythm (Carpenter & Grossberg 
1993; Collette et al. 1997; Salzmann 1992; Swaab 1997), are affected in AD (Blin et al. 
1997; Braak & Braak 1991a; Goudsmit et al. 1990; Haroutunian et al. 1998; Swaab 
1997). In addition, the LC and NRD show severe neuropathology in AD (Arendt et al. 
1997; Braak & Braak 1996; O'Mahony et al. 1994). Atrophy of, among others, the 
frontal lobe, the hippocampus, the amygdala, the hypothalamic SCN, and the LC has 
also been observed in aging (Brody 1992; Coffey et al. 1992; Coleman & Flood 1987; 
Decarli et al. 1994; Swaab 1997). One could speculate that through the ARAS, 
stimulation of these brain structures indirectly contributes to the observed treatment 
effects of TENS. 
 In addition to the role of the ARAS in conveying TENS to subcortical and 
cortical areas, the influence of TENS in AD and aging might also be mediated through 
more direct pathways. TENS could activate e.g. the hippocampus and the hypothalamus 
through spinoseptal and spinohypothalamic pathways, respectively (Burstein & Giesler 
1989; Giesler et al. 1994). In sum, one might argue that the improvements in memory, 
(affective) behavior, and the rest-activity rhythm in AD and aging by TENS result from 
activation of either the ARAS or, indirectly, of adjacent cortical and subcortical areas. 
The rationale underlying the effects on comatose patients was that RMNS also activates 
the ARAS (Cooper et al. 1999). Due to its strong connections with, among others, the 
NBM, which is the origin of the cholinergic ascending pathways to the cerebral cortex 
(Cummings & Back 1998), the ARAS plays a crucial role in wakefulness (Cooper et al. 
1999). In other words: stimulating the ARAS might shorten the duration of coma. 
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Discussion 
Compared to the impressive number of articles on the role of TENS in analgesia, only a 
relatively small number of studies has focused on the influence of TENS on non-pain 
related cognitive and behavioral functioning. As far as the authors are aware, the 
influence of TENS on cognition and behavior has been examined in three patients 
groups, i.e. neglect due to stroke, AD and aging, and coma. Effects of TENS range from 
enhancement in somatosensory functioning, visuospatial abilities and postural control in 
neglect, to improved memory, affective behavior and rest-activity rhythm in AD and 
aging and acceleration of awakening in coma. 
 A major difference across the studies is the duration of stimulation. In the AD 
studies, patients were stimulated daily for six weeks, while in the majority of the neglect 
studies stimulation consisted of a single session of 10 to 30 minutes. The treatment 
effects in AD could not be maintained after a stimulation-free period of six weeks, 
while in the neglect studies, effects disappeared within 20 to 30 minutes. In the AD 
studies, administration of tests and scales to assess treatment effects always took place 
the day following the last stimulation session. Cognitive and behavioral assessment was 
never conducted immediately after application of TENS. Future research could possibly 
provide more information about the rate of decline in treatment effects to the pre-
treatment level of functioning. The fact that effects in AD declined during the six weeks 
without treatment is not surprising considering the progressive nature of the disease. 
Consequently, maintenance of treatment effects in AD probably requires continuous 
stimulation. 
 In stroke, one might expect a more structural recovery because of mechanisms 
such as adaptive plasticity (Nudo et al. 2001). Future studies must show whether a 
longer application of TENS in neglect patients, e.g. six or eight weeks, will prevent a 
decline of treatment effects. The effectiveness of prolonged treatment with TENS is 
supported by the finding that comatose patients showed a structural recovery after they 
were treated with TENS for a longer period, i.e. eight weeks (Cooper et al. 1999). 
 The possibility that TENS stimulates specific (sub)cortical areas, which are 
part of the ARAS, is supported by a recent study using functional Magnetic Resonance 
Imaging (fMRI) (Kwan et al. 2000). In that study, it was observed that TENS applied to 
the right median nerve with an intensity that provoked pain, activated the posterior part 
of the anterior cingulate cortex (ACC). The ACC plays a crucial role in attention (Pardo 
et al. 1990); its stimulation though TENS might have contributed to the treatment 
effects observed in the various studies. Although in the TENS-studies reviewed here, 
the intensity of stimulation was not painful, the intensity did cause motor activity, i.e. 
visible muscular contractions. Interestingly, another fMRI study showed that fine co-
coordinated motor activity of the hand and fingers enhanced the activity of the ACC 
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(Davis et al. 1997). It seems worthwhile to examine whether the ACC might react to 
TENS with an intensity which is painless but which is high enough to cause motor 
activity. This would support the assumption that TENS has an effect on specific 
supraspinal brain areas. In addition, fMRI might reveal whether improved performance 
on cognitive or behavioral functioning is indeed related to an enhanced activity in 
specific areas of the brain. 
 A point of concern is the applicability of TENS in clinical practice. The more 
distal location of the electrodes on the forearm to stimulate the right median nerve of 
comatose patients (Cooper et al. 1999) seems much more practical than the proximal 
location of the electrodes on the trapezius muscle of the AD patients (Scherder et al. 
1995). Placing both electrodes on the trapezius muscle cannot take place without 
personal assistance whereas the subject himself can apply the electrodes on the right 
forearm without additional help. Therefore, in future studies, the effectiveness of RMNS 
should be further examined in other groups of patients, e.g. AD patients. Note that 
applying TENS without personal assistance is not recommended in moderate and 
severely cognitive impaired patients. 
 Finally, TENS might become an attractive non-pharmacological alternative for 
the treatment of cognitive and behavioral disturbances. TENS is simple to apply, very 
well tolerated by elderly persons and is completely safe except for subjects with a 
pacemaker and subjects with epileptic activity (Scherder et al. 1999a). However before 
firm conclusions about the effectiveness of TENS in cognitive and behavioral disorders 
can be drawn, further research in the neurophysiological basis for the mechanisms 
underlying TENS is a prerequisite. 
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Chapter 3 
Activation of dorsal raphe nucleus and locus 
coeruleus by Transcutaneous Electrical Nerve 
Stimulation in Alzheimer’s disease 
A reconsideration of stimulation parameters derived from 
animal experimental studies 
Abstract 
In 1990 a series of studies started, in which the effects of Transcutaneous Electrical 
Nerve Stimulation (TENS) were examined on cognition, behavior, and the rest-activity 
rhythm of patients with Alzheimer’s disease (AD). In those studies, TENS aimed 
primarily at stimulating the dorsal raphe nucleus (DRN) and the locus coeruleus (LC) 
by a combination of low- and high-frequency stimulation (2 Hz and 160 Hz, 
respectively), a pulse width of 0.1 ms, and an intensity that provoked muscular twitches. 
TENS was applied 30 minutes a day, during a six-week period. In order to make reliable 
comparisons between studies, identical stimulation parameters were used in all studies 
thus far. TENS appeared to have a positive effect on cognition, behavior, and the rest-
activity rhythm, but the effects disappeared after cessation of stimulation. In order to 
optimize TENS treatment in AD, the present paper is meant to reconsider the once 
selected stimulation parameters by reviewing the relevant literature published since 
1991. The results derived from animal experimental studies show that for an optimal 
stimulation of the LC and DRN, the pulse width should be more than 0.1 ms. 
Limitations and suggestions for future research will be discussed. 
 
 
 
 
Scherder EJA, Luijpen MW, van Dijk KRA. Activation of dorsal raphe rucleus and locus coeruleus by 
transcutaneous electrical nerve stimulation in Alzheimer’s disease: A reconsideration of stimulation 
parameters derived from animal experimental studies. Chinese Journal of Physiology 2003; 46(4):143-150. 
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Alzheimer’s disease 
Epidemiology 
At the age of 65, the prevalence of dementia is about 1.5% and increases to about 30% 
at the age of 80 (Ritchie & Lovestone 2002). Within dementia, Alzheimer’s disease 
(AD) is the most common cause, affecting 60% to 70% of all cognitively impaired 
elderly. The number of AD patients has been estimated at 2.3 million in the USA 
(Cummings & Cole 2002). The number of new cases of AD each year (incidence) is 
approximately 360.000, implying 40 new cases each hour (Cummings & Cole 2002). 
Besides problems for the individual patients and their surroundings, the increasing 
proportion of elderly people in most countries will cause great burden to health care 
systems and economy in the near future.  
 Since there is no cure for AD at this moment, research on (non-) 
pharmacological interventions that may stabilize or even improve the clinical course of 
the disease is crucial. 
Neuropathology in AD  
AD is characterized by a progressive neuropathology in the temporoparietal, frontal and 
occipital lobes (Coleman & Flood 1987). More specifically, the hippocampus, which 
plays a crucial role in memory (Lisman & Otmakhova 2001), is affected (Braak & 
Braak 1991b; Salehi & Swaab 1999) even in a preclinical stage (Fox et al. 1996). The 
prefrontal cortex, which is involved in executive functions like cognitive flexibility, 
planning, and response inhibition (Duke & Kaszniak 2000) also degenerates in AD 
(Coleman & Flood 1987). Furthermore, the hypothalamus and particularly the 
hypothalamic suprachiasmatic nucleus (SCN), involved in affective behavior and the 
regulation of the circadian rest-activity rhythm, respectively (Swaab 1997; Swaab et al. 
1998; Van Someren et al. 2002), show neuropathological changes in AD (Swaab 1997; 
Swaab et al. 1998). Importantly, nightly restlessness is often the main reason for 
institutionalization (Pollak & Perlick 1991). 
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“Use it or lose it” 
It is noteworthy that the neuropathological hallmark of AD is not cell death but atrophy 
(Swaab et al. 2002). Shrunken cells that still have some metabolism characterize brain 
atrophy. Swaab et al. (2002) provide convincing evidence that the decreased 
metabolism in AD can be enhanced by the reactivation of shrunken cells. This 
reactivation may result from neuronal stimulation that subsequently slows down or even 
restores degenerative processes, a hypothesis that has been paraphrased as “use it or lose 
it” (Swaab 1991). In other words, despite the severe neuropathology in cortical and 
subcortical areas, suppressing clinical symptoms and positively influencing the course 
of this progressive disease by neuronal stimulation is still possible. Neuronal 
stimulation could take place by various types of pharmacological and, interestingly, also 
by non-pharmacological stimuli. An example of a non-pharmacological treatment 
strategy that might enhance the decreased metabolism in AD is Transcutaneous 
Electrical Nerve Stimulation (TENS). 
Transcutaneous Electrical Nerve Stimulation (TENS) in AD 
In the preceding twelve years, TENS has been widely studied in AD patients (Scherder 
et al. 1992; Scherder et al. 1995; Scherder et al. 1998; Scherder et al. 1999b; Van 
Someren et al. 1998). In all but one study, a 30 minutes-a-day and five days-a-week 
TENS treatment was applied to patients in a relatively early stage of AD, based on the 
assumption that the earlier the intervention, the more effective. Each study also included 
a control group that received sham stimulation. Neuropsychological functions, behavior, 
and rest-activity rhythm were assessed at three moments, i.e. before and directly after 
the six-week treatment period, and again after a treatment-free period of six weeks. 
 Except for the first pilot-study (Scherder et al. 1992), the stimulation 
parameters used were exactly the same in all studies. The TENS-device (Premier 10s) 
generated two ‘bursts’ per second (2 Hz) of biphasic impulses with an internal 
frequency of 160 Hz (burst-TENS) (Eriksson et al. 1979). The pulse width was 100 
µsec. Based on animal experimental studies (Cedarbaum & Aghajanian 1978; Cheng & 
Pomeranz 1981) available at that time, it was argued that low-frequency TENS (2 Hz) 
comprising high intensity 0.1 ms spikes could activate the locus coeruleus (LC) whereas 
high-frequency (10 Hz) stimulation comprising the same pulse width and intensity 
increased the activity of the dorsal raphe nucleus (DRN). The DRN and LC are the 
origin of the ascending serotonergic and noradrenergic neurotransmitter systems, 
respectively (Kayama & Koyama 1998), and show neuronal loss in early AD (Lyness et 
al. 2003). Importantly, studies have shown afferent and efferent pathways that connect 
the DRN and LC with the hypothalamus, and specifically with the SCN (Cedarbaum & 
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Aghajanian 1978; Kawano et al. 1996; Krout et al. 2002; Vertes 1991), the 
septal/hippocampal region (Font et al. 1997; Foote et al. 1983; Legoratti-Sanchez et al. 
1989; Vertes 1991), and the frontal lobe (Ritchie & Lovestone 2002; Vertes 1991). 
 Results of the TENS-studies show that, in comparison with a placebo 
treatment, TENS improved nonverbal short-term memory, nonverbal and verbal long-
term recognition memory, and executive functioning (verbal fluency) in AD patients. 
Moreover, TENS had a positive effect on affective behavior, e.g. depressive symptoms 
declined. Another important finding was that nightly restlessness decreased in TENS-
treated patients.  
 Notably, in all studies, after cessation of stimulation the observed 
improvements disappeared. In order to optimize TENS treatment in AD, e.g. 
maintaining positive effects after ending the treatment, the present paper reconsiders the 
once selected stimulation parameters to stimulate primarily the DRN and LC, by 
reviewing relevant literature published since 1991. All reviewed studies are animal 
experimental studies. A frequency of <10 Hz will be considered low and a frequency of 
10 Hz will be considered high (Scherder et al. 1995). 
 The present paper will first focus on indirect electrical stimulation, i.e. 
stimulation through the peripheral nervous system, of the DRN/serotonergic system and 
the LC/noradrenergic system. Subsequently, studies on direct stimulation of both brain 
stem nuclei and its effect on supraspinal areas, particularly the hippocampus, the 
hypothalamus including the hypothalamic SCN, and the prefrontal cortex will be 
presented. Limitations and suggestions for future research are discussed.  
Indirect DRN and LC stimulation 
Increased activity of the DRN, measured by c-fos protein expression, has been observed 
after low-frequency (3 Hz) electro-acupuncture (EA) of Zusanli (St 36) in the hind leg 
of rats (Dai et al. 1992). The intensity was high enough (20 V) to provoke slight 
muscular twitches of the hind limb. The pulse width was 10 ms and the duration of EA 
was 1 hour. An increase in activation of the LC-hypothalamic pathway of aged rats has 
been observed after EA of Shenshu (UB23) (Zhu et al. 2000). Stimulation parameters 
were: a frequency of 4 Hz, an intensity of 1-3 V, a continuous wave pulse form, and a 
duration of stimulation of 3 minutes. No information on the pulse width was provided. 
The LC-noradrenergic neurons of rats could also be activated by sciatic nerve 
stimulation with a frequency of 0.1 Hz, a pulse width of 0.5 ms, and an intensity of 1.3 
mA (Rouzade-Dominguez et al. 2001). The trial consisted of 60 pulses. Again, no 
information on the waveform was provided.  
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 In one study, activation of both the DRN and LC was measured (Kwon et al. 
2000). Zusanli was stimulated with a frequency of 4 Hz or 100 Hz and a pulse width of 
0.5 ms. An intensity of 5 times threshold (mean value 6 V) provoked a muscle twitch. 
Duration of stimulation was 2 hours and the pulse form was biphasic. Results show that 
low-frequency stimulation of 4 Hz had a larger effect on the LC compared to the DRN. 
However, both brain stem areas were equally activated by high-frequency stimulation of 
100 Hz. 
 Taken together, although both brain stem nuclei respond to low- and high-
frequency indirect stimulation, the LC reacts somewhat stronger to low-frequency 
stimulation than the DRN. The various stimulation parameters and concurrent results 
are presented in Table 3.1. 
 
 
Table 3.1 Indirect stimulation of the dorsal raphe nucleus (DRN) and the locus coeruleus (LC) 
Indirect DRN stimulation Pulse form Pulse width Intensity Frequency 
Duration of 
stimulation Results 
Dai and Zhu, 1992 na 10 ms 20 V 3 Hz 1 hour Increased activity DRN 
Kwon et al., 2000 Biphasic impulses 0.5 ms 6 V 
4 Hz and 
100 Hz 2 hours 
Increased activity 
DRN, 
particularly with 100 
Hz 
 
      
Indirect LC stimulation       
Rouzade-Dominquez et al., 
2001 na 0.5 ms 1.3 mA 0.1 Hz 
trial of 60 
pulses Increased activity LC 
Zhu et al., 2000 Continuous 
wave 
na 1-3 V 4 Hz 3 minutes 
Increased activity in 
the brain stem-
hypothalamus pathway 
Kwon et al., 2000 Biphasic impulses 0.5 ms 6 V 
4 Hz and 
100 Hz 2 hours 
Increased activity LC, 
particularly with 4 Hz 
na = not available 
Direct DRN and LC stimulation 
Direct DRN stimulation and the hippocampus 
Ezrokhi et al. (1999) observed that direct high-frequency stimulation of the DRN of rats 
had a beneficial influence on the long-term potentiation (LTP) decay at the synapses of 
the hippocampus. LTP implies an activity-dependent increase in synaptic transmission 
efficiency that may last for hours and represents the mechanism underlying conscious 
memory (Bliss & Collingridge 1993). In the study of Ezrokhi et al. (1999), the 
stimulation parameters were: a frequency of 100 Hz, a pulse width of 0.4 ms, and 
intensity between ± 100 – 400 µA. Biphasic square constant current pulses were used 
Chapter 3 
 34 
and the duration of stimulation varied from hours to days. Unfortunately, there was no 
further information on which intensity was the most effective. 
 In another study, the effects of direct DRN stimulation on various brain areas 
were examined (McQuade & Sharp 1997). The amount of 5-hydroxytryptamine (5-HT) 
increased in, among others, the ventral hippocampus and the medial septum. No effect 
was observed in the dorsal hippocampus. Stimulation parameters were: a frequency of 5 
Hz, an intensity of 300 µA and 1 ms pulse width. Duration of stimulation was 20 
minutes. The waveform was not mentioned. In an earlier study, McQuade and Sharp 
(1995) applied the same intensity and pulse width in four different frequencies, i.e. 2, 3, 
5 and 10 Hz. The results show that the higher the frequency, the more release of 5-HT 
in the hippocampus of the anaesthetized rat. 
Direct DRN stimulation and the hypothalamus 
Activity of several hypothalamic nuclei can be enhanced by electrical stimulation of the 
DRN neurons. Saphier (1991) observed that subgroups of neurons in the hypothalamic 
paraventricular nucleus (PVN) of rats responded differently to DRN stimulation. The 
PVN plays a role in autonomic and neuroendocrine processes (Swanson & Sawchenko 
1980). Direct stimulation of the DRN took place at a frequency of 0.2 Hz – 0.5 Hz, a 
pulse width of 1 ms and an intensity of 1 mA. The pulse form was a bipolar square 
wave. Eight out of 15 neurons were activated (53%), two cells showed an inhibition 
(13%) whereas four cells (33%) did not respond at all. Considering the latency of the 
response after stimulation of the DRN, a monosynaptic pathway between the DRN and 
the PVN is suggested (Saphier 1991).  
 Interestingly, Weidenfeld et al. (2002) observed in a recent animal 
experimental study that, by DRN stimulation, the PVN showed an increase in its 
extracellular release of 5-HT, with a subsequent activation of the hypothalamus-
pituitary-adrenocortical (HPA) axis. The stimulation parameters were: a frequency of 
100 Hz, a pulse width of 1 ms, an intensity of 0.5 mA, and duration of stimulation of 5 
minutes. No information about the waveform was available.  
Direct DRN stimulation and the frontal lobe 
Gartside et al. (2000) compared single-pulse stimulation with twin-pulse stimulation 
(burst firing) of the DRN with respect to the release of 5-HT in the medial prefrontal 
cortex of rats. Stimulation parameters included a frequency of 3 Hz, a pulse width of 1 
ms, and an intensity of 300 µA. The pulse-form was a square-wave and duration of 
stimulation was 10 minutes. The stimuli were applied singly or in pairs with an interval 
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of 10 ms between the pulses (burst firing). The results show that, compared to the single 
pulses, the twin pulses doubled the release of 5-HT in the medial prefrontal cortex. 
 In sum, the literature points to a positive relationship between the frequency of 
DRN stimulation and release of 5-HT in adjacent brain areas. The utilization of a burst 
signal resulted in a higher release of 5-HT in the medial prefrontal cortex (for details, 
see Table 3.2). 
 
 
Table 3.2 Direct dorsal raphe nucleus (DRN) stimulation and its effect on the hippocampus, hypothalamus and 
prefrontal cortex. PVN: Paraventri-cular nucleus; 5-HT: 5- hydroxytryptamine; LTP: long-term potentiation 
 Pulse form 
Pulse 
width Intensity Frequency 
Duration of 
stimulation Results 
Ezrokhi et al., 1999 
Biphasic 
square - 
wave 
0.4 ms 
±100-400 
A 
100 Hz 1 minute 
Restoration of a decay in 
LTP in CA1 
McQuade and Sharp, 1997 na 1 ms 300 A 5 Hz 20 minutes 
Release of 5-HT in 
ventral hippocampus and 
medial septum 
McQuade and Sharp, 1995 na 1 ms 300 A 2,3,5,10 Hz 20 minutes 
The higher the 
frequency, the more the 
release of 5-HT in the 
hippocampus 
Saphier, 1991 Bipolar 
square -wave 
1 ms 1 mA 0.2 – 0.5 Hz na 
Excitation (53%) and 
inhibition (13%) of PVN 
neurons 
Weidenfeld et al., 2002 na 1 ms 0.5 mA 100 Hz 5 minutes 
Increase in the 
hypothalamic PVN 
extracellular 5-HT levels 
Gartside et al., 2000 Square-wave 1 ms 300 A 
3 Hz: single or 
twin-pulses 
10 minutes 
Release of 5-HT in the 
medial prefrontal cortex. 
Twin twice as much as 
single 
na = not available 
 
Direct LC stimulation and the hippocampus 
In the study of Ezrokhi et al. (1999), it was observed that decay in LTP at synapses of 
the perforant pathway and dentate gyrus of the hippocampal formation could be restored 
by high-frequency (50-100 Hz) stimulation of the LC. Other stimulation parameters 
were: a pulse width of 0.1 – 0.4 ms, an intensity of 65 – 300 µA, and a biphasic square 
constant current waveform. The study design included variability in stimulation 
frequency, pulse width and intensity but information about the most effective 
combination of these three parameters is lacking. The duration of stimulation was 1 
min. 
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 It has been suggested that both LTP and short-term potentiation of the 
perforant-path in the awake rat results from a phasic instead of tonic LC cell firing 
(Klukowski & Harley 1994). Interestingly, particularly non-noxious stimuli yield a 
phasic activation of LC cells (AstonJones & Bloom 1981). 
Direct LC stimulation and the hypothalamus 
LC-stimulation with 100 Hz, pulse width of 0.2 ms, a sinusoidal waveform, and an 
intensity of 60 µA, increased the density of 2-receptor sites in the hypothalamus of rats 
(Velley et al. 1991). The authors argue that this sequence of events causes a reduction in 
stress reaction and hence improves cognitive functioning. In another animal 
experimental study, direct LC stimulation increased the activity in the hypothalamic 
paraventricular nucleus (PVN), reflected in an increase in the noradrenergic metabolite 
3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) (Lookingland et al. 1991). 
Electrical stimulation of the LC took place by monophasic pulses, with a pulse width of 
1 ms, an intensity of 400 µA, and a frequency of 15 Hz.  
Direct LC stimulation and the frontal lobe 
Florin-Lechner et al. (1996) stimulated the LC of rats either with a tonic stimulation 
(evenly spaced pulses) or with a phasic stimulation (bursts of pulses). In the tonic 
stimulation condition, 3, 5, or 10 Hz was used for 20 minutes. The results showed a 
frequency-dependent release of norepinephrine in the prefrontal cortex, i.e. the higher 
the frequency, the higher the release. Interestingly, compared to the 3 Hz tonic 
stimulation, bursts of 3 pulses (presented at 6, 12, and 24 Hz, every second) produced a 
much larger increase in norepinephrine, with the largest increase at 12 Hz. It is 
concluded that the physiologically relevant ‘burst’ activity of LC neurons releases 
norepinephrine in the prefrontal cortex in the most effective way. 
 In sum, similar to the DRN, frequency of direct LC-stimulation and release of 
norepinephrine in associated areas show a positive relationship. A summation of the 
effects of the various stimulation parameters is presented in Table 3.3. 
Discussion 
The goal of the present study is to examine whether studies on the effects of indirect and 
direct stimulation of the DRN and LC published from 1991 until now still support the 
originally selected stimulation parameters that were used in our TENS-studies. In those 
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Table 3.3 Direct locus coeruleus (LC) stimulation and its effect on the hippocampus, hypothalamus and prefrontal 
cortex. LTP: long-term potentiation; PVN: paraventricular nucleus (hypothalamus) 
 
Pulse form 
Pulse 
width Intensity Frequency 
Duration of 
stimulation Results 
Ezrokhi et al., 
1999 
Biphasic 
square 
constant 
current 
0.1 – 0.4 
ms 
65 – 300 A 50-100 Hz, one 
to two trains: 
15-20 seconds 
interval 
1 minute Restoration of a decay in LTP in 
perforant pathway and dentate 
gyrus 
Velley et al., 
1991 
Sinusoidal 
waveform 
0.2 ms 60 A 100 Hz 15 minutes Increase in 2-receptor sites 
density in the hypothalamus 
Lookingland 
et al., 1991 
Monophasic 
pulses 
1 ms 400 A 15 Hz 10 minutes Increase in the noradrenergic 
metabolite 3-methoxy-4-
hydroxyphenylethyleneglycol 
(MHPG) in the PVN 
Florin-
Lechner et al., 
1996 
na 0.2 ms 700 A Tonic: 3,5,10 
Hz 
 
 
Bursts of   6 Hz 
Bursts of 12 Hz 
Bursts of 24 Hz 
20 minutes The higher the frequency, the 
higher the norepinephrine increase 
in prefrontal cortex 
 
Bursts more effective than tonic 
Highest increase in norepinephrine 
at 12 Hz 
na = not available 
 
 
 
TENS-studies, it was argued that low-frequency TENS (2 Hz) with a pulse width of 0.1 
ms could stimulate the LC whereas high-frequency stimulation of 160 Hz, in 
combination with the same pulse width, could increase the activity of the DRN. Except 
in the pilot-study (Scherder et al. 1992), the intensity of the TENS signal used provoked 
muscular twitches. Both frequencies were combined into one TENS-mode, i.e. burst-
TENS (Eriksson et al. 1979). 
Frequency 
The results of the present review indicate that the LC, compared to the DRN, responds 
more strongly to indirect low-frequency stimulation, i.e. < 10 Hz. In addition, direct 
high-frequency stimulation of the LC with frequencies varying from 10 Hz to 100 Hz 
resulted in the highest activity increase in the hippocampus, the hypothalamus, and the 
prefrontal cortex. With respect to the DRN, the results of both direct and indirect 
stimulation studies show that this brain stem nucleus preferably responds to high-
frequency stimulation of 10 Hz, 20 Hz, and 100 Hz. 
 The finding that both the LC and the DRN respond positively to a burst-firing 
rate is not so surprising considering the electrophysiological characteristics of the 
neurons of the DRN and LC. It has been observed that a considerable number of DRN 
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and LC neurons are capable of firing in bursts (Gartside et al. 2000; Hajos et al. 1995; 
Hajos & Sharp 1996; Wrenn & Crawley 2001). 
Pulse width 
As mentioned before, the pulse width used in our TENS-studies was 0.1 ms (Scherder et 
al. 2000). Although in the direct and indirect stimulation studies reviewed here, the 
pulse width varied between 0.1 ms and 10 ms, the most frequently applied pulse widths 
were 0.4, 0.5, and 1 ms. Future research is necessary to find out whether an increase in 
pulse width is indeed more effective in the treatment of cognitive and behavioral 
disturbances in AD, reflected in e.g. the maintenance of improvements in cognition and 
behavior after cessation of stimulation.  
Intensity and pulse form 
Intensity shows considerable variation among the various studies, ranging from 65 µA 
to 1300 µA and 1 V to 20 V in some indirect stimulation studies provoking muscular 
twitches. Specific information on the pulse form is often lacking. The role these two 
stimulation parameters can play in an optimal stimulation of the DRN and LC as an 
intervention strategy in AD, should be addressed in studies to be performed. 
Limitations and suggestions 
In the first place, studies on indirect and direct stimulation of the DRN and LC reviewed 
here are not intervention studies and hence information on the most efficient 
stimulation-time and treatment-period is lacking. Although in our TENS-studies a 
stimulation-duration of 30 minutes a day and a treatment period of six weeks proved to 
be effective (Scherder et al. 2000), future studies should examine whether an extension 
of both parameters may be even more effective, for example by maintaining the 
observed effects after cessation of stimulation. Next, the studies reviewed here are all 
animal experimental studies. Hence, generalization of the results to humans should take 
place with care. In the third place, one should be cautious when deducing stimulation 
parameters for a non-invasive treatment like TENS from direct stimulation studies and 
invasive techniques like electro-acupuncture.   
 Finally, the present review does not explain why TENS is effective in AD. It is 
known that both the DRN and LC are part of the ascending reticular activating system 
(ARAS) which plays a central role in arousal (Kayama & Koyama 1998). Until now it 
has been assumed that an increase in arousal is responsible for the effects of TENS on 
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cognition and behavior in several conditions that effect the central nervous system (Van 
Dijk et al. 2002). On the other hand, in an fMRI study by Davis et al (1997) increased 
activity in the anterior cingulate cortex, a frontal lobe area involved in attention, was 
found as a from median nerve stimulation by TENS. These findings imply that future 
studies should include brain imaging techniques that will enhance the insight into the 
mechanisms underlying the effects of TENS in AD.  
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Chapter 4 
Peripheral electrical nerve stimulation in 
Alzheimer’s disease 
A randomized controlled trial on cognition and behavior 
Abstract 
In a number of studies, peripheral electrical nerve stimulation has been applied to 
Alzheimer’s disease (AD) patients who lived in a nursing home. Improvements were 
observed in memory, verbal fluency, affective behavior, activities of daily living, rest-
activity rhythm and pupillary light reflex. The aim of the present, randomized, placebo-
controlled, parallel-group clinical trial was to examine the effects of electrical 
stimulation on cognition and behavior in AD patients still living at home. Repeated 
measures analyses of variance revealed no effects of the intervention in the 
experimental group (n = 32) compared to the placebo group (n = 30) on any of the 
cognitive and behavioral outcome measures. However, the majority of the patients and 
the caregivers evaluated the treatment procedure positively, and applying the daily 
treatment at home caused minimal burden. The lack of treatment effects calls for 
reconsideration of electrical stimulation as a symptomatic treatment in AD. 
 
 
 
 
 
 
 
 
 
 
 
 
Van Dijk KRA, Scheltens P, Luijpen MW, Sergeant JA, Scherder EJA. Peripheral electrical stimulation in 
Alzheimer’s disease. A randomized controlled trial on cognition and behavior. Dementia and Geriatric 
Cognitive Disorders 2005; 19:361-368 
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Introduction 
Dysfunction of the cholinergic neurotransmitter system is one of the characteristics of 
Alzheimer’s disease (AD) (Francis et al. 1999). Early studies considered cell death in 
the nucleus basalis of Meynert (NBM) to be the cause of the diminished level of 
acetylcholine (ACh) (Mann et al. 1984; Whitehouse et al. 1982). However, only a small 
proportion of cells in the NBM is actually lost in AD (Vogels et al. 1990) and the 
observed lowered number of cholinergic markers is due to NBM atrophy rather than cell 
loss (Swaab 1991). Swaab argued that therapeutic strategies in AD could be directed 
towards stimulation of neurons to improve metabolism and possibly reactivate impaired 
neurons in e.g. the NBM (Swaab 1991; Swaab et al. 2002; Swaab et al. 2003). 
Accordingly, improved functioning might be established by stimulating the central 
nervous system exogenously, for example through an enriched environment.  
 In enriched environments, the organism typically is subject to multi-sensory 
input (Kobayashi et al. 2002). Unisensory stimulation techniques, such as bright light 
(visual sensory system) and tactile stimulation (somatosensory system) have yielded 
positive effects on several brain functions in mild cognitively impaired and demented 
patients (Luijpen et al. 2003). Walking, another type of somatosensory stimulation, 
resulted in an increased release of extracellular ACh in the hippocampus of rats 
(Nakajima et al. 2003). Somatosensory stimulation by means of peripheral electrical 
stimulation applied to the skin of rats showed an increased activity of the hippocampus 
and an elevated release of ACh in the hypothalamus (Dutar et al. 1985).  
 Somatosensory stimulation through Transcutaneous Electrical Nerve 
Stimulation (TENS) has been applied to AD patients in a number of placebo-controlled 
experiments (Scherder et al. 1992; Scherder et al. 1995; Scherder et al. 1998; Scherder 
et al. 1999b; Scherder & Bouma 1999; Van Someren et al. 1998). In those studies, a 
small electrical current was applied to the skin of the upper back of AD patients. After 
application of the electrical stimulus five days a week for a period of six weeks, 
improvements were found in memory, verbal fluency, affective behavior, activities of 
daily living and the rest-activity rhythm (for a review, see: Van Dijk et al. 2002). A 
Japanese group replicated effects on cognition and found a positive effect on pupillary 
light reflex (Guo et al. 2002). The latter is considered an indication that the cholinergic 
function has improved (Tales et al. 2001). Despite these encouraging findings, the 
positive effects of electrical stimulation must be interpreted with caution because of the 
small sample sizes: ranging from 6 (Guo et al. 2002) to 18 (Scherder et al. 1998).  
 In the studies described above, the participating AD patients lived in a nursing 
home. The research question of the present study was whether peripheral electrical 
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nerve stimulation would also demonstrate positive effects on cognition and behavior of 
patients who still live at home. This randomized, placebo-controlled, parallel-group 
clinical trial is unique since the treatment was applied by a family caregiver. Based on 
previous positive findings, it was hypothesized that after a treatment period of six weeks 
the experimental group would show improved functioning in cognition and behavior 
compared to the control group.  
Materials and Methods 
Participants 
Participants were recruited from the Alzheimer Center of the VU University Medical 
Center, the Department of Neurology of the Sint Lucas Andreas Hospital, and the 
community home care agency in Amsterdam, The Netherlands. Men and women were 
eligible if they had a diagnosis of probable AD according to the NINCDS/ADRDA 
criteria (McKhann et al. 1984). A Mini Mental State Examination (MMSE) (Folstein et 
al. 1975) score of 26 or lower and sufficient hearing and vision were required. In 
addition, it was essential that the AD patient lived at home with a partner or other 
family member who served as primary caregiver (the partner or other family member 
will further be referred to as family caregiver). Patients with a diagnosis of dementia 
other than AD, cerebrovascular disease or clinical depression were excluded, as were 
patients who had a history of cerebral trauma, disturbances of consciousness, seizures, 
epilepsy or an infectious disease. Also, patients with a cardiac pacemaker were excluded 
because of reported interference between a pacemaker and an electrical stimulator 
(Rasmussen et al. 1988). 
 After the procedure of the study had been fully explained, written informed 
consent was obtained from the patient and/or the family caregiver. The study was 
approved by the local medical ethical committees and by the Committee on Research 
Involving Human Subjects in The Hague, The Netherlands. 
Study design 
In this 12-week, randomized, placebo-controlled, parallel-group study, assessment of 
cognition and behavior took place at baseline (Pre), after the treatment period of six 
weeks (Post), and following a treatment-free period of six weeks (Delayed). 
Additionally, a questionnaire covering applicability and efficacy of the treatment 
according to the patient and the caregiver was administered after treatment. 
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Intervention 
A standard commercially available TENS device (Premier 10s) was used. It produced 
biphasic square pulses with a width of 100 sec, applied in bursts of nine pulses with a 
frequency of 160 Hz and a repetition rate of 2 Hz. Self-adhesive medical electrodes for 
electrical stimulation (XyTrode) were placed on the back at the first thoracic vertebra, 
lateral to the spine. The intensity of the stimuli was set at a level that produced painless, 
visible muscular twitches. These stimulation parameters were chosen to optimally target 
afferent nerve fibers, i.e. A-Beta, A-Delta, and C-fibers, which convey the pulses to 
sub-cortical and cortical areas (for more details, see: Scherder et al. 1995). The family 
caregiver applied the treatment 30 minutes a day, seven days a week, for a period of six 
weeks. To minimize interference in the daily routine of the participants, the patient and 
the family caregiver were free to decide at what time of the day they would administer 
the treatment. 
Randomization and blinding 
Participants were allocated to either the experimental or the placebo treatment using 
simple randomization by tossing an unbiased coin. Participants assigned to the 
experimental group received experimental treatment, whereas participants in the 
placebo group were told that the stimulator was working as soon as the green light was 
blinking without current being applied. To maintain the participants’ blindness and 
because they knew there was an experimental and a placebo condition, the two groups 
were informed as follows. The experimental group was told that different pulse 
frequencies were applied to both groups: one frequency that might have the desired 
effect and one that, on theoretical grounds, was unlikely to be effective. Hence, patients 
who received the experimental treatment, i.e. the patient felt the stimulus and the 
caregiver would observe muscle contraction, would still be under the assumption that 
they might be treated with non-effective stimuli. The participants in the placebo group 
were also told that we were applying different pulse frequencies in two groups, but that 
the pulse frequencies were in a range that could not be perceived. The 
neuropsychologist, who instructed the participants about the use of the electrical 
stimulator (K.R.A.v.D), was not blinded to group allocation because a different 
instruction was required when explaining the use of the electrical stimulator to the 
experimental and placebo groups. Patients, family caregivers, and test administrators 
were blinded to group allocation. 
Effects of TENS on cognition and behavior in AD 
 45 
Cognitive measures 
Digit Span, a subtest of the Wechsler Memory Scale (Wechsler 1945), consists of a 
Forward and a Backward condition. The Forward condition serves as a measure of 
attention for verbally presented stimuli and the Backward condition is used as a measure 
of working memory for verbally presented stimuli. The score for each condition is the 
number of correct reproduced sequences. 
 Visual Memory Span (Wechsler 1945) is the non-verbal equivalent of the Digit 
Span test. The Forward and the Backward condition serve as a measure of attention and 
working memory for visually presented stimuli, respectively. The score for each 
condition is the number of correct reproduced sequences. 
 The Eight Words Test of the Amsterdam Dementia Screening test (Lindeboom 
& Jonker 1989) was used to assess verbal episodic memory. The immediate recall score 
is the total number of correct words after five trials and is used as a measure of the 
patients’ ability to process and learn verbal stimuli. The delayed recall score is the total 
number of correctly reproduced words after a delay of approximately 10 min, measuring 
active retrieval of information from verbal memory. The recognition score is the total of 
correct responses minus incorrect responses and measures recognition of the previously 
presented stimuli. 
 Face Recognition of the Rivermead Behavioural Memory Test (Wilson et al. 
1985) was used as a measure of visual, non-verbal long-term recognition memory. 
 Picture Recognition of the Rivermead Behavioural Memory Test (Wilson et al. 
1985) serves as a measure of visual, verbal long-term recognition memory. 
 The Stroop Color Word test (Stroop 1935) was used to obtain a measure of 
interference control, i.e. the ability to disregard an automated response. The interference 
score is computed by subtracting the colors named correctly in 45 seconds on the Color 
Card from the colors named correctly in 45 seconds on the Color/Word Card. A high 
interference score is an indication of poor interference control. 
 Category Fluency test was used to measure verbal fluency (Benton  & Hamster 
1978). Categories were animals and professions. The total score for each category is the 
number of correct words produced in 60 seconds. 
Self-report questionnaires assessing emotional status 
The patients reported the status of their emotional condition using the following 
questionnaires that were administered by an interviewer.  
 The Geriatric Depression Scale (GDS) (Yesavage et al. 1983), a Dutch 30-item 
version, was administered to assess symptoms of depression. Because the sample in the 
present study included cases of severe AD and because of known limited validity and 
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reliability of the GDS when administered to cognitively impaired populations (Burke et 
al. 1989), a selection of twelve items was used to calculate the total score. The twelve 
selected items make up the GDS-12R, a screening measure appropriate for use with 
older people in nursing and residential care settings, including persons with cognitive 
impairment (Sutcliffe et al. 2000). Internal reliability of the GDS-12R was .81 and .78 
for those patients with an MMSE score below 10 (Sutcliffe et al. 2000). 
 The Philadelphia Geriatric Center Morale Scale (PGCMS) (Lawton 1975) was 
administered to obtain a measure of subjective well-being. This seventeen-item 
questionnaire is designed to measure dimensions of emotional adjustment in people 
aged 70 to 90. The total score on the seventeen items is used as a measure of global life 
satisfaction. 
Informant-based ratings of functional and emotional status 
The Philadelphia Geriatric Center Affect Rating Scale (PGCARS) (Lawton et al. 1996) 
is an observation scale designed to rate affective states in dementia. 
 The 28-item Dutch Behavioral Observation Scale for Psychogeriatric 
Inpatients (GIP-28) (De Jonghe et al. 1997) was used to assess psychiatric symptoms. 
This shortened version is a modification of the original 82-item GIP (Verstraten & Van 
Eekelen 1987) that is based on the Physical and Mental Impairment-of-Function 
Evaluation (Linn 1988). Three symptom dimensions were used as dependent variables: 
negative symptoms, cognitive symptoms, and mood/affective symptoms (De Jonghe et 
al. 2003).  
 Activities of Daily Living (ADL) is a list of selected items obtained from Katz 
et al. (1963) that are part of a larger Patient Informant Interview (Holmes et al. 1990). It 
was used as a measure of functional independence. 
Applicability and efficacy questionnaire 
In a questionnaire designed by the authors, applicability and efficacy of the treatment 
according to both the patient and the family caregiver were assessed. Part A consists of 
questions for the patient receiving the treatment and includes two subscales. 1) 
“Perceived burden”, ranging from 0 (no burden) to 12 (highest burden) and 2) 
“Perceived efficacy”, ranging from 0 (no benefit) to 4 (most benefit). Part B consists of 
items for the family caregiver and includes four subscales. 1) “Difficulties using the 
apparatus” ranging from 0 (no burden) to 8 (highest burden), 2) “Perceived burden for 
the family caregiver” ranging from 0 (no burden) to 8 (highest burden), 3) “Perceived 
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burden for the patient” ranging from 0 (no burden) to 12 (highest burden), and 4) 
“Perceived efficacy” ranging from 0 (no benefit) to 4 (most benefit). 
Statistical analysis 
Complete case method was used in which all patients with a missing response on an 
outcome variable were excluded from analysis regarding that variable. Comparisons of 
group characteristics were made using independent sample t-tests for normally 
distributed data and Mann-Whitney U tests for categorical data. Dependent variables 
that were not normally distributed were transformed using square root or log 
transformation. For purposes of clarity, all means printed in the tables are the original 
values. To determine treatment effects, dependent variables were subject to repeated 
univariate analyses of variance (ANOVAs), employing transformed scores when 
applicable, with Group (two levels: experimental and placebo) as between subjects 
factor and Time (three levels: Pre, Post, and Delayed) as within subjects factor. 
Treatment effects were hypothesized to emerge after the treatment period: therefore, 
Post versus Pre contrasts were computed. To investigate if any effects lasted when the 
treatment was discontinued, Delayed versus Pre contrasts were computed. Group 
differences on the applicability and efficacy questionnaire were analyzed using 
univariate analyses of variance (ANOVAs). To compensate for the use of multiple 
comparisons, a significance level of .01 was applied. SPSS Base for Windows Version 
11.5 was used for all analyses. 
Results 
Patient characteristics 
Of the 68 patients who were included and randomly allocated to either treatment group, 
65 (96%) completed the study. Discontinuation during the treatment phase occurred 
only in the placebo group and was due to refused treatment (n = 1), stroke (n = 1) and a 
partner who sustained an arm fracture (n = 1). An additional three cases were excluded 
from analysis because of missing data. Finally, 62 patients (91%) entered the analysis 
phase. An overview of the progress through the different phases of the trial is provided 
in Figure 4.1. 
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Figure 4.1 Flow diagram of the progress through the phases of the trial 
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 The two treatment groups were not significantly different with regard to sex, 
age, education, and MMSE (see Table 4.1). In total, there were 39 men and 23 women; 
their mean age was 71.7 years (SD 8.0; range 52 – 87). Mean years of education was 
10.5 (SD 3.6; range 6 – 20) and mean MMSE score at baseline was 15.2 (SD 6.9; range 
0 – 26). All patients lived with a partner/spouse or family member. 
 
 
Table 4.1 Characteristics of the patients 
 
experimental 
(n = 32)  
placebo 
(n = 30)  
total 
(n = 62) 
Males / females 17 / 15  22 / 8  39 / 23 
Age, years      
       Mean (SD) 71.0 (7.8)  72.5 (8.2)  71.7 (8.0) 
       Range 52-87  55-87  52-87 
Education, years      
       Mean (SD) 10.3 (3.9)  10.7 (3.3)  10.5 (3.6) 
       Range 6-20  6-20  6-20 
MMSE      
       Mean (SD) 15.7 (6.8)  14.7 (7.2)  15.2 (6.9) 
       Range 0-26  1-26  0-26 
 
 
Treatment effects 
Cognitive measures 
Independent samples t-tests indicated no significant differences between groups on 
cognitive measures before treatment. Results of repeated measures ANOVAs suggested 
no significant differences on any of the cognitive measures between groups after 
treatment (Table 4.2). 
Self-report questionnaires assessing emotional status 
Groups did not differ on the GDS-12R or PGCMS before the treatment period. 
Repeated measures ANOVAs revealed no significant differences between groups after 
treatment.
  
Table 4.2 Means (M), standard deviations (SD), and repeated analyses of variance (ANOVA) of the cognitive measures before treatment (Pre), after  treatment (Post), and 
after a treatment free period (Delayed) of the experimental group and placebo group 
  experimental  placebo  ANOVA 
  pre  post  delayed  pre  post  delayed  pre-post  pre-delayed 
  
M 
(SD)  
M 
(SD)  
M 
(SD)  
M 
(SD)  
M 
(SD)  
M 
(SD)  F df p
 
 F df p 
Digit Span Forward  4.54 (1.8) 
 5.00 
(2.1) 
 4.61 
(2.2) 
 4.17 
(2.0) 
 4.34 
(2.0) 
 4.31 
(2.0) 
 .59 1,55 .45  .03 1,55 .86 
Digit Span Backward  3.25 (1.9) 
 3.36 
(1.7) 
 3.29 
(1.8) 
 3.41 
(2.2) 
 3.28 
(1.8) 
 3.14 
(1.9) 
 .48 1,55 .49  1.1 1,55 .30 
Visual Memory Span Forward  3.89 (1.7) 
 3.79 
(2.1) 
 4.18 
(2.1) 
 4.28 
(2.1) 
 4.00 
(2.2) 
 3.90 
(2.5) 
 .25 1,55 .62  2.8 1,55 .10 
Visual Memory Span Backward 
 
 3.21 
(2.8) 
 3.36 
(2.1) 
 2.93 
(2.1) 
 3.00 
(2.2) 
 3.24 
(2.4) 
 3.38 
(2.4) 
 .07 1,55 .79  9.3 1,55 .10 
Eight Words Test                     
          Immediate Recall  15.43 (6.6) 
 15.00 
(8.1) 
 16.11 
(7.4) 
 13.00 
(8.1) 
 13.62 
(8.1) 
 14.17 
(9.0) 
 1.2 1,55 .28  1.7 1,55 .69 
          Delayed Recall  .89 (1.6) 
 .71 
(1.3) 
 1.11 
(1.8) 
 .41 
(1.0) 
 .76 
(1.3) 
 .76 
(1.7) 
 3.6 1,55 .06  .09 1,55 .77 
          Cued Recall  7.86 (5.7) 
 8.14 
(5.1) 
 7.43 
(5.0) 
 5.07 
(5.7) 
 6.07 
(5.5) 
 6.59 
(6.2) 
 .33 1,55 .57  2.4 1,55 .12 
Face Recognition 
 5.14 
(5.2) 
 6.36 
(3.0) 
 6.71 
(3.9) 
 6.14 
(4.1) 
 6.21 
(3.8) 
 7.31 
(3.3) 
 .94 1,55 .34   
.05 
1,55 .83 
Picture Recognition 
 14.21 
(6.2) 
 13.39 
(5.8) 
 11.71 
(8.6) 
 12.00 
(7.6) 
 12.14 
(7.5) 
 12.00 
(7.3) 
 .00 1,55 .97  .31 1,55 .58 
Stroop Interference  31.10 (17.0) 
 32.7 
(17.1) 
 30.5 
(16.2) 
 26.65 
(14.5) 
 30.3 
(15.7) 
 28.1 
(13.7) 
 .18 1,35 .68  .22 1,36 .64 
Verbal Fluency Animals  10.00 (6.9) 
 9.39 
(6.1) 
 8.82 
(7.1) 
 7.72 
(6.2) 
 7.83 
(6.1) 
 7.69 
(6.8) 
 1.1 1,55 .31  2.2 1,55 .14 
Verbal Fluency Professions  6.79 (5.3) 
 7.46 
(5.5) 
 6.64 
(5.9) 
 4.79 
(4.2) 
 5.24 
(5.2) 
 4.79 
(4.6) 
 1.1 1,55 .30  .003 1,55 .96 
 
  
 
Table 4.3 Means (M), standard deviation (SD), and repeated analyses of variance (ANOVA) of the behavioral measures before treatment (Pre), after  treatment (Post), and 
after a treatment free period (Delayed) of the experimental group and placebo group 
  experimental  placebo  ANOVA 
  pre  post  delayed  pre  post  delayed  pre-post  pre-delayed 
  M 
(SD) 
 M 
(SD) 
 M 
(SD)  
M 
(SD) 
 M 
(SD) 
 M 
(SD) 
 
F df p  F df p 
GDS12R ∨ 
 1.25 
(1.4) 
 1.64 
(1.8) 
 1.43 
(1.7)  
.92 
(1.2) 
 1.32 
(1.6) 
 1.14 
(1.2)  .05 1,54 .92  .59 1,54 .45 
PGCMS ∧ 
 13.32 
(2.9) 
 13.04 
(3.7) 
 13.04 
(3.5)  
14.21 
(3.3) 
 14.50 
(3.8) 
 14.39 
(3.4)  .66 1,54 .42  .358 1,54 .42 
PGARS                     
     Pleasure ∧ 
 4.03 
(1.2) 
 3.75 
(1.2) 
 3.69 
(1.2)  
3.83 
(1.2) 
 4.03 
(1.0) 
 3.69 
(1.1)  2.9 1,59 .09  .35 1,59 .56 
     Anger ∨ 
 1.97 
(1.2) 
 1.72 
(1.1) 
 1.84 
(.95)  
1.90 
(1.2) 
 1.90 
(.97) 
 2.00 
(1.1)  1.7 1,59 .19  1.3 1,59 .27 
     Anxiety ∨ 
 2.28 
(1.5) 
 2.06 
(1.4) 
 2.13 
(1.5)  
2.34 
(1.3) 
 2.14 
(1.2) 
 2.24 
(1.3)  .001 1,59 .98  .01 1,59 .91 
     Sadness ∨ 
 2.00 
(1.1) 
 2.19 
(1.1) 
 2.06 
(1.2)  
1.97 
(1.5) 
 1.93 
(1.0) 
 1.86 
1.1)  .74 1,59 .39  .38 1,59 .54 
     Interest ∧ 
 3.59 
(1.3) 
 3.69 
(1.3) 
 3.34 
(1.4)  
3.10 
(1.3) 
 3.83 
(1.3) 
 3.66 
(1.3)  4.4 1,59 .04  6.0 159 .017 
     Content ∧ 
 4.19 
(.8) 
 4.03 
(.86) 
 3.94 
(.84)  
4.17 
(.93) 
 4.48 
(.69) 
 4.24 
(.91)  3.7 1,59 .06  1.5 1,59 .23 
GIP-28                     
     Negative symptoms ∨ 
 7.03 
(3.5) 
 6.75 
(2.9) 
 6.94 
(2.8)  
7.5 
(4.0) 
 7.79 
(3.0) 
 8.00 
(3.7)  .61 1,59 .44  .51 1,59 .48 
     Cognitive symptoms ∨ 
 12.75 
(5.2) 
 10.37 
(4.3) 
 10.97 
(5.6)  
12.66 
(5.6) 
 9.93 
(6.1) 
 12.00 
(6.25)  .18 1,59 .67  1.1 1,59 .31 
     Mood/affective symptoms ∨ 
 5.69 
(5.1) 
 3.44 
(4.9) 
 3.78 
(5.3)  
5.10 
(5.3) 
 3.41 
(4.1) 
 3.52 
(4.4)  1.2 1,59 .28  1.1 1,59 .29 
ADL ∨ 
 7.38 
(6.6) 
 7.78 
(6.5) 
 8.00 
(6.7)  
8.21 
(6.8) 
 8.52 
(7.8) 
 10.03 
(9.2)  2.1 1,59 .15  .35 1, 59 .56 
∧
 High values are considered positive, ∨ Low values are considered positive 
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Informant-based ratings assessing functional and emotional status 
Family caregivers of patients in the experimental group and in the placebo group did not 
rate functional status on the ADL scale and emotional status on the PGCARS and GIP-
28 differently. Repeated measures ANOVAs revealed no effects of the intervention on 
any of the functional and emotional measures based on the caregiver’s judgments (Table 
4.3). 
Applicability and efficacy of the treatment 
Questions for patients 
Patients in both the experimental and the placebo group did not differ significantly on 
the subscales of the applicability and efficacy questionnaire. Thus, burden caused by the 
treatment and perceived efficacy of the treatment were not rated differently by the two 
groups. The means show that both burden and perceived efficacy were quite low in both 
groups. 
Questions for family caregivers 
Family caregivers who applied the real electrical stimulus also did not score differently 
on any of the subscales compared to those who applied sham stimulation. Mean scores 
indicate hardly any difficulty using the apparatus, low burden and low perceived 
efficacy in both groups (see Table 4.4). 
 
 
 
Table 4.4 Means (M), standard deviation (SD) of scores on the Applicability and Efficacy 
Questionnaire subscales of the experimental group and placebo group 
Subscale (possible range) 
experimental  
M (SD)  
placebo  
M (SD)  
total 
M (SD) 
Part A (questions for the patient)      
     Perceived burden (0-12) 2.22 (1.9)  1.60 (1.1)  1.97 (1.6) 
     Perceived efficacy (0-4) 1.10 (1.4)  0.77 (1.1)  0.97 (1.3) 
      
Part B (questions for the family caregiver)      
     Difficulties using the apparatus (0-8) 1.54 (1.3)  1.70 (1.6)  1.61 (1.4) 
     Perceived burden for the family caregiver (0-8) 1.22 (1.3)  1.26 (1.4)  1.24 (1.3) 
     Perceived burden for the patient. (0-12) 1.56 (1.3)  1.00 (0.8)  1.30 (1.1) 
     Perceived efficacy (0-4) 1.13 (1.3)  1.26 (1.2)  1.19 (1.2) 
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Discussion 
Treatment effects 
We found that peripheral electrical nerve stimulation had no beneficial influence on the 
measures of cognitive and behavioral functioning in patients in the experimental group 
compared to the placebo group after a treatment period of six weeks. 
 These results differ from the positive outcomes observed in previous studies 
using electrical stimulation in AD (Guo et al. 2002; Scherder et al. 1992; Scherder et al. 
1995; Scherder et al. 1998; Scherder et al. 1999b; Scherder & Bouma 1999; Van 
Someren et al. 1998) and the question rises how this discrepancy can be explained. 
Firstly, the number of participating patients here is three times the number included in 
the earlier studies. The lack of treatment effects in the present study could imply that the 
earlier findings observed in relatively small numbers of patients were not real treatment 
effects. Secondly, the present study included patients at all stages of AD, ranging from 
mild to severe, with a lower mean level of cognitive functioning than patients in 
previous studies using electrical stimulation. Le Bars et al. (2002) observed a treatment 
effect of a ginkgo biloba extract on, among others, the cognitive subscale of the 
Alzheimer’s Disease Assessment Scale (ADAS-Cog), irrespective of the stage of 
dementia. However, an improvement was particularly observed in very mild to mild 
demented patients whereas stabilization or hindering a further progression of the disease 
was characteristic for the effects in more advanced stages of dementia. In other words, a 
treatment effect should not automatically be considered the same as an improvement in 
functioning. In addition, results from a recent review indicate that pharmacological 
treatment in AD stabilizes cognitive functioning and enhances activities of daily living 
(Standridge 2004). In other words, patient groups that are more homogenous with 
regard to disease severity may have generated different treatment effects than those 
reported here. A third difference between the current and former studies is the age of 
disease onset: i.e. earlier in the present study. There is ample evidence that early onset is 
associated with more severe cognitive impairment, more aggressive course of the 
disease, more AD pathology, greater neocortical cholinergic cell loss, and a higher 
prevalence of apolipoprotein (APOE) 4 (Cedazo-Minguez & Cowburn 2001; Ho et al. 
2002). Therefore, the number of patients with early-onset AD included in this study 
may have reduced average treatment effects. 
 Taken together, the lack of treatment effects in the present study with its 
considerable number of patients may question the treatment effects observed in earlier 
studies with fewer participants. However, patients’ characteristics (level of cognitive 
functioning and age of onset of AD) differed between this study and previous studies. 
Perhaps the theory that stimulating the central nervous system improves metabolism and 
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reactivates impaired neurons (Swaab 1991; Swaab et al. 2002; Swaab et al. 2003) does 
not hold for AD patients in a more advanced stage and/or patients with early onset AD. 
This suggestion is supported by Geddes and Cotman (1991) who note that when 
neuropathology in AD is more severe, functional benefits of plasticity become less 
certain.   
 A large replication study with AD patients in an earlier phase of the disease 
might provide a more definitive conclusion about the beneficial effect of peripheral 
electrical nerve stimulation in AD. 
Treatment applicability 
We also examined how the patients underwent the treatment and how the family 
caregiver experienced applying the treatment. Interestingly, the majority of the patients 
and the caregivers were very positive about the procedure, and applying the daily 
treatment was accompanied with minimal burden.  
 Several studies have focused on the effects of providing care to a demented 
relative and found an increased strain on psychological and physical health of the family 
caregiver (Pinquart & Sorensen 2003; Sadik & Wilcock 2003). Other studies report a 
positive gain from caregiving (Kramer 1997; Schulz et al. 1997) or captured the 
caregivers’ experience in the term “vigilance”, operationalized as “supervising” and 
“being there” (Mahoney 2003). Another group found that when caregivers provided 
end-of-life care at home they showed faster recovery from depression and psychological 
stress after death of their relatives than caregivers of patients who were institutionalized 
(Schulz et al. 2003). Also, a study on nursing-home placement of cognitively impaired 
elderly who were cared for by their relatives, found that caregivers expressed a higher 
preference for institutionalization if he or she experienced less caregiving satisfaction 
(Spruytte et al. 2001). In sum, to our knowledge, the present study is the first to show 
that an active role for the family caregiver is feasible in symptomatic treatment of a 
demented relative. 
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Chapter 5 
 
Peripheral electrical nerve stimulation in 
Alzheimer’s disease 
A randomized controlled trial on the rest-activity rhythm 
Abstract 
Rest-activity rhythm disruption is a prominent clinical feature of Alzheimer’s disease 
(AD). The origin of the altered rest-activity rhythm is believed to be degeneration of the 
suprachiasmatic nucleus (SCN). Stimulation of the SCN may prevent age-related loss of 
neurons and might reactivate nerve cells that are inactive but not lost. Previous studies 
have demonstrated positive effects of peripheral electrical nerve stimulation on the rest-
activity rhythm in AD patients living in a nursing home. The present randomized 
controlled study examined the effects of electrical stimulation on the rest-activity 
rhythm in AD patients still living at home. Sixty-two AD patients were randomly 
assigned to either electrical stimulation or sham-stimulation. Effects on the rest-activity 
rhythm were assessed using actigraphy before and after treatment. Results show no 
significant effects of electrical stimulation when all participants were analyzed. 
Interestingly, however, post hoc analyses revealed significant effects in a subgroup of 
patients who were not using aceteylcholinesterase inhibitors (AChEIs) concomitantly. 
The interaction between AChEIs and electrical stimulation in the present sample of AD 
patients warrants further investigation. 
 
 
 
 
 
Van Dijk KRA, Luijpen MW, Van Someren EJW, Sergeant JA, Scheltens P and Scherder EJA. Peripheral 
electrical stimulation in Alzheimer’s disease. A randomized controlled trial on the rest-activity rhythm 
(submitted for publication) 
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Introduction 
Rest-activity rhythm disruption is a prominent clinical feature of Alzheimer’s disease 
(AD) (Ancoli-Israel et al. 1997; McCurry et al. 1999; Prinz 1982; Satlin et al. 1995; 
Van Someren et al. 1996). In a recent study, the prevalence of symptoms of disordered 
sleep in AD ranged from 34% (waking up at night thinking it is daytime) to 82% 
(getting up during the night) (Tractenberg et al. 2003). Therefore, it is not surprising 
that institutionalization is best predicted by rest-activity rhythm disruption and not by 
the level of cognitive functioning or number of psychiatric symptoms of the AD patient 
(Chenier 1997; Hart et al. 2003; Hope et al. 1998; Kesselring et al. 2001; Lieberman & 
Kramer 1991; Pollak & Perlick 1991). 
  The origin of the altered rest-activity rhythm in AD is believed to be 
degeneration of the suprachiasmatic nucleus (SCN) (Liu et al. 2000; Swaab et al. 1996), 
which is part of the hypothalamus and considered the biological clock of the brain 
(Inouye and Shibata, 1994). Interestingly, application of bright light has shown to 
positively influence rest-activity rhythm disturbances in some AD patients (Fetveit et al. 
2003; Koyama et al. 1999; Lyketsos et al. 1999; Satlin et al. 1992; Van Someren et al. 
1997; Yamadera et al. 2000). One explanation for this therapeutic action is that light 
stimulates the SCN through a central pathway, i.e. the retino-hypothalamic nerve tract, 
and thus prevents age-related loss of neurons in this nucleus (Van Someren et al. 1997). 
The latter has been found in animal experiments (Lucassen et al. 1995) and is in line 
with the “use it or lose it” hypothesis which states that an organism profits from 
neuronal stimulation (Swaab 1991). 
 The biological clock may also be stimulated through pathways originating in 
the peripheral nervous system. An intervention aimed at stimulating peripheral nerves is 
application of electrical stimuli to the skin. Two placebo-controlled studies have 
demonstrated positive effects of Transcutaneous Electrical Nerve Stimulation (TENS) 
on the rest-activity rhythm in institutionalized AD patients in terms of improved 
stability (Scherder et al. 1999b; Van Someren et al. 1998). It was argued that 
stimulation of peripheral nerves with electrical stimuli might activate the SCN through 
four projections that have been identified in animal experimental studies. First, the 
spino-hypothalamic tract: a direct pathway from spinal cord to the SCN (Cliffer et al. 
1991). Second, a spino-septal-hypothalamic tract: an indirect pathway from the spinal 
cord to the septal nuclei (Burstein & Giesler 1989), and subsequently to the SCN 
(Pickard 1982). Third and fourth are spino-brainstem-hypothalamic tracts: from the 
spinal cord to the brain stem locus coeruleus (LC) (Kawano et al. 1996) and further to 
the SCN (Krout et al. 2002) and from the spinal cord to the raphe nuclei (Hay-Schmidt 
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et al. 2003; Kawano et al. 1996) and subsequently to the SCN (Krout et al. 2002; Moga 
& Moore 1997). 
 In addition, the LC and the raphe nuclei are known to innervate the basal 
forebrain (Jones 2003). From the basal forebrain, including the nucleus basalis of 
Meynert (NBM), cholinergic cells project to the cerebral cortex (Jones 2004) and to the 
SCN (Yamadera et al. 2000). The noradrenergic LC and serotonergic raphe nuclei are 
part of the ascending reticular activating system (ARAS) (Kayama & Koyama 1998), 
which is known to play an important role in the regulation of sleep and wakefulness 
(Siegel 2004). Hence, assuming homologous pathways exist in these animals and 
humans, stimulation of peripheral nerves could account for the effects of electrical 
stimulation previously found in AD patients. 
 Considering the positive effects of electrical stimulation on the rest-activity 
rhythm in AD patients living in a nursing home, the present, randomized, placebo-
controlled, parallel-group clinical study examined the effects of peripheral electrical 
stimulation in AD patients still living at home. Based on earlier studies, it was 
hypothesized that after a treatment period of six weeks, the experimental group that 
received electrical stimulation would show improved functioning of the rest-activity 
rhythm, compared to the placebo group. 
Methods 
Participants 
Participants were recruited from the Alzheimer Center of the VU University Medical 
Center, from the Department of Neurology of the Sint Lucas Andreas Hospital, and 
from the community home care agency in Amsterdam, The Netherlands. Both men and 
women were eligible if they met the diagnostic criteria of the NINCDS/ADRDA for 
probable AD (McKhann et al. 1984). A Mini Mental State Examination (MMSE) 
(Folstein et al. 1975) score of 26 or lower and sufficient hearing and vision were 
required. It was essential that the AD patient was living at home with a partner or other 
family member who served as primary caregiver. Concomitant use of 
acetylcholinesterase inhibitors (AChEIs) for symptomatic treatment of AD was allowed 
only if the dose was stable before the first assessment and remained unchanged changed 
during the trial. Patients with a diagnosis of dementia other than AD, cerebrovascular 
disease or clinical depression were excluded, as were patients who had a history of 
cerebral trauma, disturbances of consciousness, seizures, epilepsy, or an infectious 
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disease. Patients with a cardiac pacemaker were excluded because of reported 
interference between a pacemaker and an electrical stimulator (Rasmussen et al. 1988). 
 After the procedure of the study had been fully explained, written informed 
consent was obtained from the patient and/or the family caregiver. The study was 
approved by the local medical ethical committees and by the Committee on Research 
Involving Human Subjects in The Hague, The Netherlands. 
 Sixty-eight patients were included and randomly allocated to either an 
experimental group that received electrical stimulation, or to a placebo group that 
received sham stimulation. Sixty-five patients (96%) completed the study. 
Discontinuation during the treatment phase occurred only in the placebo group and was 
due to refused treatment (n=1), stroke (n=1) and a partner who sustained an arm fracture 
(n=1). Three additional cases were excluded from analysis because no actigraph data 
were available. Finally, 62 patients (91%) entered the analysis phase. The two groups 
did not differ significantly with regard to sex, age, education, and MMSE as indicated 
by chi-square and t-tests (see Table 5.1 for group characteristics). 
 In view of the hypothesized involvement of the cholinergic system in the 
mechanism underlying the effects of electrical stimulation in AD and the use of AChEIs 
in a part of the sample, we explored the possible interaction between AChEIs and 
electrical stimulation. The experimental and placebo group were both split into AChEI 
users (AChEI +) and AChEI non-users (AChEI −), resulting in four groups: 
experimental AChEI − (n = 16), experimental AChEI + (n = 15), placebo AChEI − (n = 
18), and placebo AChEI + (n = 13). Post hoc multiple analyses of variance 
(MANOVAs) and chi-square tests indicated no significant differences between the 
groups with respect to age, education, MMSE, and sex. 
 
 
Table 5.1 Characteristics of the patients 
 
Experimental 
group (n = 31)  
Placebo 
group (n = 31) 
Males / females 16 / 15  22 / 9 
Age, years    
       Mean (SD) 71.5 (8.6)  72.8 (8.3) 
       Range 52-89  55-87 
Education, years    
       Mean (SD) 10.5 (3.9)  10.7 (3.3) 
       Range 6-20  6-20 
MMSE    
       Mean (SD) 15.7 (6.9)  14.8 (7.1) 
       Range 0-26  1-26 
AChEI use (n)    
       Rivastigmine (n) 13  12 
       Donepezil (n) 2  1 
AChEI use = acetylcholinesterase inhibitor use, subdivided in Rivastigmine 
(Exelon) and Donepezil (Aricept) 
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Randomization and blinding 
Using simple randomization by tossing a coin, the participants were allocated to the 
experimental or placebo group. Those assigned to the experimental group were given 
the real treatment, i.e. electrical stimuli applied to the skin, whereas participants in the 
placebo group were told that the stimulator was working as soon as a green light was 
blinking, without an actual current being applied. To maintain the participants’ 
blindness and since the participants knew there was an experimental and a placebo 
condition, the two groups were informed as follows. The experimental group was told 
that different pulse frequencies were applied to both groups: one frequency that may 
have the desired effect and one that, on theoretical grounds, was unlikely to be effective. 
Hence, patients who received the experimental treatment, i.e. the patient felt the 
stimulus and the caregiver observed muscle contraction, would still be under the 
assumption that they might be treated with non-effective stimuli. The participants in the 
placebo group were also told that different pulse frequencies were applied in two 
groups, but that the pulse frequencies were in a range that could not be perceived. 
Patients, family caregivers, and test administrators were blinded to group allocation. 
Study design 
In this 12-week, randomized, placebo-controlled, parallel-group study, assessment of 
the rest-activity rhythm by means of actigraphy took place at baseline (Pre-assessment), 
after the treatment period of six weeks (Post-assessment) and following a treatment-free 
period of six weeks (Delayed-assessment). 
Intervention 
A standard TENS device and two self-adhesive medical electrodes (type: Premier 10s 
and Xytrode, respectively; Xytron Medical, Apeldoorn, The Netherlands) were used. 
The electrodes were placed on the back at the first thoracic vertebra, lateral to the spine. 
The electrical stimulator produced biphasic square pulses with a width of 100 sec, 
applied in bursts of nine pulses with a frequency of 160 Hz and a repetition rate of 2 Hz. 
The intensity of the stimuli was set at a level that produced painless, visible muscular 
twitches. These stimulation parameters were chosen to target afferent nerve fibers, i.e. 
A-Beta, A-Delta, and C-fibers, which convey the pulses to cortical and sub-cortical 
areas (Scherder et al. 1995; Scherder et al. 2003). The family caregiver applied the 
treatment 30 minutes a day, seven days a week, for a period of six weeks. The patient 
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and family caregiver were free to decide what time of the day they administered the 
treatment in order to minimize interference in the daily routine of the participants. 
Assessment of Rest-Activity Rhythm 
Actigraphy is considered a valid measure of rest-activity rhythms (Pollak et al. 2001) 
and has been successfully used in healthy elderly and demented elderly patients (Huang 
et al. 2002; Martin et al. 2000; Van Someren et al. 1996). Traditionally, actigraphy has 
been recorded from the non-dominant wrist but studies that investigated different 
placement locations found no difference between the dominant wrist, non-dominant-
wrist, ankle, or trunk (Jean-Louis et al. 1997; Sadeh et al. 1994) or favored the dominant 
wrist when assessment of optimal variability of motor movement was of interest 
(Middelkoop et al. 1997). Therefore, an actiwatch (Cambridge Neurotechnology Ltd., 
Cambridge, Great Britain) was worn on the dominant wrist. The small (3 x 4 x 1 cm) 
and light-weight actigraph made home recordings of circadian rhythm during several 
days possible and caused minimal burden to the participant. Analyses were based on 
data obtained in 1 min epochs during 4 consecutive days (M = 96 hours, SD = 2, range: 
72-96). 
 The following non-parametric variables were computed and are described in 
more detail elsewhere (Van Someren et al. 1998). First, interdaily stability (IS) is a 
measure of the strength of coupling of the rest-activity rhythm to Zeitgebers 
(environmental time-cues). High values represent a stable rhythm and are considered 
positive. Second, intradaily variability (IV) serves as a measure of fragmentation of the 
rhythm. A normal rest-activity pattern will show one major active period (day) and one 
major resting period (night) and thus a low IV, whereas a fragmented rhythm will show 
many transitions between rest and activity during the 24-hour cycle and high IV values. 
Third, the relative amplitude (RA) is a normalized variable based on the most active 
period in the 24-hour cycle in relation to the least active period. A normal pattern will 
display a large difference between daytime activity and nightly rest. Thus, a high RA is 
considered positive. 
Statistical analysis 
Missing data 
Two values were missing from 62 participants (<1%) at three assessments due to non-
compliance, i.e. the patient did not wear the actigraph long enough to compute rest-
activity rhythm variables. Twenty-one values (11%) were missing due to technical 
failure of actigraphs. Patterns of missing data were analyzed per treatment group to 
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evaluate whether data were Missing Completely at Random (MCAR) (Little & Rubin 
2002). Little’s MCAR tests suggested that data were MCAR for all three dependent 
variables (chi-squares with 6 degrees of freedom ranged from 4.49 (p = .61) to 11.50 (p 
= .12)). Missing values on dependent variables IS, IV, and RA were imputed using the 
expectation maximization (EM) method (Dempster et al. 1977) available in the SPSS 
software. The EM method allowed for analysis of the entire sample of 62 participants. 
Analyses of effects of electrical stimulation 
Paired samples t-tests indicated no differences between the Pre-assessment (baseline 
before treatment) and the Delayed-assessment (after a washout period of six weeks) on 
any of the dependent variables, justifying pooling of data from these two assessments 
(Kirk 1995). This procedure resulted in reduced variability and increased statistical 
power. The two assessments combined are further referred to as Pooled baseline 
assessment. To evaluate the effects of the treatment, repeated measures analyses of 
variance (ANOVAs) with Group (two levels: experimental versus placebo) as between 
subjects factor and Time (two levels: Post versus Pooled baseline) as within subjects 
factor were conducted. When interactions between Group and Time occurred, within 
group t-tests were conducted.  
Analyses of interactions between electrical stimulation and AChEI use 
Post hoc analyses of possible interaction effects between electrical stimulation and 
AChEI use were performed. Separately, the experimental and placebo group were 
subject to repeated measures ANOVAs with AChEI use (two levels: AChEI + versus 
AChEI −) as between subjects factor and Time (two levels: Post versus Pooled baseline) 
as within subject factor. All statistical tests were two-tailed and the critical value for 
significance was p < .01 to compensate for multiple tests. SPSS Base software for 
Windows Version 11.5 was used for all statistical analyses. 
Results 
The experimental group and the placebo group did not differ on the actigraphy variables 
IS, IV or RA at baseline as indicated by independent samples t-tests. Overall IS before 
treatment was .60 ± .015 (M ± SEM), IV was 1.07 ± .037 and RA was .85 ± .013. These 
values are comparable to previous values found in AD patients in a nursing home 
setting and indicative of a less stable and more fragmented rest-activity rhythm 
compared to non-demented elderly (Scherder et al. 1999b; Van Someren et al. 1998). 
Chapter 5 
 62 
Effects of electrical stimulation 
Repeated measures ANOVAs with Group (two levels: experimental versus placebo) as 
between subjects factor and Time (two levels: Post versus Pooled baseline) as within 
subjects factor revealed a significant Group x Time interaction effect for RA (F(2,60) = 
13.76, p < .001) and near significant effects for IS (F(2, 60) = 5.90, p = .018) and IV 
(F(2,60) = 4.24, p < .04). Further analyses using within group t-tests revealed a trend for 
improved IS and IV in the experimental group (t(30) = 1.85, p = .07, and t(30) = -1.98, 
p = .06, respectively) and a significant worsening of RA in the placebo group (t(30) = -
.35, p = .002). 
 
Table 5.2 Means (M) and standard errors of the mean (SEM) of the experimental and placebo group 
 experimental group (n=31)  placebo group (n=31)   
 pre  post  delayed  pre  post  delayed  ANOVA pooled baseline vs post 
Actigraphy M (SEM)  
M 
(SEM)  
M 
(SEM)  
M 
(SEM)  
M 
(SEM)  
M 
(SEM) 
 
F(2,60) 2 p 
IS .58 (.023)  
.60 
(.020)  
.58 
(.018)  
.61 
(.020)  
.57 
(.023)  
.60 
(.022) 
 
5.90 .09 0.018 
IV 1.02 (.049)  
.98 
(.055)  
1.11 
(.051)  
1.11 
(.055)  
1.08 
(.055)  
.96 
(.056) 
 
4.25 .07 0.044 
RA .86 (.015)  
.86 
(.017)  
.85 
( .018)  
.84 
(.022)  
.79 
(.027)  
.86 
(.019) 
 
13.76 .19 0.001 
 
IS = interdaily stability, IV = intradaily variability, RA = relative amplitude, pre = baseline, post = after six weeks treatment, delayed = 
after six weeks treatment free, pooled baseline =the average of pre and delayed,  2 = partial eta squared effect size 
 
 
Interactions between electrical stimulation and AChEI use 
To investigate a possible interaction effect between AChEIs and electrical stimulation, 
the experimental and placebo group separately were subject to repeated measures 
ANOVAs with AChEI use (two levels: AChEI + versus AChEI −) as between subjects 
factor and Time (two levels: Post versus Pooled baseline) as within subjects factor. The 
experimental group revealed a near significant AChEI x Time interaction effect for IS 
(F(2,29) = 5.00, p = .03), whereas the placebo group showed no significant interaction. 
The effect size in the experimental group was large, i.e. partial 2 (Cohen 1977) was .15, 
which means that 15% of the variance of treatment outcome in the experimental group 
could be attributed to AChEI use, with better outcome for the group not using an 
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AChEI. Furthermore, within group t-tests revealed a significant effect of the 
experimental treatment on IS (t(15) = 3.12, p = .007) and a near significant effect on IV 
(t(15) = -2.53, p = .02) in the AChEI − group, but no significant effects in the AChEI + 
group (t(17) = -.87, p = .40, and t(17) = 1.60, p = .13, respectively) (see Figure 5.1). 
 
 
 
 
Figure 5.1 Mean values for Interdaily Stability of the experimental (left) and placebo (right) group 
at pooled baseline and after treatment. There are separate lines for acetylcholinesterase inhibitors 
users (AChEI +) and non-users (AChEI −). Error bars indicate standard errors of the mean (SEM), 
shown only one sided for reasons of clarity. 
 
Discussion 
This paper presents data from a randomized clinical trial on peripheral electrical nerve 
stimulation in AD with three times as many participants as any earlier study on this 
topic to date. Effects of peripheral electrical stimulation, compared to placebo, on the 
rest-activity rhythm in AD patients living at home were examined. Results indicated a 
group effect for the amplitude of the rhythm (RA). However, this effect was due to a 
significant worsening in the placebo group, not to improvement in the experimental 
group. Furthermore, a near significant group effect was observed for the stability (IS) 
and fragmentation (IV) of the rhythm. The latter two could be attributed to 
improvements in the experimental group. 
 These results are similar to effects found in earlier studies which showed a 
more stable rest-activity rhythm after treatment (Scherder et al. 1999b; Van Someren et 
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al. 1998) and a trend towards a positive effect on the fragmentation of the rhythm 
(Scherder et al. 1999b). Therefore, we believe that the near significant findings on the 
rest-activity rhythm, in part, support the hypothesis that neuronal stimulation enhances 
the rest-activity rhythm in AD patients. 
 Interestingly, the present sample permitted studying the interaction between 
electrical stimulation and AChEI intake since half of the participants were using 
AChEIs during the trial. Post hoc analyses indicated that 15% of the variance of 
treatment outcome on IS in the experimental group could be attributed to AChEI use, 
with better outcome for the group not using AChEIs. In addition, the part of the 
experimental group not using AChEIs displayed a significant within group treatment 
effect for stability of the rhythm and a near significant effect for fragmentation, whereas 
the part of the experimental group also using AChEIs displayed no effects of electrical 
stimulation at all. 
 The finding that effects were most pronounced in the subgroup that was not 
using AChEIs gives food for thought. First, AChEIs are aimed at improving cholinergic 
function (Scarpini et al. 2003) and electrical stimulation, among others, was 
hypothesized to enhance ACh concentration in the brain. Concentration-effect curves 
are often asymmetrically shaped like an inverted U curve (Giraldo et al. 2002) and 
therefore it is possible that the subgroup using AChEIs benefited optimally from the 
pharmacological treatment, and electrical stimulation did not have an additional effect. 
Of course, this is merely speculation and future research using e.g. positron emission 
tomography (PET) to measure cholinergic function is necessary. Second, if indeed 
patients that are not using AChEIs benefit from electrical stimulation, this treatment 
may be of importance for those patients who do not tolerate AChEIs due to side effects 
like nausea, vomiting, diarrhea, and anorexia (Birks et al. 2000; Birks & Harvey 2003; 
Loy & Schneider 2004). Perhaps, in those patients an improved rest-activity rhythm 
may positively influence cognitive and/or behavioral symptoms, a relation that has been 
suggested in several studies (Van Someren et al. 2002).  
 In conclusion, the results of the present study show near significant effects of 
electrical stimulation on the rest-activity rhythm in AD. This partially lends support to 
the hypothesis that neuronal stimulation enhances the rest-activity rhythm in AD 
patients. The fact that treatment effects were specifically pronounced in those patients 
who were not concomitantly using AChEIs warrants further investigation. Use of 
imaging techniques such as PET may disentangle the complex interactions between 
AChEIs and electrical stimulation and may also provide more insight into the 
underlying mechanisms of this non-pharmacological treatment. 
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Chapter 6 
Assessment of executive functions in Alzheimer’s 
disease using computerized tests 
Abstract 
Executive functions (EFs) are often impaired early in the course of Alzheimer’s disease 
(AD). Since EFs play a crucial role in self-care, communicative functioning, and 
financial capacity, and because executive dysfunction has been linked to more 
neuropsychiatric symptomatology, evaluation of EFs is essential. In the past decades 
there has been a growing interest in computerized tests of cognitive functions but only a 
limited number of studies employed computerized tests of EFs in AD patients. The goal 
of the present study was to administer computerized EF tests of planning, inhibition, 
working memory, and attention in AD. Sixteen AD patients who met the 
NINCDS/ADRDA diagnostic criteria for probable AD and seventeen healthy elderly 
controls participated in the study. Results show that the AD patients score significantly 
lower on tests of planning and near significantly lower on attention. Differences on the 
tests of working memory and inhibition were in the expected direction but not 
significant. Although replication with larger groups is required, the current study 
indicates that a battery of computerized EF tests can be used in AD patients and healthy 
elderly persons and partially differentiates between groups. 
 
 
 
 
 
 
 
 
Van Dijk KRA, Holleman MA, De Sonneville LMJ, Oosterlaan J, Sergeant and JA. Scherder EJA. 
Assessment of executive functions in Alzheimer’s disease using computerized tests (submitted for 
publication) 
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Introduction 
Memory impairment is among the first signs of Alzheimer’s disease (AD) and an 
essential symptom for a clinical diagnosis (American Psychiatric Association 1994; 
Brandt & Rich 1995; McKhann et al. 1984). However, there is growing evidence that 
executive functions (EFs) are often also impaired early in the course of AD (Binetti et 
al. 1996; Collette et al. 1999; Lafleche & Albert 1995). A recent study including 137 
cases with AD, classified 64% of the AD patients as having executive dysfunctions 
(Swanberg et al. 2004), and even individuals who do not meet clinical criteria for AD 
but who are likely to be in a prodromal phase of the disease, showed executive 
dysfunctions (Albert et al. 2001; Lam et al. 2004). EFs can be defined as higher order 
cognitive capabilities necessary for the synthesis of external stimuli, formations of goals 
and strategies, preparation for action, and the use of feedback (Luria 1988). They 
include cognitive functions such as planning, working memory, inhibition, attention and 
fluency, and they are known to be primarily, but not solely, mediated by the prefrontal 
cortex (Pennington & Ozonoff 1996; Stuss & Alexander 2000). Since EFs play a crucial 
role in self-care (Boyle et al. 2003), communicative functioning (Bayles 2003), and 
financial capacity (Earnst et al. 2001), and because executive dysfunctions have been 
linked to more neuropsychiatric symptomatology (Chen et al. 1998), evaluation of EFs 
of AD patients in clinical practice is essential. 
 In the past decades there has been a growing interest in computerized tests of 
cognitive functions (Butcher et al. 2000; Collie & Maruff 2003; Kane & Kay 1992). 
Although a computer should not be used as a substitute for the human examiner (Tien et 
al. 1996) and cannot replace clinical judgment (Butcher et al. 2000), there are evident 
advantages of computers in terms of ease of administration, detailed objective measures 
of speed and accuracy, automated scoring, and availability of different parallel versions. 
Moreover, studies that have examined the use of computerized measures to detect 
memory deficits in healthy elderly persons (De Jager et al. 2002) and patients with 
questionable dementia (Fowler et al. 2002), found deterioration with computerized 
measures before significant decline was noted on standard paper-and-pencil tests. 
 Only a limited number of studies employed computerized tests of EFs in AD 
patients. Swainson et al. (2001) administered a battery of traditional paper-and-pencil 
tests and computerized measures to patients with mild AD. One of the computerized 
measures included in that study was a modified Tower of London (TOL) planning test 
(Shallice 1982) which was taken from the Cambridge Neuropsychological Test 
Automated Battery (CANTAB) (Owen et al. 1990). Results of this computerized TOL 
showed that the group of AD patients performed significantly worse when compared 
Assessment of EFs in AD 
 67 
with groups of patients with questionable dementia, major depression, and healthy 
elderly controls (Swainson et al. 2001). In a study by Amieva et al. (2002) on inhibitory 
breakdown using a Stop-Signal motor inhibition task (Logan & Cowan 1984), a 
significant difference between AD patients and normal elderly controls was found 
regarding the number subjects in each group committing at least one error. 
 The goal of the present study was to administer computerized EF tests in AD 
which are comparable to the tests used by Swainson et al. (2001) and Amieva et al. 
(2002) in order to assess planning and inhibition. In addition, the battery was extended 
with computerized tests of working memory and attention and a group of normal elderly 
controls was included for comparison. 
Method and material 
Participants 
A sample of AD patients and normal elderly controls was recruited among residents of a 
nursing home in Amsterdam, The Netherlands. The main inclusion criterion for the AD 
group was a diagnosis of probable AD according to the NINCDS/ADRDA guidelines 
(McKhann et al. 1984). Exclusion criteria for the AD group were cerebrovascular 
disease, clinical depression, a history of cerebral trauma, disturbances of consciousness, 
seizures, epilepsy, infectious diseases, and hearing and vision loss. The inclusion 
criteria for the normal control group were absence of diagnosis of probable AD or other 
types of dementia and exclusion criteria were the same as those for the AD group. 
 Participants were 16 AD patients (4 men and 12 women) and 17 healthy 
elderly persons (2 men and 15 women). The two groups were not significantly different 
with regard to sex, age and education. Mean age was 83.3 (SD 4.5; range 74 – 90) and 
84.8 (SD 4.8; range 77 – 92) years for the AD and control group, respectively. Mean 
years of education was 8.3 (SD 2.4; range 6 – 13) and 7.5 (SD 2.2; range 6 – 12). The 
mean MMSE score of the AD group was 19.8 (SD 3.8; range 12 – 26) and differed 
significantly from the mean MMSE score of the control group which was 26.1 (SD 2.1; 
range 22 – 29) (t(31) = 6.1, p < 0.001). 
Neuropsychological measures 
All participants were administered four computerized EF tests, two control measures for 
basic psychomotor functions and one widely used non-computerized EF test (see Table 
6.1 for an overview). 
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Computerized EF measures 
Planning 
The Stockings of Cambridge closely resembles the classical TOL (Shallice 1982) and is 
first described by Owen et al. (1990). It is part of the CANTAB which ran on a standard 
PC with a 12-inch touch sensitive screen. Participants were seated approximately 0.5 m 
from the screen. Prior to the test, participants are familiarized with the touch screen in a 
“motor screening task” in which they are instructed to touch the screen at a cross that 
appears at a pseudo-random location on the screen. The planning task involves an 
example set of three colored balls (red, blue and green) in a certain configuration at the 
top half of the screen and a set of colored balls in another configuration in the lower half 
of the screen. The participants are instructed to rearrange the balls in the lower half in 
such a way that it is the same as the example at the top half of the screen. A ball can be 
moved by touching it and, after the rim of the ball starts flashing, touching a desired 
new location. 
 An extensive instruction is followed by six practice items, which can be solved 
within one or two moves, and twelve subsequent test trials: two items with two and 
three moves, and four items with four and five moves. The test trials are the same 
problems as used in the original TOL (Shallice 1982). The participants are instructed to 
try to solve the problems in a minimum possible number of moves and encouraged to 
plan their moves before actually enacting the solution to the problems. The correct 
solution of the trials can be attained in a minimum of two, three, four and five moves, 
respectively. The minimum number of moves required is included in the oral 
instructions and stated on the screen during presentation of the problems. The program 
registers the number of moves that the subject needs to reach the solution from which 
the following variables are computed: “number of problems solved in the minimum 
moves” and “mean number of moves above the minimum”. The latter is the average of 
number of moves needed above the minimum for two, three, four and five move 
problems. After the planning task, a motor control condition is presented. In the motor 
condition, the participant is instructed to move the balls in the lower display promptly as 
the upper display changes. Moves in the control condition correspond to moves in the 
planning condition and latencies are recorded for the motor initiation and execution time 
of each response. The motor initiation and execution times are used to obtain the 
measure “mean initial thinking time”. This measure is calculated as the time between 
presentation of the problem in the main planning condition on the screen and the first 
touch, minus the corresponding latency to make the same move in the control condition. 
Using this method, measures of thinking time are not confounded by the time needed to 
perform the motor initiation and execution. This measure is an average of the mean 
initial thinking time for two, three, four and five move problems. 
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Working memory 
Spatial Span is another CANTAB subtest and was used as a measure of working 
memory. Traditionally, working memory was believed to be assessed, among others, by 
the backward conditions of the digit span and spatial span tasks from the Wechsler 
Memory Scale-Third Edition  (WMS-III: Wechsler 1997) (Groeger et al. 1999; Lezak 
1995). Recent data of 1030 persons of the original WMS-III standardization sample 
(Wechsler 1997) indicated that not only backward but also forward span tasks recruit 
working memory resources (Hester et al. 2004). The Spatial Span test that was 
administered in the present study was a computerized version of the Corsi Block 
Tapping test (Milner 1971), in which a pseudo random pattern of nine white squares 
was shown on the touch sensitive screen. A sequence of squares changes color for three 
seconds each and at the end of the presentation of the sequence, a tone indicates the 
participant to touch the same boxes in the same order. The number of boxes in the 
sequence increases from two to nine boxes with three sequences per level. The test 
terminates after failure on all sequences at a particular level. The main working memory 
measure “span length” is the final level at which the subject successfully recalled at 
least one sequence of boxes. A secondary measure was the “number of errors” (boxes 
not in sequence). 
Attention 
The Amsterdam Neuropsychological Tasks (ANT) (De Sonneville 1999) is a 
computerized battery of tests that has been shown to be highly sensitive in detecting 
cognitive deficits in several clinical populations (De Sonneville et al. 2002; Huijbregts 
et al. 2002; Kalff et al. 2005). Focused Attention is a subtest of the ANT in which a 
schematic fruit bowl with pieces of fruit is presented at the centre of a 15-inch computer 
screen. The bowl is oval shaped and the pieces of fruit are located on the top, bottom, 
left and right. There is one target object (apple) and several non-target objects (e.g. pear, 
banana and cherries). In addition, there are two target locations: the vertical locations 
(top and bottom) of the fruit bowl. The participant is instructed only to press a button 
when a target object is presented at a target location. A target presented in a non-target 
location should be ignored and a response suppressed. Stimulus duration is 2000 ms, the 
event rate is 3000 ms, and the valid response window is 200-2300 ms. There are 12 
practice trials and 40 test trials. Of the 40 test trials, 50% are relevant targets at relevant 
locations, 25% are relevant targets at irrelevant locations, and 25% are trials without 
relevant targets. “Number of hits of relevant targets” is the main outcome variable and 
represents the ability to focus attention on the target object at the target locations. 
Inhibition  
A Stop-Signal Task was used as measure of inhibition of a prepotent response (Logan 
1994; Logan & Cowan 1984). The task involves two types of trials: “go” trials and 
Chapter 6 
 70 
“stop” trials presented on a 15-inch computer screen. Go trials start with a fixation cross 
presented at the center of the screen during 500 ms, followed by a cartoon airplane 
pointing either to the left or right for a duration of 1000 ms. The inter-stimulus-interval 
is 500 ms. Participants are instructed to press the button on the right when an airplane is 
pointing to the right and the button on the left when an airplane is pointing to the left. 
Stop trials consist of a go trial and an auditory Stop-Signal presented through 
headphones (1000 Hz, 50 ms, volume adjusted to audible level for each participant). 
Stimuli are presented in blocks of 64 trials, 25% of which are stop trials. To ensure 
familiarity with the paradigm, the task starts with two practice blocks. During the first 
practice block, consisting of go trials only, the instruction is to respond as quickly and 
accurately as possible to the airplanes. In the second practice block, with 25% randomly 
presented stop trials, the instruction is to respond as quickly and accurately as possible 
but to try to suppress a response when a stop-signal is presented. Two practice blocks 
are followed by four test blocks. 
 In this version of the Stop-Signal Task a tracking mechanism varies the 
interval between the go and the stop-signal. The use of a tracking mechanism has 
several theoretical and practical advantages: for instance, it establishes that each 
participant has a 50% chance of response inhibition on stop trials (for more information, 
see: Band et al. 2003). This version of the task is described in further detail by Scheres 
et al. (2003). The dependent variable in the Stop-Signal Task is the “stop-signal reaction 
time” which reflects the latency of the inhibition process and is calculated by 
subtracting the mean time at which the participant is still able to inhibit a response from 
the mean go trial reaction time. 
Control measures 
Information processing 
Baseline Speed from the ANT was used as a simple reaction time measure with minimal 
cognitive demands. Participants are instructed to press a button as quickly as possible 
when a fixation cross at the target location at the center of the screen changes into a 
square. The valid response window is 150-6000 ms, the stimulus disappears after a 
response, and the post-response interval varies randomly between 500 and 2500 ms. 
There are 10 practice trials and 32 test trials for both right and left hand. The outcome 
variable was the average of the simple reaction times for the left and right hand and 
served as a measure of information processing. 
Motor skills 
Finger Tapping from the ANT resembles the classical finger tapping test from the 
Halstead-Reitan Battery (Reitan & Wolfson 1993). Participants are instructed to tap a 
button with their index finger as many times as possible during a certain interval. After 
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the instruction, the test starts with a practice run of 5 seconds followed by a test run of 
13 seconds. Only taps in the last 10 seconds are scored as valid taps. There is a right 
hand and a left hand condition. The outcome measure was the average number of taps 
for the left and the right index finger and served as a measure of simple motor skills. 
Verbal fluency 
The Category Fluency test (Benton  & Hamster 1978) was used to measure verbal 
fluency. This task, which is known to be affected in AD (Henry et al. 2004), was 
included in order to get an indication of whether, and two what extent, a classical 
widely used EF measure is affected in the present sample of AD patients. In this test, 
participants are asked to produce as many words as possible belonging to a specific 
semantic category in a 60 seconds interval. The categories were animals and 
professions, and the dependent variable was the sum of the total correct words for each 
category. When the same item was named more than once, only the first was counted. 
 
 
Table 6.1 Overview of the neuropsychological measures 
Neuropsychological function  Test  Dependent variable 
Planning  Stockings of Cambridge  Number of problems solved in minimum moves 
    Mean number of moves above minimum 
    Mean initial thinking time (s) 
     
Working memory  Spatial Span  Span length 
    Number of errors (boxes not in sequence) 
     
Attention  Focused Attention  Number of hits of relevant targets 
     
Inhibition  Stop Signal Task  Stop signal reaction time (ms) 
     
Information processing  Baseline Speed  Simple reaction time (ms) 
     
Motor skills  Finger Tapping  Number of taps 
     
Fluency  Category Fluency  Number of correct animals and professions 
 
Statistical analysis 
To determine if performance on the computerized EF tests was related to basic 
psychomotor functions, Pearson correlation coefficients were calculated between 
performance measures derived from the EF tasks and basic information processing and 
motor function. Differences between groups were determined in analyses of variance 
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(ANOVAs) or, if appropriate, in analyses of covariance (ANCOVAs), with one-sided 
tests. To compensate for the use of multiple comparisons, a level of significance of .01 
was applied and an alpha from .01 to .05 was considered a trend. Partial eta squared 
effects sizes were calculated and characterized as small, medium or large when 
corresponding with .01, .06 and .14, respectively (Cohen 1977). If a score of a 
participant was missing on a particular variable, the individual was excluded from 
analysis regarding that variable. SPSS Base for Windows Version 12.0 was used for all 
analyses. 
Results 
Pearson correlation coefficients indicated that slower information processing speed was 
significantly associated with lower scores on measures of working memory (r = -.40, p 
< .05) and inhibition (r = .41, p < .05). Therefore, information processing speed was 
entered as covariate in all analyses of the computerized EF measures to ensure that 
group differences were not due to slowed information processing. In addition, there 
appeared to be a significant association between information processing and motor 
skills on one hand and the fluency score on the other hand (r = -.51, p < .01, r = .39, p < 
.05, respectively) and therefore, information processing speed and motor skills were 
controlled for when analyzing differences between groups on the fluency task. Averages 
and statistics of the computerized EF measures and control measures are given in Table 
6.2. 
Group differences on computerized EF measures 
Planning 
The AD patients needed significantly more moves above the minimum necessary to 
solve the problems. In addition, there was a near significant difference between groups 
on the number of problems solved in minimum moves, with lower scores for the AD 
patients. The effect sizes for these differences were both very large. The two groups did 
not differ on mean initial thinking time. 
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Table 6.2 Group means and standard deviations of the neuropsychological measures 
 group   
 AD  NC  ANOVA / ANCOVA 
 M SD  M SD  F df p 2
 
Planning (Stockings of Cambridge)           
   Number of problems solved in minimum moves    4.3     1.5      6.4     2.1  6.4 1,24 .01* .21 
   Mean number of moves above minimum    2.0       .8      1.3       .6  8.9 1,24 .003** .27 
   Mean initial thinking time (s)  17.4   12.2    16.4   12.6    .0 1,24 .50 .00 
Working memory (Spatial Span)           
   Span length    3.8     1.0      4.3       .9  1.0 1,24 .17 .04 
   Number of errors (boxes not in sequence)  12.3     5.6    12.5     5.6    .2 1,24 .33 .01 
Attention (Focused Attention)           
   Number of hits of relevant targets   19.1     1.3    19.9      .3  3.8 1,26 .03* .13 
Inhibition (Stop Signal Task)           
   Stop signal reaction time (ms) 377.6 281.3  266.9 187.5    .6 1,26 .22 .02 
Information processing (Baseline Speed)           
   Simple reaction time (ms) 649.2 355.2  456.7 129.5  4.1 1,29 .05 .13 
Motor skills (Finger Tapping)           
   Number of taps   28.7   12.5    27.6   12.6    .1 1,29 .81 .00 
Fluency (Category Fluency)           
   Number of correct animals and professions  17.8    5.0    27.8     8.2  10.9 1,20 .003** .33 

2 
= (partial) eta squared effect size, ** = statistically significance (p < .01), * = statistical trend (.01  p < .05) 
 
 
Working memory 
No significant differences between the groups were found. 
Attention 
There was a trend for the difference between groups in the number of hits of relevant 
targets with slightly more correct hits for the non-demented elderly. The effect size was 
medium to large. 
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Inhibition 
The two groups did not differ significantly on the stop-signal reaction time, the measure 
of latency of the inhibition process. 
Group differences on the control measures 
Information processing 
Simple reaction times were near significantly slower in the AD group when compared 
with the control group. 
Motor skills 
No significant differences between the groups were observed. 
Fluency 
The correct number of words generated by the normal elderly controls was significantly 
higher and showed a very large effect size. 
Discussion 
The goal of the present study was to administer computerized EF tests in AD which are 
comparable to the tests used by Swainson et al. (2001) and Amieva et al. (2002) in order 
to assess planning and inhibition. In addition, the battery was extended with 
computerized tests of working memory and attention and a group of normal elderly 
controls was included for comparison. 
 The difference between the two groups on one of the three measures of the 
planning task (mean number of moves above the minimum) was significant and near 
significant on another (number of problems solved in minimum moves). In addition, the 
difference between groups on the attention test showed a trend with better scores for the 
normal controls. Group differences on the tests of working memory and inhibition were 
not significant. 
 Swainson et al. (2001) used a modified version of the Stockings of Cambridge, 
in which the participants were asked to calculate how many moves were required to 
match two sets of colored balls and to respond by touching the corresponding number 
on the screen. Their main index of performance (number of attempts to select the 
correct number of moves needed at the 5-move level) is related to the planning 
measures which showed (near) significant differences in the present study. Therefore, 
our results seem to support earlier findings of impaired planning in AD using this task. 
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Normative data of a group of 222 persons between the ages 50 and 69, on the same 
version of the planning task as used in the present study, show slightly higher scores 
(number of problems solved in minimum moves: M = 7.5, SEM = 0.2) when compared 
to our control group, a difference that may be explained by the fact that the average age 
of our control group was much higher. The third measure from the Stockings of 
Cambridge (mean initial thinking time) did not differ between groups and we are not 
aware of any other study reporting this index for AD patients and elderly controls. In a 
study in which frontal lobe patients and normal controls were subject to the same test, 
thinking times did not differ between groups either (Owen et al. 1990). The 26 normal 
controls in that study were much younger (age: M = 44.6, SD = 3.5) and showed shorter 
thinking times (ranging from 3.12 to 11.54 s). The longer thinking times in the present 
study in both the AD group and the control group can very likely be explained by the 
general cognitive slowing which is typical for AD patients as well as for normal elderly 
controls (Salthouse 2000; Storandt & Beaudreau 2004). 
 One study that used a Stop-Signal Task in AD patients reported that the AD 
group did not show significant differences on their main index (number of errors on 
stop-trials) when compared with normal controls (Amieva et al. 2002). However, the 
number of subjects in that study that committed at least one error was significantly 
higher in the AD group and therefore, offers limited evidence that AD patients in an 
early stage of the disease (MMSE: M = 24.6, SD = 1.9) have more problems stopping an 
ongoing motor response than normal elderly controls. Unfortunately, the authors did not 
calculate the stop-signal reaction time, which is the primary measure of the inhibition 
process from the stop-signal paradigm (Logan 1994; Logan & Cowan 1984). In the 
present study we used a version of the Stop-Signal Task with a tracking mechanism 
which allows the participant a 50% chance of successful inhibition on stop trials and 
consequently, makes error analysis unsuitable for group comparisons. Instead, we used 
the stop-signal reaction time, representing the latency of the inhibition process. 
Although we did not detect statistically significant differences between groups, it is 
interesting to note that the mean stop-signal reaction time of the AD group was much 
longer. The absence of group differences could likely be attributed to the large variance 
within the AD group. Whether the Stop-Signal Task can significantly differentiate 
between AD patients and normal controls, awaits investigation with larger groups. 
 Group differences on the measure of focused attention showed a trend and a 
medium to large effect size. Although not significant, this finding is in the same 
direction as reported in the comprehensive review by Perry and Hodges (1999) which 
states that aspects of selective attention (similar to our measure of focused attention) are 
vulnerable to AD. The present findings are in contrast with Nebes and Brady (1989) and 
Lafleche and Albert (1995), however, who reported sparing of focused attention in AD. 
It is noteworthy that the AD patients in the later study were an earlier stage of the 
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disease (MMSE: M = 25.1, SD = 2.4) (Lafleche & Albert 1995) which might explain 
this discrepancy. 
 Scores on the working memory measure did not differ between groups in the 
present study. A study in which the same task from the CANTAB was administered 
showed similar scores (span length: M = 4.0, SD = .4) for 13 AD patients who were in a 
comparable stage of the disease (MMSE: M = 19.2, SD = 1.6) (Lange et al. 1995). 
Normative data from 19 healthy elderly controls show somewhat higher scores than our 
control group (span length: M = 5.0, SD = .9), but taking into account the fact that the 
group in that study was much younger (age: M = 55.9, SD = 5.3) (De Luca et al. 2003), 
we believe that our control group scored within normal limits. Since there is an 
abundance of literature reporting working memory deficits in AD (e.g., Baddeley et al. 
1986; Collette et al. 1999; Collette et al. 1997; Waters & Caplan 2002; White & 
Murphy 1998), it can be argued that working memory is affected in our AD group but 
the task used in the present study is not suitable to detect this deficit. 
 The present study included a rather limited number of participants and 
therefore, additional replication is required. Nevertheless, the current study indicates 
that a battery of computerized EF tests can be used in healthy elderly persons and AD 
patients and partially differentiates between groups. 
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Chapter 7 
Summary and conclusions 
Summary 
Chapter 1 provides an introduction into the prevalence and pathophysiology of 
Alzheimer’s disease (AD). It is argued that decreased neuronal metabolism is the major 
pathological hallmark of AD. The theory of Swaab which states that neuronal 
stimulation may protect neurons against degenerative changes in aging and AD, is 
briefly introduced. One way to stimulate the central nervous system is using peripheral 
electrical nerve stimulation. Several previous studies have examined the effects of 
electrical stimulation in AD and found improvements on cognition, behavior, the rest-
activity rhythm, and the pupillary light reflex. The present thesis examines the effects of 
peripheral electrical stimulation in a substantially larger group of AD patients than any 
other study on this topic to date. 
 For Chapter 2, an extensive literature search was performed in order to review 
the effects of Transcutaneous Electrical Nerve Stimulation (TENS) on non-pain related 
cognitive and behavioral functioning. Eight studies were identified on neglect due to 
stroke, six studies on AD, one study on aging, and two studies on coma due to traumatic 
brain injury. The results of the various studies revealed that TENS has a variety of 
effects. These effects consist of enhanced somatosensory functioning, visuospatial 
abilities, and postural control in neglect as well as improved memory, affective 
behavior, and rest-activity rhythm in AD, and acceleration of awakening in coma. 
Effectiveness of TENS is discussed in relation to various stimulation parameters: 
duration, frequency, pulse width, and intensity. It is argued that arousal may underlie 
the beneficial influence of TENS in various conditions. Finally, suggestions are offered 
for future research. 
 Chapter 3. Since 1990, a series of studies have examined the effects of TENS 
on cognition, behavior, and the rest-activity rhythm of patients suffering from AD. In 
these studies, TENS was aimed at stimulating the dorsal raphe nucleus (DRN) and the 
locus coeruleus (LC) with a combination of low- and high-frequency (2 Hz and 160 Hz, 
respectively), a pulse width of 0.1 ms, and an intensity that provoked muscular twitches. 
TENS was applied 30 minutes a day, five days per week, during a six-week period. For 
the purpose of reliable comparisons between studies, identical stimulation parameters 
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were used in all studies thus far, including the study presented in this thesis. In order to 
optimize TENS treatment in AD, chapter 3 is meant to reconsider the once selected 
stimulation parameters by reviewing the relevant literature published since 1991. The 
results derived from animal experimental studies show that for optimal stimulation of 
the LC and DRN, the pulse width should be more than 0.1 ms.  
 Chapter 4 presents a randomized, placebo-controlled, parallel-group clinical 
trial on the effects of peripheral electrical stimulation on cognition and behavior in a 
group of AD patients that is three times as large as the samples in any earlier study on 
this topic. Participating patients still lived at home and the treatment was applied by a 
family caregiver for 30 minutes a day during six weeks. The majority of the patients and 
the caregivers evaluated the treatment procedure positively and applying the daily 
treatment at home caused minimal burden. Repeated measures analyses of variance 
revealed no effects of the intervention in the experimental group (n = 32) compared 
with the placebo group (n = 30) on any of the cognitive and behavioral outcome 
measures. 
 In Chapter 5 data are presented regarding the effects of peripheral electrical 
stimulation on the rest-activity rhythm from the same study as described in chapter 4. 
Effects on the rest-activity rhythm were assessed using actigraphy. Results show no 
significant effects of electrical stimulation when all participants were analyzed. 
Interestingly, however, post hoc analyses revealed significant effects in a subgroup of 
patients who were not using acetylcholinesterase inhibitors (AChEIs) concomitantly.  
 Chapter 6. Executive functions (EFs) are often impaired early in the course of 
AD. Since EFs play a crucial role in self-care, communicative functioning, and financial 
capacity, and because executive dysfunctions have been linked to increased 
neuropsychiatric symptomatology, evaluation of EFs is essential. In the past decades 
there has been a growing interest in computerized tests of cognitive functions but only a 
limited number of studies employed computerized tests of EFs in AD patients. The goal 
of the present study was to administer computerized EF tests of planning, inhibition, 
working memory, and attention in AD. Sixteen AD patients and seventeen healthy 
elderly controls participated in the study. Results show that the AD patients score 
significantly lower on tests of planning and near significantly lower on attention. 
Differences on the tests of working memory and inhibition were in the expected 
direction but not significant. Although replication with larger groups is required, the 
current study indicates that a battery of computerized EF tests can be used in AD 
patients and healthy elderly persons and partially differentiates between groups. 
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Conclusions 
It is important to acknowledge that the results of this study do not lead to a simple 
general conclusion which states that peripheral electrical nerve stimulation is, or is not, 
an effective symptomatic treatment in AD. Given the complex nature of the disease and 
the restrictions of the present study setup, it would be presumptuous to assume that such 
a general conclusion can be drawn. Yet, the following, more modest, conclusions can be 
formulated:  
1. The vast majority of the patients and the caregivers evaluated the treatment 
procedure positively. Applying the daily treatment at home caused minimal 
burden. This shows that an active role for the family caregiver is feasible in 
symptomatic treatment of a demented relative. 
2. In the study reported in chapters 4 and 5 we did not find significant effects of 
electrical nerve stimulation on the main measures of cognition, behavior, and 
the rest-activity rhythm. The hypothesis that this type of treatment is beneficial 
in AD is not supported by our findings. 
3. Patient characteristics (level of cognitive functioning and age of onset of AD) 
differed between this study and previous studies which could imply that the 
theory that stimulating the central nervous system improves metabolism and 
reactivates impaired neurons, does not hold for AD patients in a more 
advanced stage and/or patients with early-onset AD. Thus, heterogeneity of the 
present sample possibly masked significant treatment effects. 
4. Near significant effects of electrical stimulation on the rest-activity rhythm 
were found, in conjunction with significant results in a subgroup of patients 
that was not using acetylcholinesterase inhibitors (AChEIs) concomitantly. 
 
From these conclusions it is apparent that more research is needed before firm 
conclusions about the general effectiveness or ineffectiveness of peripheral electrical 
nerve stimulation in AD can be drawn. Three recommendations for future investigations 
are of particular importance: 
i. Larger and more homogeneous groups of participants need to be included. In 
this way the issue of heterogeneity of patient groups can be dealt with in more 
detail. 
ii. Refined stimulation parameters, such as a longer pulse width and prolonged 
duration of stimulation, should be applied. This will give more insight into 
effects of treatment with peripheral electrical nerve stimulation. 
iii. More advanced methods, such as brain imaging techniques and computerized 
neuropsychological tests, should be used. Improved outcome measures may 
increase the sensitivity for treatment effects. 
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Nederlandse samenvatting 
Inleiding 
De ziekte van Alzheimer (Alzheimer’s disease: AD) komt voor bij 1% van de mensen 
van 65 jaar en ouder en bij 22% van de mensen van 90 jaar en ouder en is daarmee de 
meest voorkomende oorzaak van dementie. Een steeds voortschrijdende verslechtering 
van de kwaliteit van het hersenweefsel (progressieve neurodegeneratie) veroorzaakt 
algehele achteruitgang van kennis (verminderde cognitie), problemen met activiteiten 
van het dagelijks leven, neuropsychiatrische symptomen, verstoring van het rust-
activiteitritme en slaapproblemen. De zorg voor een patiënt met AD plaatst een enorme 
druk op familieleden en ook de kosten van de ziekte voor de samenleving zijn groot en 
zullen naar verwachting aanzienlijk stijgen ten gevolge van de vergrijzende populatie. 
“Use it or lose it” 
Onderzoek van de laatste decennia toont aan dat afsterven van hersencellen minder is 
dan men eerder aannam en dat niet celdood maar een verminderd functioneren van de 
cel door verlaagde stofwisseling, het cruciale kenmerk is van AD. Tevens zijn er 
aanwijzingen dat verhoogde activiteit van de hersenen – en dus een verhoogde 
stofwisseling – beschermend werkt tegen neurodegeneratie. Deze hypothese staat ook 
wel bekend als “Use it or lose it" (Swaab, 1991). Therapeutische strategieën bij een 
neurodegeneratieve ziekte als AD zouden zich kunnen richten op stimulatie van het 
centraal zenuwstelsel om verder verminderde stofwisseling tegen te gaan en om 
mogelijk gedeactiveerde cellen weer aan te sturen en te reactiveren.  
 Een aantal observaties biedt steun voor de theorie dat stimulatie van het brein 
een positieve werking heeft. Ten eerste blijkt een hogere opleiding en een baan die een 
groter beroep doet op de hersenen een zekere bescherming te bieden tegen de uiting van 
symptomen van de AD. Ten tweede blijken cognitief stimulerende activiteiten (zoals 
regelmatig lezen, spelletjes doen en museumbezoek) de ontwikkeling van dementie 
tegen te gaan. Ten slotte blijkt dat blootstelling aan extra helder licht een positieve 
uitwerking heeft op rust-activiteitritme, cognitie en stemming van ouderen met- en 
zonder dementie. 
Nederlandse samenvatting 
 82 
Elektrische zenuwstimulatie bij AD 
Een andere manier om de hersenen te stimuleren is het toedienen van elektrische 
prikkels op de huid door middel van Transcutane Elektrische Neuro Stimulatie (TENS). 
Perifere zenuwbanen geleiden de prikkels naar de hersenen waar deze inactieve 
hersencellen mogelijk weer reactiveren. Eind jaren negentig zijn in een serie 
placebogecontroleerde studies positieve effecten van deze vorm van zenuwstimulatie 
gevonden bij AD patiënten. Er bleek onder andere verbetering van cognitieve functies 
(zoals het geheugen), het gedrag en het rust-activiteitritme. Hoewel deze bevindingen 
bemoedigend zijn, moeten ze met voorzichtigheid geïnterpreteerd worden omdat de 
groepen deelnemers aan deze studies relatief klein waren: variërend van 6 tot 18. 
Doel van het proefschrift 
Het doel van het huidige proefschrift was om de effecten van elektrische 
zenuwstimulatie te onderzoeken in een groep AD patiënten die aanzienlijk groter is dan 
in de studies tot nu toe.  
Bevindingen 
Hoofdstuk 2 is een literatuuroverzicht van zestien studies die de effecten van 
elektrische zenuwstimulatie op niet-pijngebonden cognitief en gedragsmatig 
functioneren hebben onderzocht. Acht studies worden besproken die de effecten van 
elektrostimulatie onderzochten bij een beroerte, zes studies bij AD en twee studies bij 
coma tengevolge van traumatisch hersenletsel. De studies toonden verscheidene 
effecten van elektrostimulatie. Somatosensorisch functioneren, visuospatiële functies en 
houdingscontrole verbeterden na een beroerte, aspecten van het geheugen, gedrag en 
rust-activiteitritme verbeterden bij AD en bovendien bleken comapatiënten sneller te 
ontwaken uit hun coma. De effectiviteit van TENS wordt in dit hoofdstuk 
bediscussieerd in relatie tot de stimulatieparameters: duur, frequentie, pulsbreedte en 
intensiteit. Wij beargumenteren dat een verhoogde prikkeling, of arousal, ten grondslag 
ligt aan de positieve effecten van TENS bij de verschillende condities. 
 
Hoofdstuk 3. De studies die sinds 1990 zijn uitgevoerd waarin TENS werd toegepast 
bij AD hadden onder andere tot doel twee hersenkernen te stimuleren: de nucleus raphe 
dorsalis en de locus coeruleus. Dit zou bereikt kunnen worden door het toedienen van 
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een combinatie van een lage en een hoge frequentie (respectievelijk 2Hz en 160 Hz), 
een pulsbreedte van 0.1 ms en een intensiteit die kleine motorische contracties laat zien. 
TENS werd in die studies toegediend gedurende 30 minuten per dag, 5 dagen per week, 
6 weken lang. Om de studies goed met elkaar te vergelijken was ervoor gekozen om 
identieke stimulatieparameters te gebruiken. Dit geldt tevens voor de klinische studie 
die in het huidige proefschrift wordt beschreven. Het doel van hoofdstuk 3 is om vast te 
stellen of, in het licht van dierexperimentele studies vanaf 1991, de eerder gekozen 
stimulatieparameters wel optimaal zijn. Resultaten van dierexperimenteel onderzoek 
laten zien dat voor een optimale stimulatie van de bovengenoemde hersenkernen de 
pulsbreedte waarschijnlijk meer dan 0.1 ms moet zijn. 
 
Hoofdstuk 4 betreft een gerandomiseerd, placebogecontroleerd effectonderzoek, waarin 
de effecten van perifere elektrische zenuwstimulatie op cognitie en gedrag worden 
onderzocht bij een groep AD patiënten, die ten minste drie keer zo groot is als de 
eerdere studies op dit gebied. De deelnemers woonden thuis en de 30 minuten durende 
behandeling werd zes weken lang door de partner, of een ander familielid, thuis 
toegepast. De resultaten toonden geen effecten bij de 32 patiënten die behandeld werden 
met elektrische zenuwstimulatie, wanneer deze werden vergeleken met de 30 patiënten 
die een placebobehandeling hadden gekregen. Het is noemenswaardig dat de 
behandeling als positief werd geëvalueerd door het overgrote deel van de deelnemers en 
dat het uitvoeren van de dagelijkse behandeling geen extra belasting veroorzaakte. 
 
In hoofdstuk 5 worden de resultaten van perifere elektrische zenuwstimulatie op het 
rust-activiteitritme gepresenteerd verkregen uit dezelfde studie als beschreven in 
hoofdstuk 4. Effecten op het rust-activiteitritme werden bepaald door gebruik te maken 
van actigrafie (bewegingsmeting door middel van een polsbandje). Bij analyse van de 
gehele groep bleken geen significante resultaten van elektrische zenuwstimulatie. 
Echter, uit verdere analyses bleek dat er wel significante resultaten waren bij patiënten 
die niet tegelijk een acetylcholinesteraseremmer gebruikten (een klasse medicijnen die 
voorgeschreven wordt voor symptomatische behandeling van AD). 
 
Hoofdstuk 6. Executieve functies zijn vaak aangedaan in een vroeg stadium van de AD. 
Omdat EFs een cruciale rol spelen bij zelfverzorging, communicatie en financiële 
vaardigheden en omdat stoornissen in executieve functies in eerdere onderzoeken 
geassocieerd bleken met meer neuropsychiatrische problematiek, is evaluatie van 
executieve functies bij AD patiënten essentieel. In de laatste decennia is er een 
groeiende interesse in gecomputeriseerde tests voor het meten van cognitieve functies, 
maar slechts weinig studies onderzochten de toepassing van gecomputeriseerde tests om 
executieve functies te meten bij AD patiënten. Het doel van het huidige hoofdstuk was 
om een aantal executieve functies (planning, inhibitie, werkgeheugen en aandacht) bij 
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AD patiënten in kaart te brengen gebruik makend van gecomputeriseerde tests. Zestien 
AD patiënten en zeventien gezonde ouderen werkten mee met deze studie. De resultaten 
lieten zien dat de AD patiënten significant slechter scoorden op de planningstaak en er 
bleek een statistische trend voor een groepsverschil op de aandachtstaak. De verschillen 
in werkgeheugen en inhibitie bleken in de verwachte richting, echter niet significant. 
Hoewel replicatie van deze bevindingen in een grotere groep nodig is, laat de huidige 
studie zien dat een batterij gecomputeriseerde tests voor executieve functies gebruikt 
kan worden bij AD patiënten en gezonde ouderen en dat deze batterij gedeeltelijk 
onderscheid kan maken tussen de groepen. 
Conclusies 
Het is van belang te erkennen dat op grond van de resultaten van dit proefschrift geen 
eenvoudige algemene conclusie getrokken kan worden zoals: “perifere zenuwstimulatie 
is wel (of niet) een effectieve symptomatische behandeling voor AD”. Gezien de 
complexe aard van de ziekte en de beperkingen van de huidige studie zou het 
aanmatigend zijn om te veronderstellen dat een dergelijk algemene conclusie nu 
getrokken kan worden. Vooralsnog kunnen de volgende meer bescheiden conclusies 
worden geformuleerd: 
1. Het overgrote deel van de patiënten en hun partners, of andere familieleden, 
rapporteerden dat zij de behandeling als positief hebben ervaren. Dit toont aan 
dat een actieve begeleidende rol van de partner, of een ander persoon uit de 
directe omgeving van de patiënt, mogelijk is. 
2. In de studies die in hoofdstuk 4 en 5 worden beschreven vonden wij geen 
significante resultaten van elektrische zenuwstimulatie op de maten van 
cognitie, gedrag en rust-activiteitritme. De hypothese dat deze vorm van 
behandeling effectief is bij AD wordt door onze bevindingen niet ondersteund. 
3. Kenmerken van de onderzochte patiëntengroep (niveau van cognitief 
functioneren en leeftijd waarop de ziekte zich openbaarde) verschillen 
enigszins tussen de huidige studie en de eerdere studies. Dit zou kunnen 
betekenen dat de theorie die stelt dat stimulatie van het centrale zenuwstelsel 
metabolisme verhoogt en inactieve hersencellen reactiveert, niet geldt voor 
patiënten in een verder gevorderd stadium en/of in het geval dat de ziekte zich 
vroeg in het leven manifesteert. Kortom, heterogeniteit van de onderzochte 
groep kan mogelijk positieve effecten van de behandeling hebben versluierd. 
4. Wij vonden wel effecten van elektrische zenuwstimulatie op het rust-
activiteitritme die naar significantie neigen, evenals significante resultaten bij 
een groep patiënten die niet tegelijk een acetylcholinesteraseremmer gebruikte. 
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Op basis van deze conclusies is het duidelijk dat meer onderzoek nodig is voordat 
robuuste conclusies over de algemene effectiviteit, of ineffectiviteit, van perifere 
elektrische zenuwstimulatie bij AD getrokken kunnen worden. Drie aanbevelingen voor 
toekomstig onderzoek zijn van bijzonder belang: 
i. Grotere en meer homogene subgroepen deelnemers dienen te worden 
onderzocht. Op deze mannier kan het probleem van heterogeniteit van de 
patiëntengroepen beter worden ondervangen. 
ii. Verfijnde stimulatieparameters, zoals langere pulsbreedte en een langere duur 
van de behandeling, moeten worden toegepast. Dit zal meer inzicht geven in de 
effecten van een behandeling met elektrische zenuwstimulatie. 
iii. Geavanceerde onderzoeksmethoden, zoals beeldvormende technieken en 
gecomputeriseerde neuropsychologische tests, moeten worden gebruikt omdat 
verfijnde diagnostiek de sensitiviteit voor behandeleffecten verbetert. 
  86 
 
 
  87 
Dankwoord
Dit proefschrift had ik niet kunnen schrijven zonder inbreng en steun van anderen die ik 
heel graag wil bedanken. Om te beginnen dank ik alle patiënten en hun partners en 
familieleden voor hun tijd, enthousiasme en bereidheid deel te nemen aan de studies.  
 Onmiskenbaar ben ik grote dank verschuldigd aan Erik Scherder. Hij is de 
initiator en stuwende kracht achter dit project en gedurende ruim vier jaren heeft hij als 
mijn promotor en mentor een grote invloed gehad op dit werk en mijn vorming als 
wetenschapper. Philip Scheltens dank ik voor zijn rol als promotor in het tot stand 
komen van dit proefschrift: de waardevolle adviezen tijdens de instroom, de snelle 
revisies tijdens het schrijven en de connectie met het Alzheimer Centrum VUmc. De 
leden van de leescommissie wil ik bedanken voor de tijd die zij hebben besteed aan het 
lezen van het manuscript en voor hun bereidheid deel te nemen aan de oppositie.  
 Meike Holleman bedank ik voor haar bijdrage als co-auteur van hoofdstuk 6 en 
voor haar correcties op de tekst van het gehele proefschrift. Ook ben ik dank 
verschuldigd aan Marijn Luijpen voor de stimulerende gesprekken over ons onderwerp 
en zijn bijdrage aan verschillende hoofdstukken. Joe Sergeant wil ik bedanken voor zijn 
rol als co-auteur, commissie-lid en hoofd van de afdeling Klinische Neuropsychologie 
waar ik ruim vier jaar met veel plezier heb gewerkt. Eus van Someren dank ik voor de 
hulp bij analyse van de actigrafie data en zijn adviezen bij hoofdstuk 5. Sipke Huismans 
wil ik bedanken voor statistische adviezen. Henry Weinstein, bedankt voor de hulp bij 
de werving van deelnemers. Erik van Rossum, alsmede de overige medewerkers van de 
dienst Informatisering Techniek en Media: bedankt voor de onmisbare ondersteuning op 
het gebied van computer programmatuur. Daarnaast wil ik de overige co-auteurs 
bedanken voor hun waardevolle bijdragen. 
 Dank aan de studenten, oud-medestudenten en assistenten die hielpen bij de 
dataverzameling en -verwerking: Annemieke Bakker Arkema, Ineke Dekker, Marijtje 
Godefrooij, Hanneke Godijn - ten Klooster, Chantal Hoekstra, Meike Holleman, Ine 
Konersman, Gijs Lauret, Daniëlle Moraal, Anne-Eva Prick, Marleen Rademaker, 
Marieke Roffels, Annet Timmerman en Sabine Vreeswijk. 
 Ook dank aan Amsterdam Thuiszorg, met name Wies Bos, voor de contacten 
met de thuiswonende patiënten in de regio Amsterdam. Xytron Medical, vooral Hans 
Blankenstijn en Jolanda van Capelle, bedankt voor het kosteloos beschikbaar stellen van 
de elektrostimulatoren. Ook ben ik dank verschuldigd aan de staf en het verplegend en 
verzorgend personeel van het Zorgcentrum Sint Jacob voor hun hulp bij hoofdstuk 6.  
Dankwoord 
 88 
 Ik wil graag ook al mijn (oud) collega’s van de afdeling Klinische 
Neuropsychologie bedanken voor hun interesse, hulp en gezelligheid, in het bijzonder 
mijn kamergenoten op de VU en mede-promovendi Anneke Goudriaan en Katrien van 
Meel. Dank aan het secretariaat en de mede-studenten van de Experimenteel 
Psychologische Onderzoeksschool (EPOS). 
 Eén project heeft het proefschrift niet gehaald: De effecten van 
elektrostimulatie bij gezonde proefpersonen in een fMRI studie. Toch wil ik hier Dirk 
Heslenfeld alvast bedanken voor zijn enthousiasme en tijd die hij heeft gestoken in de 
dataverzameling: wordt vervolgd! 
 Roland Higler, ‘old school’ vriend vanaf de kleuterschool en Jasper 
Nieuwesteeg, oud-studiegenoot en ‘new school’ vriend tijdens tien jaar Amsterdam, 
bedank ik voor het terzijde staan als paranimfen. 
 Ten slotte wil ik mijn familie bedanken, in het bijzonder mijn vader voor de 
inhoudelijke gesprekken en input. Mijn overige vrienden, dank ik voor de steun en de 
afleiding.  
 
Bovenal dank ik mijn vrouw Hülya Kara en dochter Elisa voor hun steun, geduld, 
inspiratie en liefde. 
 
 
 
Amsterdam, juli 2005
  89 
About the author
Koene van Dijk was born on October 23, 1975 in Rotterdam. He obtained a masters 
degree in clinical neuropsychology at the Vrije Universiteit, Amsterdam in 2000. His 
masters’ thesis was based upon research in AIDS dementia at the University of 
California in Los Angeles performed in 2000. From January 2001 until March 2005, he 
was a PhD student at the Experimental Psychological Research School (EPOS) and the 
Department of Clinical Neuropsychology of the Vrije Universiteit, Amsterdam. He will 
join the Department of Psychiatry & Neuropsychology and the Department of 
Neurocognition at the University of Maastricht in the fall of 2005. 
  90 
  91 
References 
A 
Albert MS, Moss MB, Tanzi R, Jones K (2001): Preclinical prediction of AD using 
neuropsychological tests. JINS 7:631-639.  
American Psychiatric Association (1994): Diagnostic and statistical manual of mental 
disorders (4th edition). Washington, DC: American Psychiatric Association.  
Amieva HA, Lafont S, Auriacombe S, Le Carret N, Dartigues JF, Orgogozo JM, 
Fabrigoule C (2002): Inhibitory breakdown and Dementia of the Alzheimer Type: A 
general phenomenon? J Clin Exp Neuropsychol 24:503-516.  
Ancoli-Israel S, Klauber MR, Jones DW, Kripke DF, Martin J, Mason W et al (1997): 
Variations in circadian rhythms of activity, sleep, and light exposure related to dementia 
in nursing-home patients. Sleep 20:18-23.  
Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D, Marcova L (1-15-
1997): Plastic neuronal remodeling is impaired in patients with Alzheimer's disease 
carrying apolipoprotein epsilon 4 allele. J Neurosci 17:516-529.  
Armstrong RA, Myers D, Smith CUM (1993): The Spatial Patterns of Plaques and 
Tangles in Alzheimers-Disease do Not Support the Cascade Hypothesis. Dementia 
4:16-20.  
Ashby P, Verrier M (1976): Neurophysiologic changes in hemiplegia. Possible 
explanation for the initial disparity between muscle tone and tendon reflexes. Neurology 
26:1145-1151.  
Assal F, Cummings JL (2002): Neuropsychiatric symptoms in the dementias. Curr Opin 
Neurol 15:445-450.  
AstonJones G, Bloom FE (1981): Norepinephrine-Containing Locus Coeruleus Neurons 
in Behaving Rats Exhibit Pronounced Responses to Non-Noxious Environmental 
Stimuli. J Neurosci 1:887-900.  
B 
Baddeley A, Logie R, Bressi S, Dellasala S, Spinnler H (1986): Dementia and Working 
Memory. Q J Exp Psychol A 38:603-618.  
Band GPH, van der Molen MW, Logan GD (2003): Horse-race model simulations of 
the stop-signal procedure. Acta Psychol (Amst) 112:105-142.  
References 
 92 
Bayles KA (2003): Effects of working memory deficits on the communicative 
functioning of Alzheimer's dementia patients. J Commun Disord 36:209-219.  
Benton  AL, Hamster KS (1978): Multilingual aphasia ezamination (Manual, revised).: 
Iowa City, IA: University of Iowa.  
Binetti G, Magni E, Padovani A, Cappa SF, Bianchetti A, Trabucchi M (1996): 
Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry 
60:91-93.  
Birks,J, Grimley Evans,J, Iakovidou,V, and Tsolaki,M. Rivastigmine for Alzheimr's 
disease. Art. No: CD001191. The Cochrane Database of Systematic Reviews [Issue 4]. 
2000.  
Birks,JS and Harvey,R. Donepezil for dementia due to Alzheimr's disease. Art. No: 
CD001190. The Cochrane Database of Systematic Reviews [Issue 3]. 2003.  
Blass JP, Gibson GE, Hoyer S (2002): The role of the metabolic lesion in Alzheimer's 
disease. J Alzheimers Dis 4:225-232.  
Blin J, Ivanoiu A, Coppens A, De VA, Labar D, Michel C, Laterre EC (1997): 
Cholinergic neurotransmission has different effects on cerebral glucose consumption 
and blood flow in young normals, aged normals, and Alzheimer's disease patients. 
Neuroimage 6:335-343.  
Bliss TVP, Collingridge GL (1993): A Synaptic Model of Memory - Long-Term 
Potentiation in the Hippocampus. Nature 361:31-39.  
Bobillier P, Seguin S, Petitjean F, Salvert D, Touret M, Jouvet M (1976): The raphe 
nuclei of the cat brain stem: a topographical atlas of their efferent projections as 
revealed by autoradiography. Brain Res 113:449-486.  
Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL (2003): 
Executive dysfunction and apathy predict functional impairment in Alzheimer disease. 
Am J Geriatr Psychiatry 11:214-221.  
Braak H, Braak E (1991b): Neuropathological Staging of Alzheimer-Related Changes. 
Acta Neuropathol (Berl) 82:239-259.  
Braak H, Braak E (1996): Evolution of the neuropathology of Alzheimer's disease. Acta 
Neurol Scand 93:3-12.  
Braak H, Braak E (1991a): Demonstration of amyloid deposits and neurofibrillary 
changes in whole brain sections. Brain Pathol 1:213-216.  
References 
 93 
Brandt J, Rich J. Memory disorders in the dementias. Baddeley, A. D., Wilson, B. A., 
and Watts, F. N. (eds). Handbook of memory disorders.  243-270. 1995. Chichester 
(UK): Wily and Sons.  
Brody H (1992): The aging brain. Acta Neurol Scand Suppl 137:40-44.  
Burke WJ, Houston MJ, Boust SJ, Roccaforte WH (1989): Use of the geriatric 
depression scale in dementia of the Alzheimer type. J Am Geriatr Soc 37:856-860.  
Burstein R, Giesler GJ (1989): Retrograde Labeling of Neurons in Spinal-Cord That 
Project Directly to Nucleus Accumbens Or the Septal Nuclei in the Rat. Brain Res 
497:149-154.  
Butcher JN, Perry JN, Atlis MM (2000): Validity and utility of computer-based test 
interpretation. Psychol Assess 12:6-18.  
C 
Carpenter GA, Grossberg S (1993): Normal and Amnesic Learning, Recognition and 
Memory by A Neural Model of Cortico-Hippocampal Interactions. Trends Neurosci 
16:131-137.  
Carrol EN, Badura AS (2001): Focal intense brief transcutaneous electric nerve 
stimulation for treatment of radicular and postthoracotomy pain. Arch Phys Med 
Rehabil 82:262-264.  
Cedarbaum JM, Aghajanian GK (1978): Activation of Locus Coeruleus Neurons by 
Peripheral Stimuli - Modulation by A Collateral Inhibitory Mechanism. Life Sci 
23:1383-1392.  
Cedazo-Minguez A, Cowburn RF (2001): Apolipoprotein E: a major piece in the 
Alzheimer's disease puzzle. J Cell Mol Med 5:254-266.  
Chen ST, Sultzer DL, Hinkin CH, Mahler ME, Cummings JL (1998): Executive 
dysfunction in Alzheimer's disease: Association with neuropsychiatric symptoms and 
functional impairment. J Neuropsychiatry Clin Neurosci 10:426-432.  
Cheng RSS, Pomeranz B (1981): Mono-Aminergic Mechanism of Electroacupuncture 
Analgesia. Brain Res 215:77-92.  
Chenier MC (1997): Review and analysis of caregiver burden and nursing home 
placement. Geriatr Nurs (Minneap) 18:121-126.  
Cliffer KD, Burstein R, Giesler GJ (1991): Distributions of Spinothalamic, 
Spinohypothalamic, and Spinotelencephalic Fibers Revealed by Anterograde Transport 
of Pha-l in Rats. J Neurosci 11:852-868.  
References 
 94 
Coffey CE, Wilkinson WE, Parashos IA, Soady SAR, Sullivan RJ, Patterson LJ et al 
(1992): Quantitative Cerebral Anatomy of the Aging Human Brain - A Cross-Sectional 
Study Using Magnetic-Resonance-Imaging. Neurology 42:527-536.  
Cohen J (1977): Statistical power analysis for the behavioral sciences. New York: 
Academic Press. 
Cohen, J. (1988): Statistical power analysis for the behavioral sciences. 2nd ed. 
Hillsdale, NJ: Lawrence Earlbaum Associates. 
Coleman PD, Flood DG (1987): Neuron Numbers and Dendritic Extent in Normal 
Aging and Alzheimers-Disease. Neurobiol Aging 8:521-545.  
Collette F, Salmon E, Van der Linden M, Degueldre C, Franck G (1997): Functional 
anatomy of verbal and visuospatial span tasks in Alzheimer's disease. Hum Brain Mapp 
5:110-118.  
Collette F, Van der Linden M, Salmon E (1999): Executive dysfunction in Alzheimer's 
disease. Cortex 35:57-72.  
Collie A, Maruff P (2003): Computerised neuropsychological testing. Br J Sports Med 
37:2-3.  
Cooper JB, Jane JA, Alves WM, Cooper EB (1999): Right median nerve electrical 
stimulation to hasten awakening from coma. Brain Inj 13:261-267.  
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al 
(1993): Gene Dose of Apolipoprotein-e Type-4 Allele and the Risk of Alzheimers-
Disease in Late-Onset Families. Science 261:921-923.  
Cummings JL, Back C (1998): The cholinergic hypothesis of neuropsychiatric 
symptoms in Alzheimer's disease. Am J Geriatr Psychiatry 6:S64-S78.  
Cummings JL, Cole G (2002): Alzheimer disease. JAMA 287:2335-2338.  
Cusumano S, Paolin A, Dipaola F, Boccaletto F, Simini G, Palermo F, Carteri A (1992): 
Assessing Brain-Function in Posttraumatic Coma by Means of Bit-Mapped Seps, 
Baeps, Ct, Spet and Clinical Scores - Prognostic Implications. Electroencephalogr Clin 
Neurophysiol 84:499-514.  
D 
Dai JL, Zhu YH, Li XY, Huang DK, Xu SF (1992): C-Fos Expression During 
Electrocupuncture Analgesia in Rats - An Immunohistochemical Study. Acupunct 
Electrother Res 17:165-176.  
References 
 95 
Davis KD, Taylor SJ, Crawley AP, Wood ML, Mikulis DJ (1997): Functional MRI of 
pain- and attention-related activations in the human cingulate cortex. J Neurophysiol 
77:3370-3380.  
De Jager CA, Milwain E, Budge M (2002): Early detection of isolated memory deficits 
in the elderly: the need for more sensitive neuropsychological tests. Psychol Med 
32:483-491.  
De Jonghe JFM, Goedhart AW, Ooms ME, Kat MG, Kalisvaart KJ, van Ewijk WM, 
Ribbe MW (2003): Negative symptoms in Alzheimer's disease: a confirmatory factor 
analysis. Int J Geriatr Psychiatry 18:748-753.  
De Jonghe JFM, Ooms ME, Ribbe MW (1997): [Short version of the Dutch Behavioral 
Rating Scale for Psychogeriatric Inpatients (GIP-28)]. Tijdschr Gerontol Geriatr 
28:119-123.  
De Luca CR, Wood SJ, Anderson V, Buchanan JA, Proffitt TM, Mahony K, Pantelis C 
(2003): Normative data from the Cantab. I: Development of executive function over the 
lifespan. J Clin Exp Neuropsychol 25:242-254.  
De Sonneville LMJ. Amsterdam Neuropsychlogical Tasks: a computer-aided 
assessment program. Den Brinker, B. P. L. M., Beek, P. J., Brand, A. N., Maarse, S. J., 
and Mulder, L. J. M. (eds). Cognitive ergonomics, clinical assessment and computer-
assisted leanring: Computers in Psychology, Vol. 6.  187-203. 1999.  
De Sonneville LMJ, Boringa JB, Reuling IEW, Lazeron RHC, Ader HJ, Polman CH 
(2002): Information processing characteristics in subtypes of multiple sclerosis. 
Neuropsychologia 40:1751-1765.  
Decarli C, Murphy DGM, Gillette JA, Haxby JV, Teichberg D, Schapiro MB, Horwitz 
B (1994): Lack of Age-Related Differences in Temporal-Lobe Volume of Very 
Healthy-Adults. Am J Neuroradiol 15:689-696.  
Delaere P, He Y, Fayet G, Duyckaerts C, Hauw JJ (1993): Beta-A4 Deposits Are 
Constant in the Brain of the Oldest Old - An Immunocytochemical Study of 20 French 
Centenarians. Neurobiol Aging 14:191-194.  
Dempster AP, Laird NM, Rubin DB (1977): Maximum Likelihood from Incomplete 
Data Via Em Algorithm. J R Stat Soc Ser B Meth 39:1-38.  
Dubelaar EJG, Verwer RWH, Hofman MA, Van Heerikhuize JJ, Ravid R, Swaab DF 
(2004): ApoE epsilon 4 genotype is accompanied by lower metabolic activity in nucleus 
basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size 
of the Golgi apparatus. J Neuropathol Exp Neurol 63:159-169.  
References 
 96 
Duke LM, Kaszniak AW (2000): Executive control functions in degenerative 
dementias: A comparative review. Neuropsychol Rev 10:75-99.  
Duranti R, Pantaleo T, Bellini F (1988): Increase in Muscular Pain Threshold Following 
Low-Frequency High-Intensity Peripheral Conditioning Stimulation in Humans. Brain 
Res 452:66-72.  
Dutar P, Lamour Y, Jobert A (1985): Activation of identified septo-hippocampal 
neurons by noxious peripheral stimulation. Brain Res 328:15-21.  
E 
Earnst KS, Wadley VG, Aldridge TM, Steenwyk AB, Hammond AE, Harrell LE, 
Marson DC (2001): Loss of financial capacity in Alzheimer's disease: The role of 
working memory. Aging Neuropsychol Cogn 8:109-119.  
Eriksson MBE, Sjolund BH, Nielzen S (1979): Long-Term Results of Peripheral 
Conditioning Stimulation As An Analgesic Measure in Chronic Pain. Pain 6:335-347.  
Ezrokhi VL, Zosimovskii VA, Korshunov VA, Markevich VA (1999): Restoration of 
decaying long-term potentiation in the hippocampal formation by stimulation of 
neuromodulatory nuclei in freely moving rats. Neuroscience 88:741-753.  
F 
Facco E, Munari M, Baratto F, Behr AU, Giron GP (1993): Multimodality evoked 
potentials (auditory, somatosensory and motor) in coma. Neurophysiol Clin 23:237-258.  
Fetveit A, Skjerve A, Bjorvatn B (2003): Bright light treatment improves sleep in 
institutionalised elderly - an open trial. Int J Geriatr Psychiatry 18:520-526.  
FlorinLechner SM, Druhan JP, AstonJones G, Valentino RJ (1996): Enhanced 
norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. 
Brain Res 742:89-97.  
Folstein MF, Folstein SE, McHugh PR (1975): "Mini-mental state". A practical method 
for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.  
Font C, MartinezMarcos A, Lanuza E, Hoogland PV, MartinezGarcia F (1997): Septal 
complex of the telencephalon of the lizard Podarcis hispanica .2. Afferent connections. 
J Comp Neurol 383:489-511.  
Foote SL, Bloom FE, AstonJones G (1983): Nucleus Locus Ceruleus - New Evidence of 
Anatomical and Physiological Specificity. Physiol Rev 63:844-914.  
Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ (2002): Paired associate 
performance in the early detection of DAT. JINS 8:58-71.  
References 
 97 
Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, 
Rossor MN (1996): Presymptomatic hippocampal atrophy in Alzheimer's disease - A 
longitudinal MRI study. Brain 119:2001-2007.  
Francis PT, Palmer AM, Snape M, Wilcock GK (1999): The cholinergic hypothesis of 
Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137-147.  
Fratiglioni L, Paillard-Borg S, Winblad B (2004): An active and socially integrated 
lifestyle in late life might protect against dementia. Lancet Neurol 3:343-353.  
G 
Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S (1997): 
An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. 
Alzheimer Dis Assoc Disord 11:S33-S39.  
Gartside SE, Hajos-Korcsok E, Bagdy E, Harsing LG, Sharp T, Hajos M (2000): 
Neurochemical and electrophysiological studies on the functional significance of burst 
firing in serotonergic neurons. Neuroscience 98:295-300.  
Geddes JW, Cotman CW (1991): Plasticity in Alzheimer's disease: too much or not 
enough? Neurobiol Aging 12:330-333.  
Giesler GJ, Katter JT, Dado RJ (1994): Direct Spinal Pathways to the Limbic System 
for Nociceptive Information. Trends Neurosci 17:244-250.  
Giraldo J, Vivas NM, Vila E, Badia A (2002): Assessing the (a)symmetry of 
concentration-effect curves: empirical versus mechanistic models. Pharmacol Ther 
95:21-45.  
Glanz M, Klawansky S, Stason W, Berkey C, Chalmers TC (1996): Functional 
electrostimulation in poststroke rehabilitation: A meta-analysis of the randomized 
controlled trials. Arch Phys Med Rehabil 77:549-553.  
Gomez-Isla  T, Hollister R, West H, Mui S, Growdon JH, Petersen RC et al (1997): 
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. 
Ann Neurol 41:17-24.  
Goudsmit E, Hofman MA, Fliers E, Swaab DF (1990): The Supraoptic and 
Paraventricular Nuclei of the Human Hypothalamus in Relation to Sex, Age and 
Alzheimers-Disease. Neurobiol Aging 11:529-536.  
Groeger JA, Field D, Hammond SM (1999): Measuring memory span. JINS :359-363.  
Guariglia C, Coriale G, Cosentino T, Pizzamiglio L (2000): TENS modulates spatial 
reorientantion in neglect patients. Neuroreport 11:1945-1948.  
References 
 98 
Guariglia C, Lippolis G, Pizzamiglio L (1998): Somatosensory stimulation improves 
imagery disorders in neglect. Cortex 34:233-241.  
Guo Y, Shi X, Uchiyama H, Hasegawa A, Nakagawa Y, Tanaka M, Fukumoto I (2002): 
A study on the rehabilitation of cognitive function and short-term memory in patients 
with Alzheimer's disease using transcutaneous electrical nerve stimulation. Front Med 
Biol Eng 11:237-247.  
H 
Hajos M, Gartside SE, Villa AEP, Sharp T (1995): Evidence for A Repetitive (Burst) 
Firing Pattern in A Subpopulation of 5-Hydroxytryptamine Neurons in the Dorsal and 
Median Raphe Nuclei of the Rat. Neuroscience 69:189-197.  
Hajos M, Sharp T (1996): A 5-hydroxytryptamine lesion markedly reduces the 
incidence of burst-firing dorsal raphe neurones in the rat. Neurosci Lett 204:161-164.  
Hardy J (1992): An Anatomical Cascade Hypothesis for Alzheimers-Disease. Trends 
Neurosci 15:200-201.  
Hardy J, Selkoe DJ (2002): Medicine - The amyloid hypothesis of Alzheimer's disease: 
Progress and problems on the road to therapeutics. Science 297:353-356.  
Haroutunian V, Perl DP, Purohit DP, Marin D, Khan K, Lantz M et al (1998): Regional 
distribution of neuritic plaques in the nondemented elderly and subjects with very mild 
Alzheimer disease. Arch Neurol 55:1185-1191.  
Hart DJ, Craig D, Compton SA, Critchlow S, Kerrigan BM, McIlroy SP, Passmore AR 
(2003): A retrospective study of the behavioural and psychological symptoms of mid 
and late phase Alzheimer's disease. Int J Geriatr Psychiatry 18:1037-1042.  
Hay-Schmidt A, Vrang N, Larsen PJ, Mikkelsen JD (2003): Projections from the raphe 
nuclei to the suprachiasmatic nucleus of the rat. J Chem Neuroanat 25:293-310.  
Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003): Alzheimer disease in 
the US population - Prevalence estimates using the 2000 census. Arch Neurol 60:1119-
1122.  
Henry JD, Crawford JR, Phillips LH (2004): Verbal fluency performance in dementia of 
the Alzheimer's type: a meta-analysis. Neuropsychologia 42:1212-1222.  
Hester RL, Kinsella GJ, Ong B (2004): Effect of age on forward and backward span 
tasks. JINS 10:475-481.  
Hitoto T, Tsuruoka M, Hiruma Y, Matsui Y (1998): A delta afferent fiber stimulation 
activates descending noradrenergic system from the locus coeruleus. Neurochem Res 
23:1461-1465.  
References 
 99 
Ho GJ, Hansen LA, Alford MF, Foster K, Salmon DP, Galasko D et al (2002): Age at 
onset is associated with disease severity in Lewy body variant and Alzheimer's disease. 
Neuroreport 13:1825-1828.  
Holmes D, Teresi J, Weiner A, Monaco C, Ronch J, Vickers R (1990): Impacts 
associated with special care units in long-term care facilities. Gerontologist 30:178-183.  
Hope T, Keene J, Gedling K, Fairburn CG, Jacoby R (1998): Predictors of 
institutionalization for people with dementia living at home with a carer. Int J Geriatr 
Psychiatry 13:682-690.  
Howson DC (1978): Peripheral Neural Excitability - Implications for Trans-Cutaneous 
Electrical Nerve-Stimulation. Phys Ther 58:1467-1473.  
Hozumi S, Hori H, Okawa M, Hishikawa Y, Sato K (1996): Favorable effect of 
transcranial electrostimulation on behavior disorders in elderly patients with dementia: 
A double-blind study. Int J Neurosci 88:1-10.  
Huang YL, Liu RY, Wang QS, Van Someren EJW, Xu H, Zhou JN (2002): Age-
associated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav 
76:597-603.  
Huijbregts SCJ, De Sonneville LMJ, van Spronsen FJ, Licht R, Sergeant JA (2002): The 
neuropsychological profile of early and continuously treated phenylketonuria: orienting, 
vigilance, and maintenance versus manipulation-functions of working memory. 
Neurosci Biobehav Rev 26:697-712.  
I 
Ingvar DH, Ciria MG (1975): Assessment of severe damage to the brain by 
multiregional measurements of cerebral blood flow. Ciba Found Symp :97-120.  
J 
Jean-Louis G, von Gizycki H, Zizi F, Spielman A, Hauri P, Taub H (1997): The 
actigraph data analysis software .1. A novel approach to scoring and interpreting sleep-
wake activity. Percept Mot Skills 85:207-216.  
Johansson BB, Haker E, von Arbin M, Britton M, Langstrom G, Terent A et al (2001): 
Acupuncture and transcutaneous nerve stimulation in stroke rehabilitation - A 
randomized, controlled trial. Stroke 32:707-713.  
Jones BE (2003): Arousal systems. Front Biosci 8:S438-S451.  
Jones BE (2004): Activity, modulation and role of basal forebrain cholinergic neurons 
innervating the cerebral cortex. Prog Brain Res 145:157-169.  
References 
 100 
K 
Kalff AC, De Sonneville LMJ, Hurks PPM, Hendriksen JGM, Kroes M, Feron FJM et 
al (2005): Speed, speed variability, and accuracy of information processing in 5 to 6-
year-old children at risk of ADHD. JINS 11:173-183.  
Kane RL, Kay GG (1992): Computerized Assessment in Neuropsychology - A Review 
of Tests and Test Batteries. Neuropsychol Rev 3:1-117.  
Karnath HO (1995): Transcutaneous Electrical-Stimulation and Vibration of Neck 
Muscles in Neglect. Exp Brain Res 105:321-324.  
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963): Studies of Illness in 
the Aged - the Index of Adl - A Standardized Measure of Biological and Psychosocial 
Function. JAMA 185:914-919.  
Katzman R (1986): Alzheimers-Disease. Trends Neurosci 9:522-525.  
Kawano H, Decker K, Reuss S (1996): Is there a direct retina-raphe-suprachiasmatic 
nucleus pathway in the rat? Neurosci Lett 212:143-146.  
Kayama Y, Koyama Y (1998): Brainstem neural mechanisms of sleep and wakefulness. 
Eur Urol 33:12-15.  
Kesselring A, Krulik T, Bichsel M, Minder C, Beck JC, Stuck AE (2001): Emotional 
and physical demands on caregivers in home care to the elderly in Switzerland and their 
relationship to nursing home admission. Eur J Public Health 11:267-273.  
Kirk RE (1995): Experimental design - procedures for behavioal sciences (3rd edition). 
Pacific Grove, California: Brook/Cole cop.  
Klawansky S, Yeung A, Berkey C, Shah N, Phan H, Chalmers TC (1995): Metaanalysis 
of Randomized Controlled Trials of Cranial Electrostimulation - Efficacy in Treating 
Selected Psychological and Physiological Conditions. J Nerv Ment Dis 183:478-484.  
Klukowski G, Harley CW (1994): Locus-Coeruleus Activation Induces Perforant Path-
Evoked Population Spike Potentiation in the Dentate Gyrus of Awake Rat. Exp Brain 
Res 102:165-170.  
Kobayashi S, Ohashi Y, Ando S (2002): Effects of enriched environments with different 
durations and starting times on learning capacity during aging in rats assessed by a 
refined procedure of the Hebb-Williams maze task. J Neurosci Res 70:340-346.  
Koyama E, Matsubara H, Nakano T (1999): Bright light treatment for sleep-wake 
disturbances in aged individuals with dementia. Psychiatry Clin Neurosci 53:227-229.  
Kramer BJ (1997): Gain in the caregiving experience: where are we? What next? 
Gerontologist 37:218-232.  
References 
 101 
Krout KE, Kawano J, Mettenleiter TC, Loewy AD (2002): CNS inputs to the 
suprachiasmatic nucleus of the rat. Neuroscience 110:73-92.  
Kwan CL, Crawley AP, Mikulis DJ, Davis KD (2000): An fMRI study of the anterior 
cingulate cortex and surrounding medial wall activations evoked by noxious cutaneous 
heat and cold stimuli. Pain 85:359-374.  
Kwon YB, Kang MS, Ahn CJ, Han HJ, Ahn BC, Lee JH (2000): Effect of high or low 
frequency electroacupuncture on the cellular activity of catecholaminergic neurons in 
the brain stem. Acupunct Electrother Res 25:27-36.  
L 
Lafleche G, Albert MS (1995): Executive Function Deficits in Mild Alzheimers-
Disease. Neuropsychology 9:313-320.  
Lam LC, Lui VW, Chiu HF, Chan SS, Tam CW (2004): Executive Function 
Impairment in Community Elderly Subjects with Questionable Dementia. Dement 
Geriatr Cogn Disord 19:86-90.  
Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW (1995): Comparison of 
Executive and Visuospatial Memory Function in Huntingtons-Disease and Dementia of 
Alzheimer-Type Matched for Degree of Dementia. J Neurol Neurosurg Psychiatr 
58:598-606.  
Lautenschlager NT, Almeida OP, Flicker L, Janca A (2004): Can physical activity 
improve the mental health of older adults? Ann Gen Hosp Psychiatry 3:12.  
Lawton MP (1975): The Philadelphia Geriatric Center Morale Scale: a revision. J 
Gerontology 30:85-89.  
Lawton MP, Van Haitsma K, Klapper J (1996): Observed affect in nursing home 
residents with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci 51:3-14.  
Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R (2002): 
Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba 
extract EGb 761 in Alzheimer's disease. Neuropsychobiology 45:19-26.  
Legoratti-Sanchez MO, Guevaraguzman R, Solanoflores LP (1989): 
Electrophysiological Evidences of A Bidirectional Communication Between the Locus 
Coeruleus and the Suprachiasmatic Nucleus. Brain Res Bull 23:283-288.  
Lewinn EB (1980): Coma Arousal Team - Procedures for the Patients Professional 
Attendants and for His Family. R Soc Health J 100:19-21.  
Lezak MD (1995): Neuropsychological Assessment, third edition.: Oxford University 
Press: New York.  
References 
 102 
Lieberman MA, Kramer JH (1991): Factors Affecting Decisions to Institutionalize 
Demented Elderly. Gerontologist 31:371-374.  
Limoge A, Robert C, Stanley TH (1999): Transcutaneous cranial electrical stimulation 
(TCES): A review 1998. Neurosci Biobehav Rev 23:529-538.  
Lindeboom J, Jonker C (1989): Amsterdamse Dementie-Screeningstest (ADS-6) 
Handleiding.: Swets & Zeitlinger B.V., Lisse.  
Linn MW (1988): Physical and Mental Impairment-of-Function Evaluation (PAMIE). 
Psychopharmacol Bull 24:755-757.  
Lisman JE, Otmakhova NA (2001): Storage, recall, and novelty detection of sequences 
by the hippocampus: Elaborating on the SOCRATIC model to account for normal and 
aberrant effects of dopamine. Hippocampus 11:551-568.  
Little RJA, Rubin DB (2002): Statistical analysis with missing data. Second edition. 
Hoboken, N.J.: John Wily and Sons, Inc.  
Liu RY, Zhou JN, Hoogendijk WJG, van Heerikhuize J, Kamphorst W, Unmehopa UA 
et al (2000): Decreased vasopressin gene expression in the biological clock of 
Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol 
59:314-322.  
Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MMB et al (2000): 
Prevalence of dementia and major subtypes in Europe: A collaborative study of 
population-based cohorts. Neurology 54:S4-S9.  
Logan GD. On the Ability to Inhibit Thought and Action: A Users' Guide to the Stop 
Signal Paradigm. Dagenbach, D. and Carr, T. H. (eds). Inhibitory processes in attention, 
memory, and language.  189-239. 1994.  San Diego: Academic Press.  
Logan GD, Cowan WB (1984): On the Ability to Inhibit Thought and Action - A 
Theory of An Act of Control. Psychol Rev 91:295-327.  
Lookingland KJ, Ireland LM, Gunnet JW, Manzanares J, Tian Y, Moore KE (1991): 3-
Methoxy-4-Hydroxyphenylethyleneglycol Concentrations in Discrete Hypothalamic 
Nuclei Reflect the Activity of Noradrenergic Neurons. Brain Res 559:82-88.  
Loy,C and Schneider,L. Galantamine for Alzheimr's disease. Art. No: CD001747. The 
Cochrane Database of Systematic Reviews [Issue 4]. 2004.  
Lucassen PJ, Hofman MA, Swaab DF (1995): Increased Light-Intensity Prevents the 
Age-Related Loss of Vasopressin-Expressing Neurons in the Rat Suprachiasmatic 
Nucleus. Brain Res 693:261-266.  
References 
 103 
Luijpen MW, Scherder EJA, Van Someren EJW, Swaab DF, Sergeant JA (2003): Non-
pharmacological interventions in cognitively impaired and demented patients - A 
comparison with cholinesterase inhibitors. Rev Neurosci 14:343-368.  
Luria AR (1988): The Working Brain: an introduction in neuropsychology. New York: 
Basic Books.  
Lyketsos CG, Veiel LL, Baker A, Steele C (1999): A randomized, controlled trial of 
bright light therapy for agitated behaviors in dementia patients residing in long-term 
care. Int J Geriatr Psychiatry 14:520-525.  
Lyness SA, Zarow C, Chui HC (2003): Neuron loss in key cholinergic and aminergic 
nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 24:1-23.  
M 
Mahoney DF (2003): Vigilance. Evolution and definition for caregivers of family 
members with Alzheimer's disease. J Gerontol Nurs 29:24-30.  
Mann DM, Yates PO, Marcyniuk B (1984): Alzheimer's presenile dementia, senile 
dementia of Alzheimer type and Down's syndrome in middle age form an age related 
continuum of pathological changes. Neuropathol Appl Neurobiol 10:185-207.  
Mann DMA (1983): The Locus Coeruleus and Its Possible Role in Aging and 
Degenerative Disease of the Human Central Nervous-System. Mech Ageing Dev 23:73-
94.  
Martin J, Shochat T, Ancoli-Israel S (2000): Assessment and treatment of sleep 
disturbances in older adults. Clin Psychol Rev 20:783-805.  
McCurry SM, Logsdon RG, Teri L, Gibbons LE, Kukull WA, Bowen JD et al (1999): 
Characteristics of sleep disturbance in community-dwelling Alzheimer's disease 
patients. J Geriatr Psychiatry Neurol 12:53-59.  
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): 
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group 
under the auspices of Department of Health and Human Services Task Force on 
Alzheimer's Disease. Neurology 34:939-944.  
McQuade R, Sharp T (1995): Release of Cerebral 5-Hydroxytryptamine Evoked by 
Electrical-Stimulation of the Dorsal and Median Raphe Nuclei - Effect of A Neurotoxic 
Amphetamine. Neuroscience 68:1079-1088.  
McQuade R, Sharp T (1997): Functional mapping of dorsal and median raphe 5-
hydroxytryptamine pathways in forebrain of the rat using microdialysis. J Neurochem 
69:791-796.  
References 
 104 
Mega MS, Cummings JL, Fiorello T, Gornbein J (1996): The spectrum of behavioral 
changes in Alzheimer's disease. Neurology 46:130-135.  
Middelkoop HAM, Van Dam EM, Smilde-van den Doel DA, van Dijk G (1997): 45-
hour continuous quintuple-site actimetry: Relations between trunk and limb movements 
and effects of circadian sleep-wake rhythmicity. Psychophysiology 34:199-203.  
Milner B (1971): Interhemispheric Differences in Localization of Psychological 
Processes in Man. Br Med Bull 27:272-277  
Mitchell S, Bradley VA, Welch JL, Britton PG (1990): Coma arousal procedure: a 
therapeutic intervention in the treatment of head injury. Brain Inj 4:273-279.  
Moga MM, Moore RY (1997): Organization of neural inputs to the suprachiasmatic 
nucleus in the rat. J Comp Neurol 389:508-534.  
N 
Nakajima K, Uchida S, Suzuki A, Hotta H, Aikawa Y (2003): The effect of walking on 
regional blood flow and acetylcholine in the hippocampus in conscious rats. Auton 
Neurosci 103:83-92.  
Nebes RD, Brady CB (1989): Focused and Divided Attention in Alzheimers-Disease. 
Cortex 25:305-315.  
Neve RL, Robakis NK (1998): Alzheimer's disease: a re-examination of the amyloid 
hypothesis. Trends Neurosci 21:15-19.  
Nudo RJ, Plautz EJ, Frost SB (2001): Role of adaptive plasticity in recovery of function 
after damage to motor cortex. Muscle Nerve 24:1000-1019.  
O 
O'Mahony D, Rowan M, Feely J, Walsh JB, Coakley D (1994): Primary Auditory 
Pathway and Reticular Activating System Dysfunction in Alzheimers-Disease. 
Neurology 44:2089-2094.  
Omura Y (1983): Non-Invasive Circulatory Evaluation and Electro-Acupuncture and 
Tes Treatment of Diseases Difficult to Treat in Western Medicine. Acupunct Electrother 
Res 8:177-255.  
Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990): Planning and 
Spatial Working Memory Following Frontal-Lobe Lesions in Man. Neuropsychologia 
28:1021-1034.  
References 
 105 
P 
Pakkenberg B, Gundersen HJG (1997): Neocortical neuron number in humans: Effect of 
sex and age. J Comp Neurol 384:312-320.  
Pan CX, Morrison RS, Ness J, Fugh-Berman A, Leipzig RM (2000): Complementary 
and alternative medicine in the management of pain, dyspnea, and nausea and vomiting 
near the end of life: A systematic review. J Pain Symptom Manage 20:374-387.  
Pardo JV, Pardo PJ, Janer KW, Raichle ME (1990): The Anterior Cingulate Cortex 
Mediates Processing Selection in the Stroop Attentional Conflict Paradigm. Proc Natl 
Acad Sci U S A 87:256-259.  
Pennington BF, Ozonoff S (1996): Executive functions and developmental 
psychopathology. J Child Psychol Psychiatry 37:51-87.  
Perennou DA, Leblond C, Amblard B, Micallef JP, Herisson C, Pelissier JY (2001): 
Transcutaneous electric nerve stimulation reduces neglect-related postural instability 
after stroke. Arch Phys Med Rehabil 82:440-448.  
Perry RJ, Hodges JR (1999): Attention and executive deficits in Alzheimer's disease - A 
critical review. Brain 122:383-404.  
Petrov T, Krukoff TL, Jhamandas JH (1992): The Hypothalamic Paraventricular and 
Lateral Parabrachial Nuclei Receive Collaterals from Raphe Nucleus Neurons - A 
Combined Double Retrograde and Immunocytochemical Study. J Comp Neurol 318:18-
26.  
Pickard GE (1982): The Afferent Connections of the Suprachiasmatic Nucleus of the 
Golden-Hamster with Emphasis on the Retinohypothalamic Projection. J Comp Neurol 
211:65-83.  
Pierce JP, Lyle DM, Quine S, Evans NJ, Morris J, Fearnside MR (1990): The 
effectiveness of coma arousal intervention. Brain Inj 4:191-197.  
Pinquart M, Sorensen S (2003): Differences between caregivers and noncaregivers in 
psychological health and physical health: a meta-analysis. Psychol Aging 18:250-267.  
Pizzamiglio L, Vallar G, Magnotti L (1996): Transcutaneous electrical stimulation of 
the neck muscles and hemineglect rehabilitation. Restor Neurol Neurosci 10:197-203.  
Pollak CP, Perlick D (1991): Sleep problems and institutionalization of the elderly. J 
Geriatr Psychiatry Neurol 4:204-210.  
Pollak CP, Tryon WW, Nagaraja H, Dzwonczyk R (2001): How accurately does wrist 
actigraphy identify the states of sleep and wakefulness? Sleep 24:957-965.  
Prinz PN (1982): Rem-Sleep and Senile Dementia - Reply. J Am Geriatr Soc 30:422.  
References 
 106 
R 
Rabins PV (1998): The caregiver's role in Alzheimer's disease. Dement Geriatr Cogn 
Disord 9:25-28.  
Rasmussen MJ, Hayes DL, Vlietstra RE, Thorsteinsson G (1988): Can transcutaneous 
electrical nerve stimulation be safely used in patients with permanent cardiac 
pacemakers? Mayo Clin Proc 63:443-445.  
Regeur L, Jensen GB, Pakkenberg H, Evans SM, Pakkenberg B (1994): No Global 
Neocortical Nerve-Cell Loss in Brains from Patients with Senile Dementia of 
Alzheimers Type. Neurobiol Aging 15:347-352.  
Reitan RM, Wolfson D (1993): The Halstead–Reitan Neuropsychological Test Battery: 
Theory and Clinical Interpretation (2nd ed.).: Neuropsychology Press, Tucson, AZ.  
Richard C, Rousseaux M, Honore J (2001): Plantar stimulation can affect subjective 
straight-ahead in neglect patients. Neurosci Lett 301:64-68.  
Ritchie K, Lovestone S (2002): The dementias. Lancet 360:1759-1766.  
Robbins TW, Everitt BJ. Arousal systems and attention. Gazzaniga, M. S., Ivry, R. B., 
and Mangun, G. R. (eds). Cognitive Neurosciences.  703-720. 1995.  
Robertson IH, Mattingley JB, Rorden C, Driver J (1998): Phasic alerting of neglect 
patients overcomes their spatial deficit in visual awareness. Nature 395:169-172.  
Roche PA, Wright A (1990): An investigation into the value of trascutaneous electrical 
nerve stimulation (TENS) for arthritic pain. Physiother Th Pr :25-33.  
Rossor MN. Neurochemical studies in dementia. Iversen, L. L., Iversen, S. D., and 
Snijder, S. H. (eds). Handbook of Psychopharmacology.  107-130. 1988. New York: 
Plenum Press.  
Rouzade-Dominguez ML, Curtis AL, Valentino RJ (2001): Role of Barrington's nucleus 
in the activation of rat locus coeruleus neurons by colonic distension. Brain Res 
917:206-218.  
Rusak B, Zucker I (1979): Neural Regulation of Circadian-Rhythms. Physiol Rev 
59:449-526.  
S 
Sadeh A, Sharkey KM, Carskadon MA (1994): Activity-Based Sleep-Wake 
Identification - An Empirical-Test of Methodological Issues. Sleep 17:201-207.  
Sadik K, Wilcock G (2003): The increasing burden of Alzheimer disease. Alzheimer Dis 
Assoc Disord 17 Suppl 3:S75-S79.  
References 
 107 
Salehi A, Dubelaar EJG, Mulder M, Swaab DF (1998): Aggravated decrease in the 
activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type 
dependent. Proc Natl Acad Sci U S A 95:11445-11449.  
Salehi A, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF (1994): Decreased 
Neuronal-Activity in the Nucleus Basalis of Meynert in Alzheimers-Disease As 
Suggested by the Size of the Golgi-Apparatus. Neuroscience 59:871-880.  
Salehi A, Ravid R, Gonatas NK, Swaab DF (1995): Decreased Activity of 
Hippocampal-Neurons in Alzheimers-Disease Is Not Related to the Presence of 
Neurofibrillary Tangles. J Neuropathol Exp Neurol 54:704-709.  
Salehi A, Swaab DF (1999): Diminished neuronal metabolic activity in Alzheimer's 
disease. J Neural Transm 106:955-986.  
Salthouse TA (2000): Aging and measures of processing speed. Biol Psychol 54:35-54.  
Salzmann E (1992): On the Role of Hippocampus and Parahippocampus Concerning 
Normal and Disturbed Memory Functions. Fortschr Neurol Psychiatr Grenzgeb 
60:163-176.  
Samuelsson H, Hjelmquist EKE, Jensen C, Ekholm S, Blomstrand C (1998): 
Nonlateralized attentional deficits: An important component behind persisting 
visuospatial neglect? J Clin Exp Neuropsychol 20:73-88.  
Saper CB. Chemical neuroanotomy of Alzheimer's disease. Iversen, L. L., Iversen, S. 
D., and Snijder, S. H. (eds). Handbook of Psychopharmacology.  131-156. 1988. New 
York: Plenum Press.  
Saphier D (1991): Paraventricular Nucleus Magnocellular Neuronal Responses 
Following Electrical-Stimulation of the Midbrain Dorsal Raphe. Exp Brain Res 85:359-
363.  
Satlin A, Volicer L, Ross V, Herz L, Campbell S (1992): Bright Light Treatment of 
Behavioral and Sleep Disturbances in Patients with Alzheimers-Disease. Am J 
Psychiatry 149:1028-1032.  
Satlin A, Volicer L, Stopa EG, Harper D (1995): Circadian Locomotor-Activity and 
Core-Body Temperature Rhythms in Alzheimers-Disease. Neurobiol Aging 16:765-771.  
Saunders AM, Strittmatter WJ, Schmechel D, Georgehyslop PHS, Pericakvance MA, 
Joo SH et al (1993): Association of Apolipoprotein-e Allele Epsilon-4 with Late-Onset 
Familial and Sporadic Alzheimers-Disease. Neurology 43:1467-1472.  
Scarpini E, Scheltens P, Feldman H (2003): Treatment of Alzheimer's disease: current 
status and new perspectives. Lancet Neurol 2:539-547.  
References 
 108 
Scherder EJA, Bouma A (1999): Effects of transcutaneous electrical nerve stimulation 
on memory and behavior in Alzheimer's disease may be stage-dependent. Biol 
Psychiatry 45:743-749.  
Scherder EJA, Bouma A, Steen AM (1992): Influence of transcutaneous electrical nerve 
stimulation on memory in patients with dementia of the Alzheimer type. J Clin Exp 
Neuropsychol 14:951-960.  
Scherder EJA, Bouma A, Steen AM (1995): Effects of short-term transcutaneous 
electrical nerve stimulation on memory and affective behaviour in patients with 
probable Alzheimer's disease. Behav Brain Res 67:211-219.  
Scherder EJA, Bouma A, Steen LM (1998): Effects of "isolated" transcutaneous 
electrical nerve stimulation on memory and affective behavior in patients with probable 
Alzheimer's disease. Biol Psychiatry 43:417-424.  
Scherder EJA, Luijpen MW, Van Dijk KRA (2003): Activation of the dorsal raphe 
nucleus and locus coeruleus by transcutaneous electrical nerve stimulation in 
Alzheimer's disease: a reconsideration of stimulation parameters derived from animal 
studies. Chin J Physiol 46:143-150.  
Scherder EJA, Van Someren EJW, Bouma A, van der Berg M (2000): Effects of 
transcutaneous electrical nerve stimulation (TENS) on cognition and behaviour in 
aging. Behav Brain Res 111:223-225.  
Scherder EJA, Van Someren EJW, Swaab DF (1999a): Epilepsy: a possible 
contraindication for transcutaneous electrical nerve stimulation. J Pain Symptom 
Manage 17:152-153.  
Scherder EJA, Van Someren EJW, Swaab DF (1999b): Transcutaneous electrical nerve 
stimulation (TENS) improves the rest-activity rhythm in midstage Alzheimer's disease. 
Behav Brain Res 101:105-107.  
Scheres A, Oosterlaan J, Swanson J, Morein-Zamir S, Meiran N, Schut H et al (2003): 
The effect of methylphenidate on three forms of response inhibition in boys with 
AD/HD. J Abnorm Child Psychol 31:105-120.  
Schulz R, Mendelsohn AB, Haley WE, Mahoney D, Allen RS, Zhang S et al (2003): 
End-of-life care and the effects of bereavement on family caregivers of persons with 
dementia. N Engl J Med 349:1936-1942.  
Schulz R, Newsom J, Mittelmark M, Burton L, Hirsch C, Jackson S (1997): Health 
effects of caregiving: the caregiver health effects study: an ancillary study of the 
Cardiovascular Health Study. Ann Behav Med 19:110-6.  
References 
 109 
Shallice T 1982: Specific Impairments of Planning. Philos Trans R Soc Lond B Biol Sci 
298[1089], 199-209. 1982.  
Siegel J (2004): Brain mechanisms that control sleep and waking. Naturwissenschaften 
91:355-365.  
Sonde L, Kalimo H, Fernaeus SE, Viitanen M (2000): Low TENS treatment on post-
stroke paretic arm: a three-year follow-up. Clin Rehabil 14:14-19.  
Spruytte N, Van Audenhove C, Lammertyn F (2001): Predictors of institutionalization 
of cognitively-impaired elderly cared for by their relatives. Int J Geriatr Psychiatry 
16:1119-1128.  
Standridge JB (2004): Pharmacotherapeutic approaches to the treatment of Alzheimer's 
disease. Clin Ther 26:615-630.  
Stern Y (2002): What is cognitive reserve? Theory and research application of the 
reserve concept. JINS 8:448-460.  
Storandt M, Beaudreau S (2004): Do reaction time measures enhance diagnosis of 
early-stage dementia of the Alzheimer type. Arch Clin Neuropsychol 19:119-124.  
Stroop JP (1935): Studies of interference in serial verbal reactions. J Exp Psychol 
18:646-662.  
Stuss DT, Alexander MP (2000): Executive functions and the frontal lobes: a 
conceptual view. Psychol Res 63:289-298.  
Sutcliffe C, Cordingley L, Burns A, Mozley CG, Bagley H, Huxley P, Challis D (2000): 
A new version of the geriatric depression scale for nursing and residential home 
populations: the geriatric depression scale (residential) (GDS-12R). Int Psychogeriatr 
12:173-181.  
Swaab DF (1991): Brain aging and Alzheimer's disease, "wear and tear" versus "use it 
or lose it". Neurobiol Aging 12:317-324.  
Swaab DF. Neurobiology and neuropathology of the human hypothalamus. Handbook 
of Chemical Neuroanatomy, the Primate Nervous System, Part 1. Vol 13, 39-137. 1997. 
Amsterdam: Elsevier Science. Bloom, F. E., Björklund.A., and Hökfelt, T.  
Swaab DF, Dubelaar EJG, Hofman MA, Scherder EJA, Van Someren EJW, Verwer 
RWH (2002): Brain aging and Alzheimer's disease; use it or lose it. Prog Brain Res 
138:343-373.  
Swaab DF, Dubelaar EJG, Scherder EJA, Van Someren EJW, Verwer RWH (2003): 
Therapeutic strategies for Alzheimer disease - Focus on neuronal reoctivotion of 
metobolicolly impoired neurons. Alzheimer Dis Assoc Disord 17:S114-S122.  
References 
 110 
Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Uylings HBM (1994): Neuronal 
Atrophy, Not Cell-Death, Is the Main Hallmark of Alzheimers-Disease. Neurobiol 
Aging 15:369-371.  
Swaab DF, Lucassen PJ, Salehi A, Scherder EJA, Van Someren EJW, Verwer ARWH 
(1998): Reduced neuronal activity and reactivation in Alzheimer's disease. Prog Brain 
Res 117:343-377.  
Swaab DF, Van Someren EJW, Zhou JN, Hofman MA (1996): Biological rhythms in 
the human life cycle and their relationship to functional changes in the suprachiasmatic 
nucleus. Prog Brain Res 111:349-368.  
Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD et al (2001): Early 
detection and differential diagnosis of Alzheimer's disease and depression with 
neuropsychological tasks. Dement Geriatr Cogn Disord 12:265-280.  
Swanberg MM, Tractenberg RE, Mohs R, Thal LJ, Cummings JL (2004): Executive 
dysfunction in Alzheimer disease. Arch Neurol 61:556-560.  
Swanson LW, Sawchenko PE (1980): Paraventricular Nucleus - A Site for the 
Integration of Neuroendocrine and Autonomic Mechanisms. Neuroendocrinology 
31:410-417.  
T 
Tales A, Troscianko T, Lush D, Haworth J, Wilcock GK, Butler SR (2001): The 
pupillary light reflex in aging and Alzheimer's disease. Aging (Milano) 13:473-478.  
Taylor DN, Lee CT, Katims JJ, Ng LKY (1989): The Effects of Cranial Tens on 
Measures of Autonomic, Somatic and Cognitive Activity. Acupunct Electrother Res 
14:29-42.  
Tien AY, Spevack TV, Jones DW, Pearlson GD, Schlaepfer TE, Strauss ME (1996): 
Computerized Wisconsin Card Sorting Test: comparison with manual administration. 
Kaohsiung J Med Sci 12:479-485.  
Tractenberg RE, Singer CM, Cummings JL, Thal LJ (2003): The Sleep Disorders 
Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's 
disease. J Sleep Res 12:331-337.  
V 
Vallar G, Rusconi ML, Barozzi S, Bernardini B, Ovadia D, Papagno C, Cesarani A 
(1995): Improvement of Left Visuospatial Hemineglect by Left-Sided Transcutaneous 
Electrical-Stimulation. Neuropsychologia 33:73-82.  
References 
 111 
Vallar G, Rusconi ML, Bernardini B (1996): Modulation of neglect hemianesthesia by 
transcutaneous electrical stimulation. JINS 2:452-459.  
Van Dijk KRA, Scherder EJA, Scheltens P, Sergeant JA (2002): Effects of 
transcutaneous electrical nerve stimulation (TENS) on non-pain related cognitive and 
behavioural functioning. Rev Neurosci 13:257-270.  
Van Someren EJW, Hagebeuk EEO, Lijzenga C, Scheltens P, de Rooij SEA, Jonker C 
et al (1996): Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol 
Psychiatry 40:259-270.  
Van Someren EJW, Kessler A, Mirmiran M, Swaab DF (1997): Indirect bright light 
improves circadian rest-activity rhythm disturbances in demented patients. Biol 
Psychiatry 41:955-963.  
Van Someren EJW, Riemersma RF, Swaab DF (2002): Functional plasticity of the 
circadian timing system in old age: light exposure. Prog Brain Res 138:205-231.  
Van Someren EJW, Scherder EJA, Swaab DF (1998): Transcutaneous electrical nerve 
stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease. 
Alzheimer Dis Assoc Disord 12:114-118.  
Velley L, Cardo B, Kempf E, Mormede P, Nassifcaudarella S, Velly J (1991): 
Facilitation of Learning Consecutive to Electrical-Stimulation of the Locus-Ceruleus - 
Cognitive Alteration Or Stress-Reduction. Prog Brain Res 88:555-569.  
Verstraten PFJ, Van Eekelen CWJM (1987): Handleiding voor de GIP: 
Gedragsobervatieschaal voor de intramurale psychogeriatrie.: Van Loghum Slaterus: 
Deventer.  
Vertes RP (1991): A Pha-l Analysis of Ascending Projections of the Dorsal Raphe 
Nucleus in the Rat. J Comp Neurol 313:643-668.  
Vogels OJM, Broere CA, ter Laak HJ, ten Donkelaar HJ, Nieuwenhuys R, Schulte BP 
(1990): Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's 
disease. Neurobiol Aging 11:3-13.  
W 
Waters G, Caplan D (2002): Working memory and online syntactic processing in 
Alzheimer's disease: Studies with auditory moving window presentation. J Gerontol B 
Psychol Sci Soc Sci 57:298-311.  
Wechsler D (1997): Technical manual for the Wechsler Adult Intelligence and Memory 
Scale-Third Edition. New York: The Psychological Corporation.  
Wechsler D (1945): A standardized memory test for clinical use. J Psychol 19:87-95.  
References 
 112 
Weidenfeld J, Newman ME, Itzik A, Gur E, Feldman S (2002): The amygdala regulates 
the pituitary-adrenocortical response and release of hypothalamic serotonin following 
electrical stimulation of the dorsal raphe nucleus in the rat. Neuroendocrinology 76:63-
69.  
West MJ, Coleman PD, Flood DG, Troncoso JC (1994): Differences in the Pattern of 
Hippocampal Neuronal Loss in Normal Aging and Alzheimers-Disease. Lancet 
344:769-772.  
White DA, Murphy CF (1998): Working memory for nonverbal auditory information in 
dementia of the Alzheimer type. Arch Clin Neuropsychol 13:339-347.  
White PF, Li ST, Chiu JW (2001): Electroanalgesia: Its role in acute and chronic pain 
management. Anesth Analg 92:505-513.  
Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982): 
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 
215:1237-1239.  
Wickelgren I (1996): The aging brain - For the cortex, neuron loss may be less than 
thought. Science 273:48-50.  
Wilson MA, Cockburn J, Baddeley AD (1985): The Rivermead Behavioural Memory 
Test.: Reading, England: Thames Valley Test Co.: Gaylord, MI: National Rehabilitation 
Services.  
Wrenn CC, Crawley JN (2001): Pharmacological evidence supporting a role for galanin 
in cognition and affect. Prog Neuropsychopharmacol Biol Psychiatry 25:283-299.  
Wright A, Sluka KA (2001): Nonpharmacological treatments for musculoskeletal pain. 
Clin J Pain 17:33-46.  
Y 
Yamadera H, Ito T, Suzuki H, Asayama K, Ito R, Endo S (2000): Effects of bright light 
on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type 
dementia. Psychiatry Clin Neurosci 54:352-353.  
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1983): 
Development and validation of a geriatric depression screening scale; a preliminary 
report. J Psychiatr Res 17:37-49.  
Z 
Zhu D, Ma Q, Li C, Wang L (2000): Effect of stimulation of shenshu point on the aging 
process of genital system in aged female rats and the role of monoamine 
neurotransmitters. J Tradit Chin Med 20:59-62. 
